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Chapter 1
Tuberculosis (TB) is an infectious disease that is caused by Mycobacterium 
 tuberculosis and spreads from person to person through aerosols produced pri-
marily by coughing. After inhalation of the infectious particles, most people will 
either eradicate the infection, or develop a latent TB infection. Latter persons 
are not sick or infectious and cannot cause further transmission of TB to their 
contacts. Worldwide, it is estimated that one third of the population is latently 
infected by Mycobacterium tuberculosis. Of the latently infected persons, only 5 
to 10% will develop active tuberculosis during their lifetime, with 62% of those 
developing active disease in the first two years and 83% in the first five years 
after infection (8). 
In the Netherlands, 867 new cases of tuberculosis are detected in 2015, ren-
dering the Netherlands a low-incidence country for tuberculosis. After five years, 
with an annual decline of 7%, the year 2015 is the first year an increase was 
detected of 6% due to immigration (64). Perhaps as a result, TB, or the ‘White 
Plaque’ as it was referred to in ancient times, is thought by many citizens, health 
care professionals and policy makers to be a disease of the past. Yet, it is still the 
second most important infectious disease worldwide in terms of its incidence and 
mortality (65). Although the global incidence of tuberculosis seems to decline 
gradually since 2004 according to the surveillance of the WHO, the absolute num-
ber of cases is still increasing owing to the steadily expanding human population. 
Both, the coinfections with HIV and the emergence of resistance to antituber-
culosis drugs contribute to the severe TB burden. The prevalence of HIV among 
TB cases rose from 3.4% in 2008 to 11% in 2015. In the European region, the 
number of patients with multidrug-resistant TB (MDR-TB) increased from 28,000 
in 2009 to almost 120,000 in 2015 (67).
Pan-susceptible TB (i.e. disease by an M. tuberculosis strain susceptible to all 
antituberculosis drugs) can be treated effectively; the success rate among new 
TB cases in 2012 was 75.6% in WHO-region Europe and amounted to 86% in the 
Netherlands. For rifampicin-resistant and multidrug-resistant TB cases, however, 
cure rates in WHO region Europe are generally as low as 46.0%. However, with 
the right strategies and personalized treatment, treatment success can be much 
higher, as shown in our country with a cure rate of 85.6% (1, 63, 66).
In order to control TB it is important to investigate and reduce transmission of 
M. tuberculosis  at national and international level and to identify risk factors for 
active transmission. For this purpose, to study the natural history of tuberculosis 
infections, molecular typing techniques have been developed that can infer the 
genetic distance between M. tuberculosis isolates based on shared DNA profiles, 
or ‘fingerprints’. Since the emergence of molecular typing techniques in the early 
1990s, drug abusers, alcohol abusers, homeless individuals, HIV/AIDS patients, 
ethnic minorities (from high-endemic settings), young males and urban residents 
have been shown to be risk groups for transmission of TB (7, 54). Therefore, 
these risk groups require the highest attention in the epidemiological surveillance.
At a higher level of abstraction, phylogenetic studies can apply these molecu-
lar typing techniques to show the population structure of M. tuberculosis and its 
ongoing evolutionary changes that influence the TB epidemic, such as the emer-
gence of resistance and adaptations to circumvent infection- or vaccine-induced 
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immunity to mycobacterial disease. 
Molecular typing techniques for the M. tuberculosis complex
In the 1980s, pioneers like Collins and De Lisle explored the possibilities to 
use restriction fragment patterns to compare M. tuberculosis in epidemiological 
studies (13). Since then, several DNA fingerprinting methods have been devel-
oped with different levels of reproducibility, stability, discriminatory power and 
demands on technical expertise (28, 32, 44). Initially, insertion sequence (IS) 
6110 restriction fragment length polymorphism (RFLP) and spoligotyping were the 
most widely applied and internationally standardized techniques. In more recent 
years, multiple-locus variable number tandem repeat analysis (MLVA) has been 
developed to address the genetic diversity of medically relevant bacterial species 
as Bacillus anthracis, Yersinia pestis, Salmonella species, Campylobacter species, 
Staphylococcus aureus, as well as Mycobacterium tuberculosis (for which it was 
generally named variable number of tandem repeat or VNTR typing) (4, 35). The 
targets of the M. tuberculosis complex used for the different typing techniques 
and the display of the results were visualized in figure 1.
IS6110 restriction fragment length polymorphism (RFLP) typing (19) has long 
served as the gold standard in typing of individual M. tuberculosis isolates to infer 
chains of human transmission. It became the gold standard because, owing to 
its high level of discrimination (32) and reproducibility, this was the first method 
that proved suitable to study person-to-person transmission at various levels as 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Spoligotyping result: 
MIRU-VNTR typing result: 
IS6110 RFLP typing result: 
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well as phylogeny (48). A drawback of RFLP typing was the high concentration 
of DNA needed, which causes a considerable time delay for the slow growing M. 
tuberculosis bacteria. 
The PCR based “Spoligotyping” (Spacer oligotyping) (29) method overcame 
this time delay and appeared to be a simple tool to study the phylogeny of M. 
tuberculosis and the geographical distribution of genotype families. The technique 
is based on the polymorphism within the CRISPR region of Mycobacterium tuber-
culosis (traditional named Direct Repeat region). An advantage of the relatively 
small fragment targeted is the applicability of this technique to clinical samples, 
with a high sensitivity. The discriminatory power of spoligotyping is generally low 
and one has to be cautious using this method to examine transmission of TB on 
individual case level (31, 62). 
In 1997, variable number of tandem repeat (VNTR) typing for M. tuberculosis 
complex isolates was developed (53). This technique was an improvement over 
IS6110 RFLP because of its standardized procedure, reduction of the hands- on-
time and use of polymerase chain reactions which introduced molecular typing 
with far less DNA input and therefore it gradually replaced IS6110 RFLP (41). In 
2006 24-locus VNTR typing method was proposed as the new international typing 
standard (52). 
The latest development in molecular typing of M. tuberculosis is sequencing 
of the near-complete bacterial genome. Next-generation sequencing techniques 
offer fast and now relatively low-cost visualization of the M. tuberculosis genome. 
These techniques offer an unprecedented high discriminatory power, though their 
interpretation requires specially trained personnel.
Use of DNA fingerprinting to support source case finding and contact 
tracing
One of the most important applications of molecular strain typing is to sup-
port source case finding and contact tracing. The aim of source case finding is to 
find the origin of TB infections, and for contact tracing the aim is to trace persons 
with a recent TB infection. Preventive therapy reduces the chance of a breakdown 
to disease. Clustering of M. tuberculosis isolates on basis of DNA fingerprinting 
contributes to the identification of the time and place of TB infections and thereby 
helps to find persons who may have been exposed to contacts with open TB cases.
All genomes are subject to evolutionary change, also DNA fingerprinting mark-
ers change over time. For a correct interpretation of DNA fingerprinting results it 
is important to take this ongoing change into consideration. It is therefore impor-
tant to determine the rate of change, or the ‘Molecular Clock’ for each marker (5). 
Ideally, at each transmission a minimal change should occur in a DNA fingerprint, 
while the strain profile can still be recognized. In that way, the primary source in 
a chain of transmission can be distinguished from the secondary and subsequent 
sources of spread. If the half-life, the time over which the pattern remains un-
changed, of a molecular typing method is lower than the rate of transmission, the 
strain of the secondary case is not identical to the source and the transmission 
won’t be identified. On the other hand the consequences of a higher half-life are 
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identical typing results – even in epidemiologically unrelated strains - which make 
it impossible to identify the chain of transmission. Therefore the stability of DNA 
fingerprints has been studied extensively (5, 24). 
The half-life of IS6110 RFLP was estimated to be 3-4 years (5). This means 
that on average, half of the strains exhibit a band shift in their IS6110 RFLP in a 
3-4 year period. This interval seems suitable for distinguishing epidemiologically 
related and unrelated isolates and therefore supports the utility of IS6110 RFLP 
typing in epidemiological studies, at least in areas of low TB endemicity and low 
degree of transmission (47, 48, 57). For the stability of VNTR typing in time a 
study in South-Africa, high-incidence geographic area, showed identical typing 
patterns for serial isolates from 98% of the included patients chronically infected 
up to 6 years (42). In addition, a mathematical modelling study performed in the 
United Kingdom confirmed this stability within the timeframe of an outbreak, with 
the conclusion that the VNTR profile is unlikely to change (24). Recent applications 
of whole genome sequencing of M. tuberculosis isolates can, because of its higher 
discriminatory power, elucidate exact transmission chains among patients that are 
clustered by our currently used fingerprinting methods (43). 
Regardless of methodology, one has to bear in mind that identical DNA finger-
prints of isolates do not prove, but only indicate possible transmission between 
the respective patients. Still, the availability of clustering data will increase the 
detection of epidemiological links and thus the visualization of transmission chains 
(33).
Even in settings with well-functioning contact tracing by interviews according 
to the stone-in-the-pond principle (55), DNA fingerprinting surveillance is supe-
rior in tracing epidemiological links, because this technique is not dependent on 
whether patients know or can remember whether they met an epidemiologically 
linked patient (33). Many of the transmissions take place outside of regular con-
tacts and through instant and brief contacts and will not be remembered by the 
persons involved. 
In an effective TB control programme, one should determine the source of 
transmission for all cases. In the study of de Vries et al. in the harbor city of Rot-
terdam in The Netherlands, TB cases were assigned to a transmission classifica-
tion model to determine the place and time of infection (58). First, a transmission 
event, suspected from contact tracing results, may be either confirmed (by identi-
cal fingerprints) or refuted (by different patterns) even before source case finding 
is performed. Second, the addition of DNA fingerprinting to conventional contact 
tracing may indicate unsuspected transmission of tuberculosis at different levels, 
and in some situations it could be used to guide conventional contact tracing. This 
is especially important in countries with low prevalence of tuberculosis, where the 
elimination of TB comes into sight (14, 37, 41, 48). 
In summary, the application of genotyping provides important information on 
TB transmission in a given area and is of added value for the performance of 
conventional epidemiological investigations (45, 59). In addition, the results of 
molecular typing can serve different purposes, the most important of which are 
described below.
16
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Recent transmission versus endogenous reactivation
In low prevalence settings, clustering of cases is strongly age-dependent (61). 
Moreover, clustered cases are more frequently of the same age category (3, 6) 
and this implies that TB transmission in for instance the Netherlands is mainly 
from young to young individuals (6). With the increasing age of TB patients in the 
native population, the chance increases that the disease is due to an endogenous 
reactivation of a remote infection and this is reflected in the almost linear inverse 
correlation between the percentage of clustering cases and age (49, 59). 
This may have important implication for studies on the population structure of 
M. tuberculosis. Cases in the higher age category reflect the population of bacteria 
that circulated in the past, whereas strains isolated from young people reflect the 
ongoing transmission and detail the current population of circulating M. tubercu-
losis strains. Source case finding and contact tracing should be initiated in case of 
proven transmission, while reactivations of old latent infections among the elderly 
are less important for source case finding and contact tracing activities.
The role of exogenous reinfection 
Recurrences of TB after curative treatment are common in high prevalence ar-
eas (57). In such cases it is informative to determine whether these are relapses, 
caused by treatment failures and hence by the same bacteria, or whether they 
are due to exogenous reinfections by new strains. Provided the M. tuberculosis 
isolates of both episodes are available, DNA fingerprinting can distinguish be-
tween relapses and reinfections. This distinction is important, mainly because the 
number of relapses is a reflection of the treatment quality and cases of treatment 
failures are more likely to have acquired drug-resistance. The number of reinfec-
tions shows the effectiveness of the local TB prevention programme.
Cross contaminations
During the process of acquisition of clinical specimens and processing in the 
laboratory many mistakes can occur. For instance, contaminated bronchoscopes 
and incorrectly labeled specimen containers are the first options in the occurrence 
of errors; at the laboratory site sample exchange, cross-contamination between 
samples and administrative mistakes can be the cause of errors.
Regular comparisons of the DNA fingerprints of M. tuberculosis strains isolated 
in a given laboratory is helpful for quality assurance of diagnostic procedures (38) 
and is recommended to decrease the number of false positive diagnosis of TB. If 
within a week time M. tuberculosis strains with the same DNA profile are isolated 
in one laboratory, this is a strong indicator of a possible cross contamination (28). 
Across studies, almost invariably performed in low-prevalence settings, the per-
centage of positive M. tuberculosis cultures associated with cross-contamination 
ranged from 0.9% to 3.5% (39). The consequences of false-positive TB detection 
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should not be underestimated; the patient may be unnecessarily exposed to po-
tentially harmful medication and there is significant cost of unnecessary treatment 
and the activities of healthcare workers. The implementation of VNTR typing con-
tributes to a faster detection of possible laboratory cross-contamination compared 
to the previously used RFLP typing method and this may reduce the impact of a 
false diagnosis of TB (36).
Transmission of resistant TB
The fitness of drug-resistant M. tuberculosis has long been subject of debate. 
In the 1950s,  Gertrud Meissner and her colleagues demonstrated that INH-resis-
tant bacteria were less virulent in a guinea pig model (40). Routine application of 
DNA fingerprinting allowed several groups to study the transmissibility and break-
down to disease in relation to resistance phenotypes and mutations underlying the 
resistance. In the Netherlands it was observed that isoniazid (INH) resistance in 
general is associated with decreased likelihood of transmission followed by break-
down to disease, while strains with a mutation at amino acid 315 of the katG gene 
are as transmissible as susceptible ones (18, 27, 50). This katG 315 mutation was 
also associated with poly resistance and a higher level of INH resistance compared 
to other mutations underlying INH resistance. Similarly, rifampicin-resistant M. 
tuberculosis strains with a S531L mutation in the rpoB gene appeared to have 
maintained the highest level of fitness in comparison to strains with other muta-
tions (21). Consequently, MDR-M. tuberculosis isolates with an amino-acid change 
S315T in the katG gene and a S531L mutation in the rpoB gene (9, 21) most likely 
have the lowest fitness cost and, hence the highest relative transmissibility.
Studies on the distribution of M. tuberculosis genotypes
From the extensive use of several DNA fingerprinting methods, genotype fami-
lies have been described. Genotype families as Beijing, Latin American Mediter-
ranean (LAM), Central-Asian-Strain (CAS), etc. were identified, each with their 
specific geographical distribution and peculiarities. Although IS6110 RFLP and 
VNTR typing can be used to recognize the genotype families to some degree, 
spoligotyping is more robust in identifying the genotypes in the M. tuberculosis 
complex. Most reliable, however, is the use of single nucleotide polymorphisms 
to mark unidirectional changes in the evolutionary development of these bacteria 
(26). Due to its ease and low costs, spoligotyping has been used most extensively 
to examine the distribution of genotype families in many geographic areas and 
a worldwide database of spoligotype patterns is held, comprising 7104 spoligo 
patterns representative of circa 58,000 strains (11, 15). The research on the 
genotype distribution of M. tuberculosis yielded important conclusions regard-
ing the evolutionary development of this bacterium. The possible correlation be-
tween genotypes and other factors like transmissibility, resistance development 
and transmission, and manifestation of the disease is an important research topic 
for which fingerprinting methods are key tools.
18
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Aims and outline of this thesis
Molecular typing studies have improved our understanding of TB epidemiology, 
etiology and the evolution of its causative agents, the M. tuberculosis complex. 
At the start of this PhD study, VNTR typing was becoming established as the new 
gold standard, replacing IS6110 RFLP. Now, close to its completion, whole genome 
sequencing is becoming an established method with the potential to become the 
gold standard in typing.
This thesis describes several aspects of molecular typing of M. tuberculosis. 
We have aimed to improve the laboratory use and outcomes of VNTR typing and 
to assess its discriminatory power. For these goals, we first assessed the repro-
ducibility of VNTR typing, both at the intra- and the interlaboratory level (chapter 
two). Second, we measured the discriminatory power of VNTR typing compared 
to that of the former gold standard, IS6110 RFLP, within the context of the Dutch 
national TB surveillance program (chapter three). Then we sought to further im-
prove the technique of VNTR typing, to improve its performance and the repro-
ducibility and accuracy of its results (chapter four). In chapter five, we studied 
the performance of VNTR typing at the supranational level, as a tool to monitor 
the spread of MDR-TB in the European Union. In the final chapter, chapter six, we 
took a closer look at the dominantly spreading clone of M. tuberculosis with a MDR 
character, as defined by VNTR typing, and performed additional typing by Whole 
Genome Sequencing to examine potential mechanisms underlying its multidrug-
resistance and successful spread.
The general discussion, chapter eight, reviews the results of the different stu-
dies and places them in their current scientific and practical context. 
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ABSTRACT
Although variable-number tandem-repeat (VNTR) typing has gained recogni-
tion as the new standard for the DNA fingerprinting of Mycobacterium tubercu-
losis complex (MTBC) isolates, external quality control programs have not yet 
been developed. Therefore, we organized the first multicenter proficiency study 
on 24-locus VNTR typing. Sets of 30 DNAs of MTBC strains, including 10 duplicate 
DNA samples, were distributed among 37 participating laboratories in 30 different 
countries worldwide.
Twenty-four laboratories used an in-house-adapted method with fragment 
 sizing by gel electrophoresis or an automated DNA analyzer, nine laboratories used 
a commercially available kit, and four laboratories used other methods. The intra- 
and interlaboratory reproducibilities of VNTR typing varied from 0% to 100%, with 
averages of 72% and 60%, respectively. Twenty of the 37 laboratories failed to 
amplify particular VNTR loci; if these missing results were ignored, the number of 
laboratories with 100% interlaboratory reproducibility increased from 1 to 5. The 
average interlaboratory reproducibility of VNTR typing using a commercial kit was 
better (88%) than that of in-house-adapted methods using a DNA analyzer (70%) 
or gel electrophoresis (50%). Eleven laboratories using in-house-adapted manual 
typing or automated typing scored inter- and intralaboratory reproducibilities of 
80% or higher, which suggests that these approaches can be used in a reliable 
way. In conclusion, this first multicenter study has documented the worldwide 
quality of VNTR typing of MTBC strains and highlights the importance of interna-
tional quality control to improve genotyping in the future.
INTRODUCTION
Since the early 1990s, the molecular typing of Mycobacterium tuberculosis 
complex (MTBC) isolates has revealed important novel insights into the epidemiol-
ogy of tuberculosis (TB). In a previous study on the intralaboratory reproducibility 
and discriminatory power of typing methods for MTBC performed in 1999, the ini-
tial and widely applied standardized IS6110 restriction fragment length polymor-
phism (RFLP) typing technique (29) appeared to be highly reproducible and more 
discriminatory than other typing techniques existing at that time (17). Therefore, 
this technique was selected as the standard for the determination of the mole-
cular epidemiology of tuberculosis (17, 29, 30) and, hence, for the study of the 
international transmission of multidrug-resistant TB (MDR-TB) and extensively 
drug-resistant TB (XDR-TB) in Europe (6, 7). However, IS6110 RFLP analysis is 
technically demanding and time-consuming, and interlaboratory comparisons of 
the generated banding patterns remained a challenge.
In recent years, variable-number tandem-repeat (VNTR) typing has become 
the new standard for the typing of MTBC strains (26), because of its short turna-
round time, simplified comparisons of digital results, and applicability to small 
amounts of DNA. VNTR typing of MTBC isolates is a multiple-locus variant-repeat 
analysis (MLVA) (20) based on the variation in the numbers of DNA tandem re-
peats at multiple genomic loci. In its simplest form, each target region is indivi-
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dually amplified by using primers annealing to the flanks of the repeat-containing 
region. The amplicon sizes are determined by electrophoresis on agarose gels in 
comparison to molecular size markers to deduce the number of tandem-repeat 
units present at each locus (11, 19, 21, 22, 25, 28).
In an automated, high-throughput version, the target loci are amplified in 
multi plex PCRs by using fluorescently labeled primers, and the amplicon sizes are 
determined by using a capillary electrophoresis (CE)-based DNA analyzer (1, 4, 
27). Although this approach uses more expensive equipment and reagents, it has 
been found to be more efficient and more accurate for the sizing of amplicons (15) 
than the manual method. Another, less frequently used method for amplicon size 
determinations is based on nondenaturing high-performance liquid chromatogra-
phy (nondHPLC) (8). In all instances, the final result of VNTR typing is a numerical 
code that corresponds to the numbers of repeats in the target locus and serves 
as a fingerprint of the respective MTBC isolate. This simple format facilitates the 
efficient and reliable exchange and comparison of genotyping results both locally 
and worldwide.
Although MLVA methods have been developed for many microorganisms in 
recent years (20), studies regarding the reproducibility of these methods are limi-
ted. To our knowledge, the only multilaboratory validation study performed was 
for MLVA of Shiga toxin-producing Escherichia coli O157 (14). For MTBC isolates, 
two small-scale initial quality control studies were previously performed at the 
Institut Pasteur, Lille, France (IPL), and at the U.S. Centers for Disease Control 
and Prevention (CDC), Atlanta, GA, demonstrating 100% intra- and interlabora-
tory reproducibilities for both agarose gel and automated VNTR typing (24, 27). 
However, no international proficiency study has been organized since the stand-
ardization of the 24-locus VNTR typing method for MTBC isolates in 2006 (26).
In 2009, the European Centre for Disease Prevention and Control (ECDC), 
Stockholm, Sweden, initiated a project, currently outsourced to the Tuberculosis 
Reference Laboratory at the National Institute for Public Health and the Environ-
ment (RIVM), Bilthoven, The Netherlands, on the molecular surveillance of the 
international transmission of MDR-TB and XDR-TB in the European Union. The 
participants of the project agreed to use 24-locus VNTR typing as the standard 
for the typing of MTBC isolates. To test the international intra- and interlaboratory 
reproducibilities of VNTR typing, panels of 30 MTBC DNAs, including 10 blinded 
duplicate DNAs, were sent to 18 of the European laboratories participating in the 
MDR-TB molecular surveillance project and to 19 other laboratories around the 
world. This report describes the results of this proficiency study on the perfor-
mance of VNTR typing and provides recommendations to improve the reprodu-
cibility and comparability of the method.
MATERIALS AND METHODS
Study design. A test panel consisting of M. tuberculosis complex DNAs was 
prepared at the RIVM and distributed among the 37 participating laboratories. 
Laboratories were asked to perform VNTR typing as they were accustomed to and 
to report the VNTR typing results to the RIVM in a numerical format. The RIVM 
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compared the results from each laboratory to those of the reference and reported 
the individual results to each of the laboratories. In a questionnaire, laboratories 
were asked to supply details on the VNTR typing method used. 
Participants. Thirty-seven laboratories in 30 countries participated in this 
quality control study. Twenty-three laboratories were located in Europe, including 
18 participating within the framework of the ECDC funded Molecular Surveillance 
of M/XDR-TB in the European Union project, outsourced to the RIVM. The remain-
ing laboratories were located in Asia (n=4), Oceania (n=1), Africa (n=1), and the 
Americas (n=8) (including North America [n=5]). 
Test panel. The quality control panel was comprised of 30 DNA samples of 
20 MTBC strains: 14 M. tuberculosis strains (including H37Rv) and 1 strain each 
of Mycobacterium bovis, M. bovis BCG, Mycobacterium microti, Mycobacterium 
canettii, Mycobacterium africanum, and Mycobacterium pinnipedii. The selected 
strains have been extensively typed in previous studies on mycobacterial inter-
spersed repetitive-unit (MIRU)-VNTR typing (27) and on comparisons of DNA typ-
ing methods (16, 17) and represent the phylogenetic variety of M. tuberculosis 
complex isolates and allelic ranges of VNTR markers (27). Ten blinded duplicate 
DNA samples of MTBC strains were included: seven M. tuberculosis strains (in-
cluding H37Rv), one M. microti strain, one M. africanum strain, and one M. bovis 
BCG strain. 
DNA was extracted as previously described (17). The DNA concentration was 
measured with the Nanodrop-1000 system (Thermo Scientific, Wilmington, DE). 
For the preparation of all 37 test panels, the DNA samples were diluted to a final 
concentration of 100 ng/µl and divided over 37 batches. The test panels were 
stored at 20°C and shipped at room temperature by courier service. Laboratories 
were asked to dilute the samples by adding molecular-grade water to achieve a 
final concentration of 10 ng/µl.
Reference typing results. The reference results were obtained at the RIVM 
by applying both an in-house VNTR typing method and a commercial kit for VNTR 
typing (GenoScreen, Lille, France). The in-house VNTR method is based on the 
protocol of the MIRU-VNTR typing manual (publicly available from the MIRU- 
VNTRplus website [www.miru-vntrplus.org]) as originally described by Supply et 
al. (26), with the following modifications: the amount of DNA polymerase was 
increased to 0.75 units per multiplex PCR, and the initial concentration of labeled 
primers for locus 2165 and locus 2163b was increased to 8 µM. For both meth-
ods, the amplicon sizes were determined by using the automated ABI 3730 DNA 
analyzer (Applied Biosystems, CA). The results of both methods were in complete 
agreement and were also in complete agreement with results previously obtained 
for these samples (16, 17, 27). Finally, one of the strains included in the panel was 
M. tuberculosis control strain H37Rv, the whole genome of which was sequenced 
previously (3), and the genome-derived numbers of repeats matched exactly with 
those found by VNTR typing at the RIVM.
Data analysis. The results of the participating laboratories were compared to 
those of the reference laboratory, the RIVM, to determine the inter- and intralabo-
ratory reproducibilities. To determine the error rate per VNTR locus, systematic 
errors were excluded because they would have a high impact on this error rate. 
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The assumption for the cutoff value for systematic errors was  >20 errors for an 
individual VNTR locus with identical differences compared to the reference results.
The conditional chi-square test was used to test the homogeneity of the dis-
tribution of errors within a group of participants using the same VNTR method. 
Assuming that the number of errors in a laboratory has a Poisson distribution and 
that this distribution is similar for all laboratories, the conditional distribution of 
the errors among laboratories given the total number of errors is multinomial, 
with the same probability for each participating laboratory. Thus, the null hypoth-
esis can be tested by means of the conditional, exact chi-square test for goodness 
of fit. A mixed-effects Poisson model was used to extricate the potential differ-
ences between the groups of methods from the evident effect of the laboratory on 
the number of errors.
RESULTS
The DNA test panel was subjected to VNTR typing by 37 laboratories in 30 
countries: 34 laboratories analyzed 24 loci (26), 2 laboratories analyzed a subset 
of 15 loci (26), and 1 laboratory typed 14 loci. The laboratories could be divided 
into four groups on the basis of the VNTR typing method used: (i) 15 laboratories 
used an in-house PCR method and determined amplicon sizes by using agarose gel 
electrophoresis, (ii) 9 laboratories used an in-house PCR method and determined 
amplicon sizes by using a CE DNA analyzer, (iii) 9 laboratories used a commercial 
kit and a CE DNA analyzer, and (iv) 4 laboratories used other methods (Table 1). 
Table 1  Methods used to perform 24-locus VNTR typing of M. tuberculosis 
complex and average inter- and intralaboratory reproducibilitiesa
Method for 
VNTR
typing
No. of
participating
laboratories
Avg % reproducibility (range) Typeability 
(%)
Interlaboratory Intralaboratory
In-house PCRb
• Sizing by gel
electrophoresis
15 50 (0–77) 74 (0–100) 97
• Sizing by DNA
analyzer 9 70 (0–100) 73 (10–100) 92
GenoScreen
commercial kit
Sizing by DNA
analyzer
9 88 (50–100) 82 (10–100) 96
Other 4 5 (0–20) 38 38 (0–60) 79
Total for all
methods 37 60 72 93
a Data include missing results as mistakes. The typeability of each method is the average 
percentage of obtained complete VNTR pattern results for the 30 samples of the panel.
b Based on or adapted from methods described previously by Supply et al. (26).
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The alternative methods used by group 4 included the use of PCR reagents 
from Tiangen Biotech (Beijing, China), the performance of VNTR typing based on 
methods described previously by Murase et al. (23), adaptations of the VNTR typ-
ing method based on multiple previously reported methods (2, 12, 18), and the 
use of the Transenomic Wave high-performance liquid chromatography system 
(Transenomic Inc., Omaha, NE) (8). 
The number of missing results as a consequence of an amplification failure 
gives an indication of the typeability of the different methods applied. The per-
centages of complete VNTR patterns reported by the laboratories did not differ 
significantly between the various methods used; these percentages were 97% for 
laboratories using an agarose gel electrophoresis-based in-house method, 92% 
for laboratories using a DNA analyzer-based in-house method, and 96% for labo-
ratories using the commercial kit and a DNA analyzer (Table 1). In contrast, the 
percentage of complete VNTR patterns was lower for those laboratories using 
other methods, 79%. If the typeability is calculated at the locus level, i.e., the 
number of results obtained as a percentage of the total number of loci typed in 
the VNTR typing of the complete set of samples, the locus typeability score is 
obtained. The typeability score for the laboratories that used an in-house PCR 
method and detected the amplicon sizes by gel electrophoresis was 99.8%. For 
the laboratories in which amplicon sizes were analyzed on a DNA analyzer, the 
in-house approach and the commercial approach yielded nearly the same results, 
99.6% and 99.5%, respectively.
Interlaboratory reproducibility. To determine the interlaboratory reproduc-
ibility of VNTR typing, the percentages of the 30 DNA samples for which the 
numbers of repeats were correctly scored for all loci typed in comparison to the 
reference laboratory results were calculated for each of the participating labora-
tories (Fig. 1). Apart from the reference laboratory, only one laboratory yielded a 
complete and fully correct 24-locus VNTR typing result for all 30 samples and thus 
had inter- and intralaboratory reproducibilities of 100%. Eleven laboratories had 
an interlaboratory reproducibility score of 90% or higher, six had a score between 
80% and 90%, five had a score between 70% and 80%, and four had a score 
between 20% and 60%. Nine of the 37 laboratories reported incorrect results for 
all 30 samples. The level of interlaboratory reproducibility was in part decreased 
by the occurrence of incomplete VNTR patterns, i.e., missing results for one or 
more loci in at least one sample. Twenty laboratories reported such incomplete 
VNTR patterns, with missing results for 1 to 9 loci of the set of 24 for one or more 
samples of the panel. If missing results were not interpreted as incorrect results, 
the individual interlaboratory reproducibility of 11 laboratories increased up to 
40% (mean, 12%; range, 3% to 40%), and the total number of laboratories with 
a 100% interlaboratory reproducibility increased from 1 to 5 (Fig. 1).
Intralaboratory reproducibility. The intralaboratory reproducibility of VNTR 
typing was determined for each laboratory by comparing the patterns reported 
for the 10 duplicate DNA samples (Fig. 2). Incomplete patterns were included in 
the calculation; i.e., missing results for a particular locus for both samples of a 
duplicate contributed positively to the intralaboratory reproducibility percentage, 
while a missing result for only one sample of a duplicate contributed negatively to 
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the intralaboratory reproducibility score. Eleven laboratories (reference excluded) 
had identical typing results for all 10 duplicated samples and thus had an in-
tralaboratory reproducibility of 100%. Twelve laboratories had an intralaboratory 
reproducibility of 80% to 90%, and four had an intralaboratory reproducibility of 
60% to 70%. Seven laboratories reported identical typing results for less than 5 
(<50%) of the duplicated samples, including two laboratories that had different 
VNTR patterns for all 10 duplicated samples.
Analysis of incorrect results. Deviations from the standard allele-calling 
system, i.e., the translation of PCR product sizes into repeat numbers, were the 
main cause of systematic errors. Systematic errors were identified for 17 of the 24 
VNTR loci, reported by 1 to 5 laboratories for each of these loci. Among the nine 
laboratories that had an incorrect analysis of all 30 samples, and thus had 0% 
interlaboratory reproducibility, six had incorrect analyses caused by systematic 
errors. The other three laboratories reported random errors. 
In two laboratories, incidents of erroneous sample exchange were detected. 
One laboratory exchanged two samples, and another laboratory tested one sam-
ple twice, leaving another sample untested. The errors due to sample exchange 
were excluded from the error analysis by VNTR locus, as were the complete num-
bers of errors of two laboratories that produced an extremely high number of 
errors (responsible for 24% and 28% of the total not typed or incorrectly typed 
samples, after the exclusion of the systematic errors). The highest number of er-
rors was identified for the locus at genomic position 4052, which was typed incor-
rectly 54 times (15% of all the errors, after the exclusion of the errors mentioned 
above). The error rate for the other VNTR loci ranged from 0% (n=0) for the locus 
at position 154 to 11.5% (n=42) for the locus at position 4156 (Fig. 3). 
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Figure 1 Interlaboratory reproducibility of VNTR typing of 30 M. tuberculosis complex DNA 
samples scored by 36 participating laboratories and the reference laboratory. The black 
bars represent the reproducibility on the basis of VNTR patterns that were completely 
identical to those obtained by the reference laboratory (laboratory 37). The grey bars rep-
resent the cumulative reproducibility when VNTR patterns that contained missing results 
were included but which were identical to those obtained by the reference laboratory when 
not considering the loci with missing results. Most laboratories used 24-locus VNTR typing, 
and three laboratories used either 14 loci (#) or 15 loci (*) for typing.
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Reproducibility by VNTR locus. When the intra- and interlaboratory repro-
ducibilities were analyzed at the level of individual loci instead of the complete 
24-locus VNTR patterns, the average scores for inter- and intralaboratory repro-
ducibility increased from 60% to 92% and from 72% to 96%, respectively. 
To determine the extent of typing errors in the 24-locus VNTR patterns of the 
incorrectly typed samples, the results of the erroneous sample substitutions in 
two laboratories and the missing loci in the results were excluded from the calcu-
lation; this left 31 laboratories for analysis. The average number of incorrect loci 
per strain was calculated for the samples with incorrect VNTR patterns. Thirteen of 
the participating laboratories had an average of one incorrect locus, which means 
that for the incorrectly typed samples, there was on average one locus that was 
different compared to the reference. Six laboratories had on average between 1 
and 2 incorrectly analyzed loci, seven laboratories had between 2 and 4 incor-
rectly analyzed loci, and five laboratories had on average more than 4 incorrectly 
analyzed loci. The latter laboratories, which were identified as the laboratories 
with the highest numbers of errors per strain, all made systematic errors. 
Reproducibility and typeability by method. The different methodologies 
applied in the laboratories impacted the typeability and the intra- and interlabo-
ratory reproducibilities (Table 1). The 15 participants that applied the in-house 
method with amplicon sizing by gel electrophoresis had average inter- and intra-
laboratory reproducibilities of 50% and 74%, respectively, and the 9 laborato-
ries that used an in-house PCR method and determined amplicon sizes with a 
DNA analyzer had scores of 70% and 73%, respectively. The best results were 
obtained by the 9 participants who used a commercial kit and a DNA analyzer, 
88% and 82%, respectively. However, the conditional chi-square test showed that 
none of the groups was homogeneous (P values of <0.001), and certain laborato-
ries had many more errors than other laboratories within the same group, which 
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Figure 2  Intralaboratory reproducibility of VNTR typing of 10 duplicated DNA samples of 
M. tuberculosis scored by 36 participating laboratories and the reference laboratory (labo-
ratory 37). The laboratory numbers correspond to those shown in Fig. 1. Most laboratories 
used 24-locus VNTR typing, and three laboratories used either 14 loci (#) or 15 loci (*) for 
typing.
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raises the question of whether these differences in reproducibility are significant 
or even meaningful. The interlaboratory reproducibility of the methodologies was 
influenced by systematic errors, which were reported by five laboratories that 
used the in-house PCR method with amplicon sizing by gel electrophoresis, by a 
single laboratory that used the in-house method and determination of amplicon 
sizes with a DNA analyzer, and by three laboratories that used other methods. In 
contrast, systematic errors were not detected for the laboratories that used the 
commercial 24-locus VNTR typing kit. 
The typeability score represents the ability of a method to deliver a typing 
result, without considering the quality of this result. The typeability score for the 
complete VNTR patterns was higher for laboratories that applied the in-house 
method with amplicon sizing by gel electrophoresis and the laboratories that used 
the commercial VNTR kit; with these approaches, on average, 97% and 96% of 
all samples, respectively, yielded a complete typing pattern. Laboratories that 
used an in-house PCR method and determined amplicon sizes with a DNA analyzer 
scored 92%, and laboratories that used other methods scored only 79%.
DISCUSSION
This is the first multicenter proficiency study of 24-locus VNTR typing of M. tu-
berculosis complex strains after its standardization in 2006. Initial tests conducted 
early in the development of this technique, with bilaterally exchanged blinded 
reference samples, demonstrated that VNTR typing was highly reproducible for a 
limited number of experienced laboratories at both the intra- and interlaboratory 
0
10
20
30
40
50
60
70
80
Er
ro
rs 
(n
)
Locus (genome position no.)
Errors Missing results
Figure 3  Distribution of detected errors by locus in the 24-locus VNTR panel calculated 
on the basis of the results of typing of 30 M. tuberculosis complex DNA samples by 35 
laboratories (excluding laboratories 2 and 5, the systematic errors, and the two incidents 
of sample exchange described in detail in the text). Among the errors, wrong results and 
missing results were distinguished.
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levels (5, 16, 17, 24, 27). However, our study showed that many laboratories 
were not able to perform 24-locus VNTR typing in agreement with the reference. 
In fact, our study demonstrates that the reproducibility of 24-locus VNTR typing 
as it is currently applied is limited, with an average interlaboratory reproducibility 
of 60% (range, 0% to 100%) and an average intralaboratory reproducibility of 
72% (range, 0% to 100%). Errors were caused by systematic deviations from the 
standard allele-calling system (i.e., rules for translating PCR product sizes into re-
peat numbers), the challenging amplification of some VNTR loci, and nontechnical 
issues such as sample exchange and incorrect software use. Appropriate analysis, 
corrections of the problems encountered, good laboratory practice, and further 
standardization are essential for the reliable use of this technique to study the 
molecular epidemiology of TB at local and international levels.
Nontechnical errors. Two incidents of sample exchanges reduced the inter- 
and intralaboratory reproducibility scores for the two respective laboratories sub-
stantially. Mistakes also occurred while managing the results with the frequently 
used Excel software program (Microsoft Co., Redmond, WA). Systematic labeling 
and handling of samples during all stages of the VNTR typing technique as well as 
schemes for data management should be incorporated into protocols to minimize 
these nontechnical errors. 
Allele-calling errors. Systematic deviations from the standard allele-calling 
system were the cause of 51% of all errors (including the missing results as sys-
tematic errors on the locus level) detected in this study, and this has significantly 
reduced the interlaboratory reproducibility measured in this proficiency study. The 
use of alternative PCR primer sequences by some groups (e.g., as described pre-
viously by Le Fleche et al. (19)) can also affect allele calling based on amplicon 
sizes. The use of nonstandard allele-calling systems is a general issue in VNTR 
typing. This problem could be solved by the standardization of the allele calling 
tables between user laboratories. The use of standard allele-calling tables and 
primers (e.g., publicly available from the MIRU-VNTRplus website [www.miru-
vntrplus.org]) establishes an unequivocal correspondence between an amplicon 
size calculated by electrophoresis on agarose gels and a conventional repeat unit 
number for these loci. The calibration of CE-based DNA analyzers with allelic lad-
ders included in the commercial kit or the use of reference samples enables the 
integration of the standard allele calling information for subsequent semiauto-
mated allele-calling specialized software. In addition, both calibration methods 
correct CE specific effects, i.e., determine the relative migration between the size 
standard and the PCR products, depending on the VNTR loci and alleles, and dif-
fer by polymers used for capillary electrophoresis and between instruments (1, 
26). To ensure compliance with the standard allele-calling system, the inclusion 
of reference strains in each run enables first-line quality control of amplicon size 
interpretations.
VNTR typing method. The highest reproducibility on average was obtained 
by the participants using the CE-based commercial kit, followed by laboratories 
using in-house-adapted CE-based typing, those using gel-based analysis, and, 
lastly, those using other methods. Analysis of amplicon sizes by gel electrophore-
sis is inexpensive and simple but requires a high degree of organization and good 
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laboratory practices, as each sample requires the individual amplification of 24 
loci, separate analysis on gels, and, finally, manual interpretation and data base 
management. Another factor that presumably negatively influenced the perfor-
mances of the gel-based VNTR typing method is the lower level of accuracy of 
allele sizing on gels, especially for larger PCR fragments. This factor can partly 
account for the larger proportion of (single- or more-repeat) errors observed for 
the locus at position 4052, having the largest repeat unit size (111 bp (26)) and 
therefore generating some of the largest allele sizes among the 24 loci (approxi-
mately 700 to 1,000 bp in this panel). Six laboratories were able to achieve an 
interlaboratory reproducibility of 80% or higher by using manual typing, suggest-
ing that the challenges are not inherent to the VNTR typing method and can be 
addressed by use of appropriate quality control and quality assurance measures. 
However, the conditional chi-square test showed that none of the groups of 
methods was homogeneous (P values of <0.001). Since each laboratory belonged 
to a single group of methods, the observed differences in reproducibility could 
very well be due to the laboratories. As an attempt to extricate the potential ef-
fects of methods from the effects of the laboratory, we have fitted a mixed effects 
Poisson model to the data, in which the number of errors is modeled in terms of 
method and locus and each laboratory contributes a random effect. The model’s 
estimates yielded no significant effect of the method (P values of 0.179 and 0.362 
for the effects of both in-house methods over the reference commercial method) 
and suggest that the differences between the three methods are due mainly to the 
laboratories using them. In particular, the estimates of the random effects reflect 
the excessive numbers of errors observed for certain laboratories very well. Note, 
however, that this lack of evidence for differences between the choices of method 
may, as usual, be due to the actual differences being relatively small and, hence, 
should not be taken as a positive statement of “no difference.” The typeability, i.e., 
the ability to report a complete VNTR pattern, was slightly better in laboratories 
that used gel electrophoresis for the detection of amplicon sizes than in those that 
used a CE DNA analyzer. This may be explained by differences in the PCR proto-
cols used to amplify the VNTR loci. The in-house methods with gel electrophoresis 
detection used monoplex PCRs, which have an advantage over multiplex PCRs 
used in combination with a CE DNA analyzer. For multiplex PCR systems, some 
loci may not be amplified as efficiently as others because of amplification compe-
tition; the amplification of relatively large targets in combination with relatively 
small targets can be particularly challenging and can be the cause of unamplified 
loci. The use of monoplex PCRs with the VNTR typing method will improve the 
amplification efficiency. Therefore, we recommend that laboratories that use CE 
DNA analyzers to estimate fragment sizes should repeat the amplification of a 
particular locus with a monoplex PCR in cases of missing loci to either determine 
the size of the amplicon or confirm the missing results.
The typeability of VNTR typing, as measured in this study, was negatively influ-
enced by the incorporation of an M. canettii isolate in the DNA panel. For instance, 
15 of 37 participating laboratories were not able to amplify the VNTR locus at po-
sition 4052 of the respective DNA sample. This can be explained by the presence 
of single nucleotide polymorphisms (SNPs) in the primer regions of M. canettii 
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isolates (P. Supply et al., unpublished data). M. canettii isolates display exceptio-
nally large and therefore more challenging alleles in other loci (e.g., VNTR loci at 
positions 802 and 2165 are also associated with typeability and/or reproducibility 
problems) (9, 10, 13). As M. canettii strains are found very rarely outside East 
Africa (9, 10, 31), the problems regarding VNTR typing are not likely to have an 
impact on the monitoring of the transmission of TB in other areas of the world. 
If considered at the level of individual loci instead of complete 24-locus geno-
types, the average inter- and intralaboratory reproducibilities increased from 60% 
to 92% and from 72% to 96%, respectively. However, any mistake in a single 
locus will finally generate an incorrect 24-locus VNTR typing pattern. Translated 
into the main objective of typing, namely, the accurate DNA fingerprinting of M. 
tuberculosis isolates for the detection of TB transmission and bacterial population 
diversity in a certain area, such individual-locus mistakes would lead to the incor-
rect confirmation or exclusion of an epidemiological link. Therefore, from a public 
health perspective, reproducibility must thus be considered at the full 24-locus 
genotype level.
The results of this study cast doubt on the validity of some of the data for VNTR 
typing reported previously. Therefore, we recommend that each laboratory that 
obtained unsatisfactory results in this proficiency study should retype part of their 
previously typed isolates with an improved procedure to evaluate the reliability of 
earlier studies. Moreover, this study underlines the importance of first-, second-, 
and third-line quality control of DNA fingerprint methods in general and of MLVA 
methods in particular. The very low reproducibility scores for some of the labora-
tories in our study of the reproducibility of VNTR typing of M. tuberculosis complex 
isolates should prompt the development of proficiency schemes for MLVA of other 
microorganisms (20). 
In summary, the results of this proficiency study suggest that the use of the 
commercial kit will provide optimal levels of VNTR typing reproducibility and type-
ability. This evaluation proved useful in detecting systematic and incidental  errors 
that reduced the reproducibility of in-house-adapted typing. In fact, 11 laborato-
ries that used in-house-adapted manual typing or automated typing scored  inter- 
and intralaboratory reproducibilities of 80% or higher, which suggests that these 
approaches can be used in a reliable way, provided that minimal standard con-
ditions are followed. Based on the information collected in this study, the main 
observation is the importance of incorporating appropriate quality control and 
quality assurance measures into protocols for genotyping methods. Continuous 
improvements of protocols, based on experiences shared by the laboratories in 
the typing network, will be made available at the RIVM Tuberculosis Reference 
Laboratory website (www.tuberculosis.rivm.nl). After the introduction of the sug-
gested improvement in the methodology, it is expected that VNTR typing will 
become more reliable in most laboratories. To investigate this, a second round of 
proficiency studies will be arranged shortly.
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Global studies on the molecular epidemiology 
of tuberculosis require standardization and 
quality control within stimulating networks
 
Reply to “Evaluation of Mycobacterial Inter-
spersed Repetitive-Unit–Variable-Number 
Tandem-Repeat Genotyping as Performed 
in Laboratories in Canada, France, and the 
 United States”
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Cited from “Evaluation of Mycobacterial Interspersed Repetitive-Unit–Variable-
Number  Tandem Repeat Genotyping as Performed in Laboratories in Canada, 
France, and the United  States”  by Lauren S. Cowan, Delaina P. Hooks, Sara 
Christianson, Meenu K. Sharma, David C. Alexander, Jennifer L. Guthrie,  Frances 
B. Jamieson, Philip Supply, Caroline Allix-Béguec, Laura Cruz Ed Desmond, Re-
becca Kramer, Sonia Lugo and James Rudrik (Journal of Clinical Microbiology, 
2012; 50:1830-1831): The external quality assessment studies conducted by de 
Beer et al. will doubtlessly contribute to improving the reliability of this technique. 
This initial study provided a beneficial learning experience for all involved, and 
the recommendations made will likely improve the typeability of strains in our 
laboratories. The future of MIRU-VNTR proficiency testing is uncertain, and the 
development of test panels is complicated and involves many variables. The first 
two panels were limited to high-quality DNA, which simplifies distribution, but 
routine genotyping is typically performed with crude lysates prepared by heat or 
mechanical disruption. The panels have also included rare and challenging alleles, 
which provide an excellent opportunity to test a protocol but might not reflect the 
quality of results generated on a routine basis.
With great interest we have taken notice of the letter of Cowan et al. (2). 
Indeed, the very high degree in worldwide standardization in typing of Myco-
bacterium tuberculosis is unique compared to the variety of techniques used for 
typing of other bacteria. However, the quality of this variable number of tandem 
repeat (VNTR) typing has hardly been studied in the international context. Thanks 
to the enthusiastic participation of 37 laboratories worldwide, the first external 
quality assessment has been conducted within the framework of an ECDC project 
on the molecular surveillance of MDR/XDR-TB in the European Union (1). The 
main purpose of the initiation of this proficiency study was to identify the flaws in 
VNTR typing in international laboratories worldwide and indeed multiple structural 
aberrations were observed. This provided laboratories the opportunity to identify 
important problems in the use of the locally adapted typing technique. 
In the letter of Cowan et al. our study was described as; “a beneficial learn-
ing experience which will likely improve the typeability”. We like to add to these 
positive comments that this first proficiency study indeed revealed that global 
standardization of a molecular typing technique can even not be done without a 
proper quality control.
The 24-loci VNTR typing of M. tuberculosis complex strains was proposed as 
the new gold standard in 2006 (5). The initial multi-center proficiency study in 
2009, however, demonstrated that the reproducibility was limited. With an aver-
age inter-laboratory reproducibility of 60% (range 0-100%) and intra-laboratory 
reproducibility of 72% (range 0-100%), we realized not all details of the tech-
nique had been worked out sufficiently and the interpretation of the protocols was 
not unambiguous.
We do agree that the outcome of an external quality assessment is highly de-
pendent on the selection of strains. Indeed, the inclusion of one Mycobacterium 
canettii isolate in the first panel may be questioned as these bacteria  are rarely 
encountered outside East-Africa (3, 4). However, if only strains are included with-
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out difficulties in typing all laboratories will score 100%, but we do not learn any-
thing. In contrast, if strains with a higher degree of difficulties are included, the 
true performance of individual laboratories becomes visible. Nevertheless, for the 
already performed and analyzed second round of quality control panel we selected 
samples to focus on specific problems in VNTR typing, e.g. double alleles and high 
number of repeats.
Another issue, not yet addressed in the quality control, is the sensitivity of 
VNTR to the quality of DNA of the Mycobacterium samples. The DNA samples so 
far used in the proficiency studies were of a high purity. To challenge the partici-
pating laboratories and reflect the daily routine more accurately, the future panels 
should also contain samples with lower quantity and quality of DNA.    
The participating laboratories perform VNTR typing with a significant variation 
in methodologies; some use a commercial test, while others explore in-house 
approaches. The determination of PCR fragment lengths is done by gel-electro-
phoresis or sophisticated capillary electrophoresis (CE)-based DNA analyzers. In 
addition, the laboratories have different degrees in experience with typing tech-
niques. In order to produce reliable typing data in all parts of the world that allow 
a meaningful interpretation by local and international health authorities, qual-
ity control within  networks on molecular epidemiology remain highly important. 
Thanks to the active role of European networks since the early 1990s, the molecu-
lar typing techniques were already standardized from their early development on. 
Within the framework of an ECDC project, the VNTR typing (5) has now become 
the new standard. To consolidate this unique degree of standardization and ensure 
the quality in the molecular epidemiology of one of the most important infectious 
diseases, an active network with a central coordination needs to be preserved. 
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ABSTRACT
Background: The quality of variable number of tandem repeats (VNTR) typ-
ing of Mycobacterium tuberculosis was first investigated in 2009 in 37 laboratories 
worldwide. The results revealed an inter and intra-laboratory reproducibility of 
respectively 60% and 72%. These data spurred an improvement in laboratory-
specific assays and global standardisation of VNTR typing.
Objective: To measure the effects of the technical improvements and in-
creased standardisation, a test panel consisting of 30 M. tuberculosis complex 
DNA samples was distributed for VNTR typing in 41 participating laboratories from 
36 countries.
Results: The inter- and intra-laboratory reproducibility increased overall to 
 respectively 78% and 88%. The 33 laboratories that participated in both the first 
and second proficiency studies improved their inter- and intra-laboratory repro-
ducibility from 62% and 72% to respectively 79% and 88%. The largest im-
provement in reproducibility was detected in 10 laboratories that use an in-house 
polymerase chain reaction technique and perform amplicon sizing using gel elec-
trophoresis. Detailed error analysis revealed a reduction in the number of system-
atic errors, sample exchange events and non-amplifiable loci.
Conclusion: This second worldwide proficiency study indicates a substantial 
increase in the reproducibility of VNTR typing of M. tuberculosis. This will contrib-
ute to a more meaningful interpretation of molecular epidemiological and phylo-
genetic studies on the M. tuberculosis complex.
INTRODUCTION
Since its introduction as the new standard for typing Mycobacterium tubercu-
losis complex (1), variable number of tandem repeats (VNTR) typing has been 
implemented in laboratories all over the world. Its worldwide use not only allows 
tracking of tuberculosis (TB) transmission to facilitate public health interventions, 
it also offers the possibility to study the structure of the M. tuberculosis popula-
tionin different areas of the world.
In 2009, the European Centre for Disease Prevention and Control (ECDC), 
Stockholm, Sweden, initiated a project on the molecular surveillance of interna-
tional transmission of multidrug-resistant (MDR-TB) and extensively drug-resistant 
TB (XDR-TB) in the European Union, and outsourced this to the Tuberculosis Ref-
erence Laboratory at the National Institute for Public Health and the Environment, 
Bilthoven, the Netherlands (RIVM). Given its short turnaround time, technical 
simplicity and the numeric data format that allows easy inter-laboratory exchange 
and comparison of data, the VNTR technique was selected to study the interna-
tional transmission of MDR- and XDR-TB in the European Union (2,3). Within the 
framework of this project, the first worldwide proficiency study on VNTR typing of 
M. tuberculosis was organised by the RIVM (4). The study disclosed limited inter- 
and intra-laboratory reproducibility at a significant number of laboratories, which 
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questions the validity of some of the previously published VNTR typing data.
In particular, incidental and systematic errors in the techniques used by indi-
vidual laboratories were highlighted. For example, some laboratories used non-
standard rules and tables for calling of alleles based on amplicon sizes, while 
other laboratories used non-optimal conditions for sizing these polymerase chain 
reaction (PCR) products, introducing deviations, especially for large amplicons in-
dicating alleles with a large number of tandem repeats. After these types of struc-
tural errors had been identified, the techniques were rapidly adjusted. To evaluate 
whether these adjustments had resulted in an improvement in the quality of VNTR 
typing, we initiated a second proficiency study involving 25 laboratories in the 
European Union and 16 elsewhere in the world.
This paper describes the findings of this second proficiency study on VNTR typ-
ing in comparison to the first quality-control study.
MATERIALS AND METHODS
Study design: Similarly to the first proficiency study in 2009, a test panel 
consisting of 30 M. tuberculosis complex DNA samples was distributed among 
the 41 participating laboratories in 2010. Additional information was collected on 
the details of the VNTR methods performed in each laboratory. As all strains were 
anonymous and no human subject was involved, ethics approval was not required 
for this study. 
Participants: Forty-one laboratories, including the RIVM reference laboratory, 
participated in the second proficiency test on VNTR typing; 33 laboratories were 
participating for the second time. Eighteen laboratories were participants in the 
RIVM/ECDC project on the molecular surveillance of MDR-TB in the European Un-
ion; an additional seven European laboratories and 16 laboratories from other 
parts of the world were also included. 
Test panel: The quality-control panel distributed comprised 30 DNA samples 
of 20 M. tuberculosis complex strains that were different from those in the first 
study. Ten samples were included in duplicate. Of all selected strains, 19 were de-
termined as M. tuberculosis and one as M. bovis bacille Calmette-Guérin. A DNA 
sample of the M. tuberculosis control strain H37Rv was also added as a known 
positive control. This positive control was not part of the proficiency test panel.
The strains were selected at the RIVM on the basis of their wide variation in the 
number of repeats at the 24 loci analysed using VNTR typing. For the validation of 
intra-laboratory reproducibility, 10 duplicates were included in the set of 30 DNA 
samples in a blinded manner. One particular sample, which contained two alleles 
in one of the 24 loci, was included in the panel in duplicate to test the ability to 
detect and call double alleles. The DNA concentration of the samples was 100  ng/
μl. The enclosed instructions requested the participating laboratories to dilute the 
samples by adding molecular grade water to achieve a final concentration of 10 
52
Chapter 2.3
ng/μl. 
Data analysis: Data analysis for this second proficiency panel was identical 
to that of the first proficiency panel (4). The results collected from the participat-
ing laboratories were compared to the reference to determine inter- and intra-
laboratory reproducibility. The reference was set starting with the results of the 
reference laboratory and taking the results of other laboratories into account. 
Reproducibility was determined both overall (i.e., by including all the participating 
laboratories), and with respect to the different laboratory methodologies used. 
The performance of laboratories that participated in both the previous and current 
proficiency studies was analysed separately to evaluate the improvement in qual-
ity between both studies in a consistent manner. 
To determine the error rate per VNTR locus and to avoid redundant recording 
of the same single error in the methodology, systematic errors were excluded and 
considered separately. The assumption for the cut-off value for systematic errors 
was >20 errors for an individual VNTR locus with identical deviations from the 
reference results in a participating laboratory. The number of incorrectly typed 
loci was analysed and divided into four categories of errors: incorrectly reported 
double alleles, undetected double allele, missing allele and a group of incorrect 
repeat counts caused by undefined errors. 
Methods of VNTR typing:  For the analysis, VNTR typing methods were divi-
ded into four groups: the in-house method based on and/or adapted from Supply 
et al. (1), in which PCR product lengths are determined 1) using gel electrophore-
sis, or 2) by automated capillary electrophoresis (i.e., DNA analyser); 3) methods 
 using the commercially available 24-loci VNTR kit from GenoScreen (Lille, France) 
to analyse PCR products on a DNA analyser, and 4) in-house methods based on 
publications or methodologies other than those mentioned for Groups 1 and 2.
RESULTS
Of the 41 laboratories that participated in the second proficiency study, 1 re-
ported 12-locus VNTR patterns, 4 reported 15-locus patterns and 36 laboratories 
performed internationally standardised 24-locus-based VNTR typing. The average 
interlaboratory reproducibility, i.e., the percentage of the 30 DNA samples for 
which the correct number of repeats was scored at all 24 (15 or 12) loci, was 78% 
(range 0–100%). Two laboratories had an incorrect analysis of all 30 samples due 
to systematic errors. 
The intra-laboratory reproducibility analysis was based on the 10 DNA dupli-
cates included in a blinded manner in the panel of samples. Twenty-seven labo-
ratories (66%), including the reference laboratory, were able to produce identical 
VNTR patterns for all 10 duplicated samples and reached a score of 100%. The 
average intra-laboratory reproducibility score was 88% (range 0–100). In total, 
14 laboratories had an incorrect analysis of at least one of the 10 duplicate sam-
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ples, while two laboratories had errors for all 10.
Due to the regular occurrence of double alleles in routine diagnostic genotyping 
practice, one strain with a known double allele was included twice in the panel. 
For this analysis, we excluded the results from the two laboratories that reported 
completely incorrect results for all 30 samples because of systematic errors in 
interpretation. Five laboratories mistakenly reported double alleles for 2 to 7 loci 
for samples that did not contain such alleles. Conversely, the one double allele 
present in the panel was missed both in the sample concerned and in its duplicate 
by 12 laboratories. In addition, the double allele was missed in only one of these 
two samples by two laboratories. The remaining errors were incorrectly reported-
numbers of repeats by 26 laboratories. Overall, 11 laboratories reported no result 
for one or more loci in the panel. Errors in relation to the loci.
If systematic errors, missing results and errors related to double alleles are 
taken into account, the total number of generic errors amounted to 291 in the 
results of 26 laboratories. The number of such errors varied depending on the 
individual loci included in the 24-locus VNTR typing set. The distribution of these 
errors is represented in Figure 1.
Results in relation to the method applied: The commercially available kit 
(GenoScreen) yielded an intra-laboratory reproducibility of 86% (range 3–100) 
and an inter-laboratory reproducibility of 92% (range 0–100). One deviating labo-
ratory performed very poorly in this method group, scoring 3% and 0%, respec-
tively, for intra- and inter-laboratory reproducibility. 
In comparison, the second and third best group, namely the in-house methods 
Figure 1  Distribution of detected errors in the 24-locus VNTR panel calculated on the 
basis of the results of typing of 30 M. tuberculosis complex DNA samples by 39 laborato-
ries. Systematic errors, missing results and errors related to double alleles were exclu ded. 
VNTR = variable number of tandem repeats.
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for amplification with automated and gel-electrophoresis analysis of PCR prod-
ucts, obtained intra-laboratory reproducibility of 73% (range 0–100) and 74% 
(range 0–100), and inter-laboratory reproducibility of 89% (range 50–100) and 
82% (range 0–100), respectively (Table). Some (n=6) laboratories performed 
very poorly in these groups, scoring 0 and 0–50% for intra- and inter-laboratory 
reproducibility, respectively. 
The seven laboratories that scored 100% for both inter- and intra-reproduci-
bility were distributed throughout the three following categories: commercial kit 
method (n=4), in-house with automated analysis method (n=2) and in-house with 
the gel electrophoresis approach (n=1). The two laboratories using other methods 
obtained scores with a wide variation for inter-laboratory reproducibility (37% and 
Figure 2 A) Inter-laboratory reproducibility of VNTR typing of 30 M. tuberculosis complex 
DNA samples scored by 33 participating laboratories in 2009 and 2010. Most laboratories 
used 24-locus VNTR typing, two laboratories used 15-loci (*) for typing. 
B) The percentage increase and decrease of inter-laboratory reproducibility of QC 2010 
compared to QC 2009 for the 33 participating laboratories. Most laboratories (31/33) used 
24-locus VNTR typing, two laboratories used 15-loci (*) for typing. VNTR = variable num-
ber of tandem repeats; QC = quality control.
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2.393%); however, both achieved a 100% score for intra-laboratory reproducibility. 
Results, 2009 vs. 2010: The results of the current second proficiency study 
were compared with those obtained in the first proficiency study in 2009, taking 
the 33 laboratories that participated in both studies into consideration. Except for 
one (laboratory number 40), the laboratories used the same method in both pro-
ficiency studies. The comparison of the individual interlaboratory reproducibility 
between both proficiency studies is shown in Figure 2A. 
The average inter- and intra-laboratory reproducibility increased substantially 
for the 33 laboratories that participated in both proficiency studies, from 62% 
to 79% and from 72% to 88%, respectively. The inter-laboratory reproducibility 
score for the proficiency study in 2010 compared to the score in 2009 showed an 
improvement in the results of 25 laboratories and a decline in the quality of six 
laboratories. The overall scores in 2009 and 2010 are compared by method in 
Figure 2B.
Excluding the ‘other methods’ group due to its small size and heterogeneity, 
the largest improvement in inter-laboratory reproducibility was detected in the 
group of laboratories that used an in-house PCR method and performed product 
sizing using gel electrophoresis, with an increase from 45% to 76% (Figure 3A). 
An increase in inter-laboratory reproducibility was observed for 10 laboratories in 
this group, by 45% on average, while one laboratory showed a decrease of 30% 
and another scored identical results in both studies. The group of laboratories that 
used an in-house PCR method and determined PCR product lengths using auto-
mated capillary electrophoresis (i.e., DNA analyser) showed the largest improve-
ment in intra-laboratory reproducibility (Figure 3B).
Table 1   Inter- and intra-laboratory reproducibility of methods used to perform 
VNTR typing of M. tuberculosis
VNTR typing method
Participating
laboratories
n
Inter-laboratory
reproducibility
mean % (range)
Intra-laboratory
reproducibility
mean % (range)
In-house PCR, based on 
Supply et al.(1)
Detection using gel elec-
trophoresis
15 74 (0–100) 82 (0–100)
Detection using DNA 
analyser
10 73 (0–100) 89 (50–100)
Commercial kit, GenoScreen 14 86 (3–100) 92 (0–100)
Other 2 65 (37–93) 100
VNTR = variable number of tandem repeats; PCR = polymerase chain reaction.
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DISCUSSION
Annual proficiency testing of VNTR typing of M. tuberculosis is an important 
and effective tool to improve typing performance. In this second proficiency study 
on VNTR typing, the average inter- and intra-laboratory reproducibility in the 
41 participating laboratories was 78% (range 0–100) and 88% (range 0–100), 
respec tively. For the 33 laboratories that participated in both proficiency stud-
ies, the average inter- and intra-laboratory reproducibility increased from 62% to 
79% and from 72% to 88%, respectively.
A major factor that contributed to improved inter and intra-laboratory repro-
ducibility was the specific improvement and standardisation in the analysis us-
ing gel electrophoresis. The 12 laboratories in this group increased their average 
 inter- and intralaboratory reproducibility scores from 42% to 76% and from 69% 
to 83%, respectively. The first report on the quality of VNTR typing mentioned 
that ‘the use of gel electrophoresis for the detection of fragment lengths appeared 
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Figure 3 A) The average inter-laboratory reproducibility of VNTR typing scored by 33 par-
ticipating laboratories in 2009 and 2010 by laboratory methodology. 
B) The average intra-laboratory reproducibility of VNTR typing scored by 33 participating 
laboratories in 2009 and 2010 by laboratory methodology. Comm. = Commercial kit; VNTR 
= variable number of tandem repeats.
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far less accurate than the analysis on automated DNA sequencers’ (4). The sec-
ond proficiency study, however, shows that the quality of the results obtained in 
gel-based analysis is now closer to that obtained with PCR product sizing using 
capillary electrophoresis by commercial or in-house methods (76% vs. 84% and 
79% for inter- and 83% vs. 92% and 90% for intra-laboratory reproducibility). 
Although initial studies showed that gel-based analysis can be highly reliable (5, 
6), it apparently takes some time to acquire the skills and experience to perform 
reliable VNTR typing using gel electrophoresis. 
A second factor that played a significant role in the improvement of the results 
from the two proficiency studies was the reduction in the number of systematic 
errors. Our analysis of the results of the second proficiency study brought to light 
only four systematic errors, one by one laboratory and three by another. This 
thus represents the most important improvement compared to the 38 systematic 
errors detected for nine laboratories in the previous study (4). In the second pro-
ficiency study, a more specific kind of error was noticed in the analysis of locus 
2461 (synonym: ETR-B), with a total of 12 errors restricted to four laboratories 
using the commercial kit. For these laboratories, a deviation of 0.5 repeat (re-
ported as an ‘s’ allele) from the regular allele 6 in this locus was observed three 
times for exactly the same samples in the panel. This problem, due to the calibra-
tion of the DNA analyser, has now been corrected by recalibration performed by all 
the laboratories using a newer version of the commercial kit (P. Supply, personal 
communication). 
A third factor that contributed positively to the increase in reproducibility was 
not specifically associated with VNTR typing techniques: sample exchange events, 
which occurred twice in the first proficiency study, were not detected in the second 
study, suggesting an improvement in good laboratory practices in the laboratories 
concerned. 
The fourth factor that played a positive role in the improvement of the results 
is the reduction in the total number of locus amplification failures (from 72 in 19 
laboratories to 52 in 10 laboratories, excluding those laboratories with extremely 
high numbers of non-amplifiable loci). However, this ability to effectively amplify 
all VNTR loci is still insufficient in some of the participating laboratories, as 10 
laboratories for the second proficiency study reported missing results (range 1–17 
missing results), and one laboratory reported 249 missing results for the complete 
set. 
In the second proficiency study, one sample with one double allele was in-
cluded in duplicate. The single double allele present in the panel was missed in 
duplicate by 12 laboratories, and only one of the duplicate samples was missed by 
two laboratories. Five laboratories mistakenly reported double alleles. Detection 
of false double alleles is mostly caused by the improper interpretation of stutter 
peaks, i.e., peaks that do not represent actual amplicons. Conversely, missing the 
double allele can indicate a technical problem, but this is more likely an incor-
rect interpretation of the peaks visualised by the analysis software. The results 
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of the first proficiency study on VNTR typing of M. tuberculosis were analysed by 
 method.
The statistical analysis reported no significant effect of the method applied, 
suggesting that the differences between the three VNTR methods were mainly due 
to the laboratories applying them (4). The results of the second proficiency study 
showed the same scenario: while the average inter- and intra-laboratory repro-
ducibility for the users of the commercial kit was 86% and 92%, one laboratory 
in this group scored 3% and 0%, respectively. Similar outliers were also detected 
in the other groups. This suggests that some laboratories lack the experience to 
produce and report good VNTR patterns, regardless of the method used.
Based on the results of this study, we conclude that the first proficiency study 
and the subsequent centrally guided improvements had a positive effect on the 
quality of VNTR typing of M. tuberculosis. Actions undertaken locally to improve 
the performance of VNTR typing were apparently also effective (7). This offers 
positive perspectives for the remaining laboratories that performed poorly in the 
current proficiency study. An important proportion of the numerous errors that 
were detected in this study were from 10 laboratories that performed below the 
average of 78% inter-laboratory reproducibility, and thus skewed the global re-
sults negatively in each of the three main method groups. This study emphasises 
the need for a continued quality control effort in VNTR typing, particularly in 
under performing laboratories. This should enable all laboratories to produce reli-
able VNTR data, thereby increasing the value of molecular epidemiological studies 
across all settings.
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ABSTRACT
Variable-number tandem-repeat (VNTR) typing with a panel of 24 loci is the 
current gold standard in the molecular typing of Mycobacterium tuberculosis com-
plex isolates. However, because of technical problems, a part of the loci often can-
not be amplified by multiplex PCRs. Therefore, a considerable number of single-
locus PCRs have to be performed for the loci with missing results, which impairs 
the laboratory work flow. Therefore, the original in-house method described by 
Supply et al. in 2006 was reevaluated. We modified seven primers and the PCR 
master mixture and obtained a strongly optimized in-house 24-locus VNTR typ-
ing method. The percentage of instantly complete 24-locus VNTR patterns de-
tected in the routine flow of typing activities increased to 84.7% from the 72.3% 
obtained with the typing conducted with the commercially available Genoscreen 
MIRU-VNTR typing kit. The analytical sensitivity of the optimized in-house method 
was assessed by serial dilutions of M. tuberculosis in bronchoalveolar lavage fluid. 
A 1:10 dilution of the different strains tested was the lowest dilution for the detec-
tion of a complete 24-locus VNTR pattern. The optimized in-house 24-locus VNTR 
typing method will reduce the turnaround time of typing significantly and also the 
financial burden of these activities.
INTRODUCTION
Since the introduction of standardized variable-number tandem-repeat (VNTR) 
typing in 2006 by Supply et al. (1), laboratories worldwide have implemented 
this method. Compared to the level of discrimination of the formerly used restric-
tion fragment length polymorphism (RFLP) typing method, that of 24-locus VNTR 
typing has proven to be sufficient to trace the transmission of tuberculosis (TB) 
in low-burden settings (1, 2). The advantages of VNTR typing over RFLP typing 
include simplified comparison of the results and applicability to small amounts of
DNA, by which the turnaround time decreased from an average of 44 days to 15 
days at our laboratory. However, in the first worldwide proficiency study of VNTR 
typing, the level of interlaboratory reproducibility was only 60% and intralabora-
tory reproducibility was only 72%. A second worldwide proficiency study revealed 
important improvements after the adjustment of some technical elements in the 
methodology and a higher degree of standardization (6). Still, laboratories apply-
ing VNTR typing face several technical challenges. First and foremost, some of the 
24 loci may not be amplified in the multiplex PCRs and have to be amplified with a 
single-locus PCR; this holds true both for the commercially available MIRU-VNTR 
typing kit (Genoscreen, Lille, France) and for the in-house methods. In practice, 
this involves a significant increase in the workload and turnaround time.
The need for an optimized, fast, and high-quality VNTR typing method is high, 
especially for municipal health services and clinicians. The results of typing are 
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used to steer the direction of source case finding and eventually to support the 
activities of the elimination of TB transmission. For the clinician, the most impor-
tant information extracted from the results of typing is whether the patient has a 
TB relapse or an exogenous TB reinfection.
Given the common use worldwide of the standardized VNTR typing method, 
we have attempted to improve the original inhouse VNTR method described by 
Supply et al. (1). In addition, we have determined the minimum amount of DNA 
required for successful VNTR typing of Mycobacterium tuberculosis in clinical ma-
terial. 
MATERIALS AND METHODS
Samples. For optimization of the in-house 24-locus VNTR typing technique, 
we used the DNA of two different M. tuberculosis strains, control strain H37Rv and 
a strain from the National Tuberculosis Reference Laboratory (NLA000901369). 
For the final quality check of the optimized in-house method, we used the panels 
used in the first (3) and second (6) proficiency studies on VNTR typing. To de-
tect the effect of the implementation of the optimized in-house technique rather 
than the commercial method used, we included the results of routine typing of M. 
tuberculosis isolates as part of the national surveillance in The Netherlands con-
ducted at the National Tuberculosis Reference Laboratory, National Institute for 
Public Health and the Environment (RIVM), Bilthoven, The Netherlands. The per-
centage of complete 24-locus VNTR patterns obtained with the commercial typing 
kit from January 2010 to November 2011 was compared with that obtained with 
the optimized in-house method from November 2011 to July 2013. 
DNA isolation. DNA isolation was performed with the QIAamp DNA Minikit 
(Qiagen, Hilden, Germany) according to the manufacturer’s protocol for DNA pu-
rification from blood and body fluids. From a positive culture medium, 1 ml was 
centrifuged for 15 min (11,800 x g). The pellet was used as the input for the DNA 
isolation procedure. From a solid medium, 1 colony was suspended in MilliQ water 
to serve as the starting material. The DNA was eluted from the column in 30 µ l of 
elution buffer and diluted to a final concentration of 10 ng/ µl.
Twenty-four-locus VNTR typing by the commercial kit. The commercial 
24-locus VNTR typing kit from Genoscreen (Lille, France) was used in accordance 
with the manufacturer’s instructions. This technique was used in a diagnostic set-
ting until November 2011.
Optimized in-house method for 24-locus VNTR typing. The original set 
of primers described by Supply et al. was evaluated by the optimized in-house 
method for 24-locus VNTR typing. Seven primers affecting the amplification of 4 
loci of the complete 24-locus VNTR set were replaced with new primers designed 
with Primer3Plus (3). The sequences of these new primers are in bold in Table 1; 
the other primers used are identical to those described by Supply et al. (1). The 
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Table 1 Primer sequences used in the optimized 24-locus VNTR typing methoda
Locus Genome 
position
Mix-
ture 
no.
Final 
Primer 
concnb 
(nM)
Primer sequence (5’- 3’ with 
labeling)
MIRU 04, 
ETR-D
580 1 400 nM
GCGCGAGAGCCCGAACTGC(FAM)c
GCGCAGCAGAAACGCCAGC
MIRU 26 2996 1 400 nM
CATAGGCGACCAGGCGAATAG(VIC)
TAGGTCTACCGTCGAAATCTGTGAC
MIRU 40 802 1 400 nM
GGGTTGCTGGATGACAACGTGT(NED)
GGGTGATCTCGGCGAAATCAGATA
MIRU 10 960 2 400 nM
GCCACCTTGGTGATCAGCTACCT(FAM)
GTTCTTGACCAACTGCAGTCGTCC
MIRU 16 1644 2 320 nM
CCCGTCGTGCAGCCCTGGTAC(VIC)
TCGGTGATCGGGTCCAGTCCAAGTA
MIRU 31, 
ETR-E
3192 2 400 nM
GTGCCGACGTGGTCTTGAT(NED)
ACTGATTGGCTTCATACGGCTTTA
Mtub 04 424 3 400 nM
GGCAGCAGAGCCCGGGATTCTTC(FAM)
CTTGGCCGGCATCAAGCGCATTATT
ETR-C 577 3 320 nM
CGAGAGTGGCAGTGGCGGTTATCT(VIC)
AATGACTTGAACGCGCAAATTGTGA
ETR-A 2165 3 400 nM
AAATCGGTCCCATCACCTTCTTAT(NED)
CGAAGCCTGGGGTGCCCGCGATTT
Mtub 30 2401 4 400 nM
CTTGAAGCCCCGGTCTCATCTGT(FAM)
ACTTGAACCCCCACGCCCATTAGTA
Mtub 39 3690 4 400 nM
CGGTGGAGGCGATGAACGTCTTC(VIC)
TAGAGCGGCACGGGGGAAAGCTTAG
QUB 4156 4156 4 400 nM
GATGTGCGGTACGTGCATC(NED)
TGACCACGGATTGCTCTAGTC
QUB 11b 2163b 5 800 nM
GTCGAAGTGAATGGTGGCAT(FAM)
GTAAGGGGGATGCGGGAAAT
Mtub 21 1955 5 400 nM
AGATCCCAGTTGTCGTCGTC(VIC)
CAACATCGCCTGGTTCTGTA
QUB 26 4052 5 640 nM
AACGCTCAGCTGTCGGAT(NED)
GCCAGGTCCTTCCCGAT
MIRU 02 154 6 400 nM
TACTCGGACGCCGGCTCAAAAT(FAM)
TGGACTTGCAGCAATGGACCAACT
MIRU 23 2531 6 400 nM
CTGTCGATGGCCGCAACAAAACG(VIC)
AGCTCAACGGGTTCGCCCTTTTGTC
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final concentrations of the forward and reverse primers for a particular locus were 
identical.
Three different commercially available PCR master mixtures were used to am-
plify the DNA control samples, i.e., PuReTaq Ready-To-Go PCR Beads (GE Health-
care, Little Chalfont, United Kingdom), Multiplex PCR 5x Master Mix (Westburg 
Benelux Office, Leusden, The Netherlands), and AmpliTaq Gold 360 Master Mix 
(Applied Biosystems, Foster City, CA).
A DNA input of 2 µl was used to perform the amplification reactions. 
The PCR products obtained with the optimized in-house method of 24-locus VNTR 
typing were visualized by gel electrophoresis (2% agarose). All VNTR analyses 
were performed according to standard laboratory procedures by three experi-
enced technicians. We considered implementation only when a specific combina-
tion of PCR master mixture and primers met the following criteria. (i) Twentyfour 
loci in monoplex reactions had to produce the expected amplicon sizes for the DNA 
controls used, and (ii) triplex PCRs had to produce identical amplicon sizes, as 
detected with a capillary electrophoresis (CE) DNA analyzer (ABI 3730).
 Implementation in a diagnostic setting. For final implementation in a 
diagnostic setting, national surveillance, the lengths of PCR products were de-
tected with a CE DNA analyzer (ABI 3730) with the addition of an internal lane 
size standard, the GeneScan 1200 Size Standard (Applied Biosystems, Foster City, 
CA). 
MIRU 39 4348 6 400 nM
CGGAAACGTCTACGCCCCACACAT(NED)
CGCATCGACAAACTGGAGCCAAAC
MIRU 20 2059 7 400 nM
GGAGAGATGCCCTTCGAGTTAG(FAM)
GGAGACCGCGACCAGGTA
MIRU 24 2687 7 400 nM
GGGCGAGTTGAGCTCACAGAA(VIC)
CGACCAAGATGTGCAGGAATACAT
MIRU 27 3007 7 400 nM
GCGATGTGAGCGTGCCACTCAA(NED)
TCGAAAGCCTCTGCGTGCCAGTAA
Mtub 29 2347 8 400 nM
GCCAGCCGCCGTGCATAAACCT(FAM)
AGCCACCCGGTGTGCCTTGTATGAC
ETR-B 2461 8 800 nM
ATGGCCACCCGATACCGCTTCAGT(VIC)
CGACGGGCCATCTTGGATCAGCTAC
Mtub 34 3171 8 320 nM GGTGCGCACCTGCTCCAGATAA(NED)
GCTCTCATTGCTGGAGGGTTGTAC
a Primers that differ from those used in the standardized method described by Supply et al. 
(1) are in bold.
b The final concentrations of the forward and reverse primers for a particular locus were 
identical.
c FAM, 6-carboxyfluorescein.
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Samples used for analytical sensitivity testing. In a recent publication 
by Akkerman et al. (4), 14 molecular assays were compared for M. tuberculosis 
complex detection in pooled bronchoalveolar lavage fluid (BALF). Serial dilutions 
of four M. tuberculosis strains with various numbers of copies (1, 5, 10, and 20) 
of the IS6110 element were used to determine the analytical sensitivity of the op-
timized 24-locus VNTR typing method in BALF. All VNTR analyses were performed 
in triplicate. 
Statistical analysis. The statistical significance of differences between the 
two tests performed was determined by Pearson’s chi-square test on a two-by-two 
table of method versus result.
RESULTS
Optimization of the in-house 24-locus VNTR typing method. The results 
of amplification by PuReTaq Ready-To-Go PCR Beads (GE Healthcare, Little Chal-
font, United Kingdom) did not meet the criteria because multiple nonspecific am-
plicons with unexpected lengths were obtained. The results of amplification by the 
Multiplex PCR 5 Master Mix (Westburg Benelux Office, Leusden, The Netherlands) 
also did not meet the expectations. In this case, the optimum annealing tempera-
tures for the different loci were too far apart to be useful in a multiplex PCR. The 
amplification results of the AmpliTaq Gold 360 Master Mix (Applied Biosystems, 
Foster City, CA) yielded the amplicon sizes expected for all of the 24 loci. Even in 
a multiplex reaction, the amplicons were clear in the analysis of the results in the 
CE DNA analyzer. Thus, the final PCR mixture of the optimized 24-locus VNTR typ-
ing method consisted of 12.5  µl of AmpliTaq Gold 360 Master Mix for each reaction 
with a total volume of 25  µl. Table 1 depicts the loci combined in the multiplex 
PCR mixtures and the final primer concentrations. The PCR program used was 10 
min at 96°C; 40 cycles of 1 min at 96°C, 1 min at 60°C, and 1 min at 75°C; and 
a final step of 7 min at 72°C. 
Quality of the optimized in-house 24-locus VNTR typing method. The 
interlaboratory reproducibility of the optimized in-house 24-locus VNTR typing 
method was tested before the implementation of this method in the daily routine. 
The results obtained with the panels used in the first and second worldwide stud-
ies of VNTR typing proficiency (5) organized by the RIVM were good; the inter-
laboratory reproducibility was 100%, and the intralaboratory reproducibility was 
97%.
Implementation of the optimized in-house VNTR typing method. In a 
20-month period (November 2011 to June 2013) after the introduction of the 
optimized in-house 24-locus VNTR typing method, 1,401 M. tuberculosis strains 
were typed by this method. The percentage of instantly complete VNTR patterns 
detected was 84.7% (n = 1,186). The performance of the commercial 24-locus 
VNTR typing method was mapped retrospectively. In a 22-month period ( January 
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2010 to October 2011), 1,638 M. tuberculosis strains were typed in the daily rou-
tine. The percentage of complete 24-locus VNTR patterns detected by this test 
was 72.3% (n=1,184). The percentage of initial complete results of the optimized 
Table 2  VNTR patterns of the four strains used to test the analytical sensitivity of 
the optimized in-house VNTR method
Locus
Genome
position 
No. of repeats in strain with following no. 
of IS6110 copies:
1 5 10 20
MIRU 04 580 5 2 2 2
MIRU 26 2996 2 5 5 6
MIRU 40 802 4 4 4 2
MIRU 10 960 4 4 4 3
MIRU 16 1644 3 3 3 3
MIRU 31 3192 4 3 2 5
VNTR 42 424 2 4 3 4
VNTR 43 577 4 3 2 4
VNTR ETR-A 2165 6 3 2 4
VNTR 47 2401 1 4 1 4
VNTR 52 3690 4 3 2 3
VNTR 53 4156 1 3 2 2
VNTR QUB11b 2163b 3 3 1 5
VNTR 1955 1955 6 3 3 5
VNTR QUB-26 4052 6 5 6 8
MIRU 02 154 2 2 1 2
MIRU 23 2531 6 5 6 5
MIRU 39 4348 3 2 2 3
MIRU 20 2059 2 2 2 2
MIRU 24 2687 2 1 1 1
MIRU 27 3007 3 3 3 3
VNTR 46 2347 3 4 4 4
VNTR 48 2461 1 2 2 2
VNTR 49 3171 3 3 1 3
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in-house 24-locus VNTR typing method was shown to be significantly higher (P 
=0.001) and was related to better yields for the loci for which new primers were 
designed.
The incomplete VNTR patterns detected were caused by missing results for one 
or more alleles because of amplification failure or because of the false detection of 
two different numbers of repeats for one or two alleles. Of the incomplete patterns 
detected by the commercial 24-locus VNTR method, 91.6% (n=416) were due 
to missing results and 8.4% (n=38) were due to the detection of double alleles. 
By the optimized 24-locus VNTR method, these were 80.9% (n=174) and 19.1% 
(n=41), respectively. 
The analytical sensitivity of VNTR typing by the optimized 24-locus VNTR meth-
od was tested with DNA from serial dilutions of the four M. tuberculosis strains 
in BALF. The 24-locus VNTR patterns of the four M. tuberculosis strains used to 
prepare dilutions are given in Table 2. Undiluted samples and 1:10 dilutions of all 
four strains yielded a complete 24-locus VNTR pattern by the optimized in-house 
method. With the 1:100 dilution of BALF with a strain with a single copy of IS6110, 
one of the three VNTR analyses yielded results for only 22 loci instead of 24; for 
the other three strains with higher IS6110 copy numbers, this dilution showed the 
complete VNTR pattern thrice. Also, with the 1:1,000 dilution of BALF with the 
strain with a single copy of IS6110, one of the triplicates showed an incomplete 
VNTR pattern of 23 loci. The 1:1,000 dilution of the other samples tested showed 
a triplicate of complete patterns for the strains with 5 and 10 IS6110 copies but 
three times showed an incomplete VNTR pattern with 10 missing loci for the strain 
with 20 IS6110 copies. At dilution one step higher, 1:10,000, incomplete VNTR 
patterns were obtained for all of the strains. Table 3 shows the results in quantita-
tion values of the M. tuberculosis detection tests for the analytical sensitivity of 
VNTR typing determined at a 1:100 dilution.
  
DISCUSSION
We have optimized the VNTR typing method. The combination of seven re-
designed primers and the use of a suitable master mixture contributed to the 
high percentage (84.7%) of complete 24-locus VNTR typing profiles in the first 
multiplex PCR run. This practical improvement is considerable, as fewer strains 
have to be reamplified by single-target PCRs, and this reduces the workload and 
turnaround time.
Another important aspect of this improvement is cost efficiency. The high cost 
of the commercially available VNTR kit and a lack of access to a CE DNA analyzer 
hamper its use in many laboratories. The optimized in-house method may be an 
important alternative, because the products of single-locus PCRs can be  analyzed 
on a gel without the need of a sophisticated DNA analyzer, and the yield of com-
plete VNTR profiles obtained by this inexpensive approach is better than that ob-
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tained by the commercial method. In a recent proficiency study of VNTR typing, 
the sizing of VNTR PCR products yielded almost the same degree of reliability as 
the commercial method (6). 
For the daily practice of molecular epidemiological studies of TB and to reduce 
the laboratory turnaround time, an adequately performing 24-locus VNTR typ-
ing method is of the utmost importance. Failing loci hamper the interpretation 
of VNTR typing results in many countries, and this has introduced a bias into the 
international comparability of VNTR typing results. Failing loci are not the result of 
a natural absence of VNTRs, as often assumed, but merely the result of technical 
problems in the typing technique used (5).
In the meantime, the commercial 24-locus VNTR method was changed from an 
eight-reaction system to a six-reaction system. The manufacturer did not disclose 
information about the technical adjustments. 
In this study, we also analyzed the analytical sensitivity of the improved in-
house VNTR typing method. The detection of the 24-locus VNTR pattern of the 
M. tuberculosis complex in BALF showed an analytical sensitivity of 1:10 for the 
optimized in-house method. A slightly more lenient definition of analytical sensi-
tivity changes the interpretation to an analytical sensitivity of 1:100. An analytical 
sensitivity of 1:100 can be used for VNTR typing. With the risk of missing a single 
Table 3    Analytical sensitivity of VNTR typing performed with 1:100 dilutiona
Assay
Cq with strain with following no. of IS6110 copies:
    1     5    10    20
In-house- Roche-5 31.20 27.19 27.35 26.21
In-house-Taqman-5 30.43 27.50 26.44 25.30
In-house-Taqman-10 29.86 26.24 25.61 24.40
Lucron 30.31 27.29 26.92 25.57
Pathofinder 29.81 26.77 25.72 24.68
MP MTB 32.66 29.48 28.77 27.81
MP MTB/NTM 32.14 28.95 28.19 27.50
In-house ITS-HRM 24.62 28.33 29.24 28.22
Cobas 32.03 33.00 34.87 31.40
GeneXpert 20.90 24.77 24.57 19.43
Goffin MTB 32.66 29.48 28.77 27.81
Goffin MTB/NTM 32.14 28.95 28.19 27.47
a Associated with the quantitation cycle (Cq) values of the diagnostic tests performed in 
the study of Akkerman et al. (4).
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locus,VNTR typing can still exclude the possibility of transmission and relapses. 
In theory, this sensitivity provides the ability to perform typing of M. tuber-
culosis directly in BALF samples, even with a minimal bacterial load. This may 
increase the applicability of typing results in the early stage of examinations of 
TB outbreaks or, in an earlier diagnostic phase, permit better discrimination of 
whether a patient has a relapse or a new infection. The moment VNTR typing can 
be performed depends on the bacterial load of the sample, shown as quantita-
tion cycle values, and can be read from Table 3 for different diagnostic tests. In 
practical diagnostics, the number of IS6110 elements is unknown; therefore, the 
results of the 10-copy IS6110 strain can be used and are most representative of 
the samples collected in The Netherlands. 
This study has some important limitations. First, we could not use a single set 
of samples to investigate the performance of the standard versus that of the im-
proved VNTR methodology. Nonetheless, the sets used to assess the performance 
of both methods are representative of the epidemiology in The Netherlands and 
were similar with regard to genotype distributions. Second, analytical sensitivity 
should ideally be determined with prospectively gathered clinical specimens for 
which quantitative cultures are performed in parallel. In our national reference 
laboratory setting, these materials cannot be gathered.
In summary, optimization of the in-house 24-locus VNTR method resulted in 
84.7% complete VNTR patterns in a diagnostic setting. This improves the labora-
tory work flow because of the reduction of the number of reamplification reac-
tions. In addition, this technique is much cheaper than the commercial 24-locus 
VNTR method and is useful for laboratories without a CE DNA analyzer.
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ABSTRACT
In order to switch from IS6110 and polymorphic GC-rich repetitive sequence 
(PGRS) restriction fragment length polymorphism (RFLP) to 24-locus variable-
number tandem-repeat (VNTR) typing of Mycobacterium tuberculosis complex 
isolates in the national tuberculosis control program in The Netherlands, a de-
tailed evaluation on discriminatory power and agreement with findings in a clus-
ter investigation was performed on 3,975 tuberculosis cases during the period of 
2004 to 2008. The level of discrimination of the two typing methods did not differ 
substantially: RFLP typing yielded 2,733 distinct patterns compared to 2,607 in 
VNTR typing. The global concordance, defined as isolates labeled unique or iden-
tically distributed in clusters by both methods, amounted to 78.5% (n=3,123). 
Of the remaining 855 cases, 12% (n=479) of the cases were clustered only 
by VNTR, 7.7% (n=305) only by RFLP typing, and 1.8% (n=71) revealed differ-
ent cluster compositions in the two approaches. A cluster investigation was per-
formed for 87% (n=1,462) of the cases clustered by RFLP. For the 740 cases with 
confirmed or presumed epidemiological links, 92% were concordant with VNTR 
typing. In contrast, only 64% of the 722 cases without an epidemiological link 
but clustered by RFLP typing were also clustered by VNTR typing. We conclude 
that VNTR typing has a discriminatory power equal to IS6110 RFLP typing but is 
in better agreement with findings in a cluster investigation performed on an RFLP 
clustering-based cluster investigation. Both aspects make VNTR typing a suitable 
method for tuberculosis surveillance systems.
INTRODUCTION
DNA fingerprinting of Mycobacterium tuberculosis isolates has been applied for 
the investigation of epidemiological links between tuberculosis (TB) cases in sev-
eral countries since DNA typing techniques were developed in the early 1990s (1–
4). In The Netherlands, IS6110 restriction fragment length polymorphism (RFLP) 
typing was used nationwide from 1993 until the end of 2008. Although RFLP 
typing revolutionized studies on the transmission of M. tuberculosis, the method 
remained technically demanding and time consuming. The analysis of the com-
plex IS6110 RFLP banding pattern requires a sophisticated computer application
and a high degree of expertise (5). Moreover, in the Netherlands, it took on 
average 44 days to the deliver the RFLP typing result to the Municipal Health 
Services, after the isolate had reached the laboratory (D. van Soolingen, personal 
communication). This major drawback significantly limited the usefulness of DNA 
fingerprinting in routine examination of transmission, as it in fact only offered 
retrospective confirmation of suspected epidemiological links. 
In 2006, 24-locus variable-number tandem repeat (VNTR) typing was favora-
bly evaluated and proposed as the new gold standard for typing of M. tuberculosis 
(6). In order to switch from RFLP to VNTR typing in 2008 in the Netherlands, it 
was considered necessary to establish a retrospective VNTR pattern database of 
possible sources of infection for a preceding period of 5 years. We therefore re-
typed isolates of all 3,975 culture confirmed TB cases diagnosed during the period 
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of 2004 to 2008. Since cluster investigation was routinely applied in The Nether-
lands on the basis of RFLP cluster results, this provided the unique opportunity to 
compare, on a large population-based scale, the validity of the clustering of cases 
on the basis of RFLP and VNTR typing and to evaluate the latter, faster method to 
trace epidemiological links.
MATERIALS AND METHODS
The cohort. The National Institute for Public Health and the Environment 
(RIVM) in Bilthoven, The Netherlands, serves as a reference laboratory for the 
secondary laboratory diagnosis of all TB cases in The Netherlands, offering iden-
tification, drug susceptibility testing, and molecular typing. During the period of 
2004 to 2008, 3,975 M. tuberculosis isolates of culture-confirmed TB cases were 
subjected to RFLP typing at the RIVM, using a previously described protocol (1). 
For isolates with 5 copies of IS6110, additional polymorphic GC-rich repetitive 
sequence (PGRS) RFLP typing (7) was performed. The additional PGRS typing 
results were combined with the IS6110 RFLP typing result to determine the clus-
tering of cases and to initiate a cluster investigation. Municipal health services 
in the Netherlands conduct contact tracing and source case finding, according to 
the “stone in the pond” principle (8), and also cluster investigations; findings are 
reported to the national surveillance unit.
The lineages of the samples included were determined based on spoligotyping 
or by the use of the MIRU-VNTRplus online database (www.miru-vntrplus.org). 
Overall, 65% (n=2,589) of the isolates belonged to the Euro-American lineage, 
9% (n=373) to the East African-Indian (EAI) lineage, 8% (n=335) to the Central 
Asian strain (CAS) lineage, and 7% (n=296) to the Beijing lineage of M. tubercu-
losis; 2% (n=66) represented Mycobacterium africanum and 2% (n=65) M. bovis. 
The final 6% (n=251) of the strains were assigned to the (sub)species M. canettii 
or M. caprae or remained unknown or unidentifiable to the genotype family level. 
VNTR typing. Purified DNA extracts of M. tuberculosis isolates were subjected 
to VNTR typing, partly by GenoScreen (Lille, France) and partly by the RIVM. Both 
entities performed 24-locus VNTR typing according to the international standard 
(6). To monitor and ensure the quality and mutual reproducibility, one negative 
control, DNA from two positive controls with known VNTR profiles (M. tuberculo-
sis strain H37Rv and M. bovis BCG strain P3) and three blinded duplicates were 
included on each 96-well plate. 
Computer and statistical analysis. BioNumerics software version 6.6.4 
(Applied Maths, Belgium) was used for the analysis of molecular typing results. 
IS6110 RFLP patterns were recorded as the fingerprint type, and VNTR typing 
results as the character type. 
The statistical significance was measured for the proportion of confirmed or 
presumed epidemiological links in the subgroup of isolates that were clustered on 
RFLP and VNTR typing compared to the subgroup of isolates clustered by RFLP 
but not by VNTR typing. A logistic regression analysis was conducted to model the 
probability to find an epidemiological link whether an isolate clustered by RFLP 
typing was confirmed or not by VNTR typing. The relation between the epidemio-
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logical status and reconfirmed status by VNTR typing within the same cluster was 
adjusted for the cluster size and correlation of samples within the same cluster. 
The models were fitted by using package Ime4 of the statistical software  package 
R. 
Clustering on the basis of RFLP and VNTR typing. For the comparison of 
the two typing methods, differences in cluster distribution were investigated, as 
well as the correlation of clustering with findings in a cluster investigation. Be-
cause, until 2009, RFLP typing was applied in The Netherlands, a cluster investiga-
tion was conducted only on the basis of RFLP clustering of cases. 
Two percent (85/3,975) of the isolates with a double allele in one of the 24 
VNTR loci were treated as follows. For cases where separate consideration of 
each of the two alleles resulted in one clustered and one unique VNTR pattern or 
two clustered patterns, the clustered pattern(s) were included (as two separated 
 cases in the case of two clustered patterns) in the total database for analysis of 
the correlation with the contact tracing data. Isolates with 1 locus with double 
 alleles were excluded from the analysis.
A total of 52 isolates for which one or two VNTR loci could not be amplified 
even after repeating the amplification in a single locus PCR were included in the 
database and all analyses, with the missing loci indicated with an “x” and treated 
as a specific allele in the pattern. 
The concordance in clustering of cases between the two typing methods was 
calculated on the basis of (i) identical cluster compositions and shared unique RFLP 
and VNTR profiles and (ii) concordance in labeling as a “clustered” or “unique” 
isolate, regardless of the cluster composition. For comparisons of deviating VNTR 
patterns of isolates within RFLP clusters the VNTR pattern with the highest aver-
age similarity in the specific RFLP cluster was considered the reference pattern. 
RESULTS
During the period of 2004 to 2008, a total of 3,975 culture-confirmed TB cases 
were diagnosed in The Netherlands and had their isolates subjected to genotyping 
analysis. Over the 5-year period, 2.1% (n=85) of the samples displayed a dou-
ble allele in one of the 24 VNTR loci. When the results of these 85 isolates were 
analyzed as two separate alleles and genotypes, 53 were unique in the database 
by either of both alleles/genotypes. For 32 of the 85 cases, one of the VNTR pat-
terns found was clustered with at least one other case, and in three cases, both 
VNTRpatterns were clustered. As for each of three latter cases, the two VNTR 
patterns were included in the database, and the total number of VNTR patterns 
of isolates for further analysis amounted to 3,978. Incomplete patterns, lacking 
one or two alleles among the 24 loci, were detected in 52 (1.3%) of the cases in 
our database. 
In total, for the 3,978 VNTR typing results, 2,607 different VNTR types were 
detected compared to 2,733 distinct RFLP types. In this data set, 47% (n=1,857) 
of the isolates belonged to one of the 486 VNTR clusters and 42% (n=1,683) be-
longed to one of the 438 clusters identified by RFLP typing. The distributions of 
the cluster sizes on the basis of the two typing techniques are highly similar, as 
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depicted in Fig. 1. 
Comparison of RFLP and VNTR typing results. The concordance between 
the two typing techniques was 78.5% (n=3,123), as defined by 1,307 isolates 
identically clustered (i.e., with a same cluster composition) and 1,816 unique 
isolates in both methods (Table 1). For the remaining 855 isolates, 12% (n= 
479) were clustered only by VNTR, 7.7% (n=305) only by RFLP typing, and 1.8% 
(n=71) by both typing methods but in a different cluster composition.
Cluster composition on the basis of RFLP and VNTR. Among the 438 RFLP 
clusters, comprising 1,683 isolates, 58% (256 clusters, including a total of 784 
isolates) (Fig. 2) displayed identical cluster sizes and composition by VNTR typing. 
An additional 47 RFLP clusters (11%) showed almost identical sizes and composi-
tions, with only one or more single cases of these clusters split off by VNTR typing.
Twenty-eight (6%) of the 438 RFLP clusters, involving 302 cases, were sub-
divided by VNTR typing into two or three clusters each, with sizes ranging from 
2 to 48 cases. One hundred seven (24%) of the 438 RFLP clusters, comprising 
241 cases, were subdivided into single VNTR patterns. Ninety (84%) of these 107 
RFLP clusters consisted of only two cases. 
Four hundred seventy-nine isolates, which exhibited unique profiles in RFLP 
typing, were clustered by VNTR typing into 226 clusters. Of these, 65% (n=148) 
represented “new” VNTR clusters, as they consisted of isolates (n=307) with 
unique RFLP profiles only. The other isolates (n=172) were grouped within 78 
existing VNTR clusters. 
The aforementioned scenarios also occurred vice versa. Out of the 486 VNTR 
clusters, including 1,857 isolates, 51% (n=241) consisted of identically sized and 
Figure 1  Distribution of cluster sizes obtained on the basis of RFLP (black bars) and VNTR 
(grey bars) typing.
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composed RFLP clusters, 15% (n=71) consisted of one defined RFLP cluster en-
larged by unique RFLP cases, 4% (n=21) were subdivided by RFLP typing into 
“subclusters” in two to four cases, and 31% (n=152), mostly (n=118) including 
two isolates only, consisted of cases with unique RFLP patterns.
Typing results in relation to cluster investigation. Information on cluster 
investigation was available for 87% (n=1,462) of the isolates in RFLP clusters. 
Of these, the epidemiological link with another cluster member was confirmed 
in 35% of the cases (n=514), there was a presumed link in 16% (n=226) of the 
cases, and no link was found in 49% (n=722) of the cases. Ninety-four percent 
(n=484) of the isolates clustered by RFLP and with a confirmed epidemiological 
link were also clustered in VNTR typing. 
Among the isolates clustered by RFLP but with only a presumed link, 88% 
(n=200) proved clustered by VNTR typing. In contrast, only 64% (n=462) of the 
isolates clustered by RFLP but devoid of epidemiological links in cluster investi-
gation were clustered by VNTR typing (Fig. 3, left). Among the 1,462 isolates in 
RFLP clusters, an epidemiological link with another member of the cluster was 
confirmed or presumed in 51% (n=740) of the cases. In the subgroup of 1,146 
isolates that were clustered on the basis of both RFLP and VNTR typing, the pro-
portion of confirmed (n=484) or presumed epidemiological links (n=200) rose 
to 60% (Fig. 3, right). In contrast, among the 316 cases clustered by RFLP but 
distinguished from the cluster by a VNTR typing result, only 56 (18%) showed 
a confirmed (n=30) or presumed (n=26) epidemiological link in contact tracing. 
This difference in percentage is statistically highly significant (P=0.001). 
VNTR locus differences among RFLP clustered cases. In total, 21% 
(n=359) of all 1,683 isolates clustered by RFLP were split off from their respec-
tive cluster on the basis of the VNTR typing result, and this involved 300 different 
VNTR patterns. The distribution of the number of loci by which the pattern devi-
ated from the reference pattern in the cluster is shown in Fig. 4 (top). Single locus 
variations were detected for 118 VNTR patterns. The patterns that diverged by 
more than two loci were not related to isolates of specific genotypes or phyloge-
netic groups on the basis of their RFLP patterns. 
Table 1  Comparison of clustering on the basis of RFLP and VNTR typing results 
of 3,978 M. tuberculosis isolates in The Netherlands, 2004–2008
VNTR Total
Cluster Unique
RFLP
  Cluster 1,378a 305 1,683
  Unique 479 1,816 2,295
  Total 1,857 2,121 3,978
a Seventy-one RFLP- and VNTR-clustered isolates showed different cluster compositions in 
RFLP and VNTR typing.
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For the single-locus variant (SLV) and the multilocus variant (MLV) patterns, 
the loci that were mostly responsible for isolates being split off their RFLP clusters 
on the basis of the VNTR pattern difference are the loci with genome position 
numbers 2163, 4052, and 3690. For MLV patterns, changes were also frequently 
seen in locus 802 and 2996 (30% and 17% of the patterns, respectively) (Fig. 4, 
bottom). 
Interestingly, the number of loci that differed in isolates split off from their 
RFLP cluster by a unique VNTR pattern was associated with the strength of the 
epidemiological links observed for the respective patients. Epidemiological link 
data were available for 87% (n=311) of the isolates split off their RFLP clusters 
by VNTR typing. In isolates of patients with proven epidemiological links that 
were split off by VNTR typing (n=19), we found a single-locus variation in 74% 
(n=14) of the isolates and >1 locus variation in the remainder (26%; n=5). In 
contrast, the percentage of >1 locus variation rose to 61% (n=11) among isolates 
of patients with presumed links only and 71% (n=103) of isolates from patients 
without epidemiological links (Fig. 5). 
DISCUSSION
This report represents the first nationwide, surveillance program based com-
parative study of RFLP and VNTR typing, integrating full population coverage over 
a 5-year time period and extensive epidemiological data. The comparison of the 
typing results of 3,978 M. tuberculosis isolates showed an overall concordance 
=in clustering of 79% and highly similar discriminatory power in the two  methods 
Figure 2  Composition of RFLP clusters by VNTR typing. In total, 69% of the RFLP clusters 
showed a completely identical (n=256) or similar (n47; with only one or more single cases 
split off by a distinctVNTRpattern) composition by VNTR typing. For 24% (n=107) of the 
RFLP clusters, VNTR typing resulted in sets of only unique patterns, whereas 6% (n=28) of 
the RFLP clusters were subdivided into 2 or 3 VNTR clusters.
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(2,607 versus 2,733 distinct patterns, respectively). Such a concordance is con-
sistent with linkage between markers expected from the clonal evolution of Myco-
bacterium tuberculosis (9,10). The expectable remaining 21% reflect the stochas-
tic component in the respective evolution of the independent molecular markers 
used. 
We detected a slightly higher level of discriminatory power of RFLP compared to 
VNTR typing (i.e., more distinct RFLP types), and hence, more clusters were iden-
tified by VNTR typing. However, this result does not reflect a comparison between 
only IS6110 RFLP and VNTR typing, because additional PGRS RFLP typing was 
used for strains with 5 copies of IS6110 (n=358). Nevertheless, it is consistent 
with those of previous comparative studies that were performed at regional (11), 
Figure 3  (Upper right) RFLP-clustered isolates (n=1,462) divided by cluster investigation 
results, classified as confirmed, presumed, and no epidemiological link. For each segment, 
the distribution of confirmed clustering by VNTR typing is shown. (Bottom left) Percentag-
es of confirmed or presumed epidemiological links for RFLP-clustered cases. Isolates with 
and without VNTR-supported clustering.
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population-based scales (12) or at a national level (13), which showed slightly 
higher to slightly lower discriminatory power of VNTR versus IS6110 RFLP typing. 
Importantly, cases with isolates that were clustered by both VNTR and RFLP 
typing had significantly more confirmed or presumed epidemiological links than 
cases with isolates clustered by RFLP only. Most (82%) split-offs by VNTR of iso-
lates previously clustered by RFLP occurred in clusters without an epidemiological 
link or without epidemiological information, and this finding was in agreement 
with findings in a previous regional study in The Netherlands (14). Of note, 71 
isolates (2% of the data set) were split off from RFLP clusters by VNTR typing and 
formed new VNTR-based clusters or expanded existing VNTR clusters. For 82% 
(n=58) of the isolates in this subset, no epidemiological link could be detected on 
the basis of the originally identified RFLP clusters. Taken together, these findings 
suggest that VNTR typing results could, in general, be in better agreement with 
the true chain of transmission than the RFLP typing results were. Yet, this can only 
be confirmed by a renewed source case investigation on the basis of the VNTR 
cluster information. 
0
20
40
60
80
100
120
1 2 3 4 5 6 >6
Sa
m
pl
es
 (n
)
No. of loci different compared to the reference of the RFLP cluster
0
5
10
15
20
25
30
35
40
45
58
0
29
96 80
2
96
0
16
44
31
92 42
4
57
7
21
65
24
01
36
90
41
56
21
63
19
55
40
52 15
4
25
31
43
48
20
59
26
87
30
07
23
47
24
61
31
71
Di
ffe
re
nc
es
 fo
r t
he
 is
ol
at
es
 sp
lit
t-
of
fs
 by
 V
NT
R 
ty
pi
ng
 (%
)
VNTR locus (genome position number)
SLV MLV
Figure 4  (Top) Number of loci that differ in VNTR typing patterns (n=300) split off from 
their RFLP cluster. (Bottom) Distribution of detected differences by locus in 24-locus VNTR 
genotypes of samples clustered by RFLP typing and split off by VNTR typing, separated by 
single-locus variation (SLV) cases and multilocus variation cases (MLV).
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In contrast, we found no clustering by VNTR typing in only 6% of the cases 
with proven epidemiological links. This is in line with the rate of change (4.9%) 
among VNTR patterns found among sets of epidemiologically linked or serial iso-
lates (6). Most (74%; n=14) of the changes seen between isolates with proven 
epidemiological links were consistently restricted to single-locus variations, again 
in general agreement with previous findings (15). These changes most likely re-
flect limited genetic drift among these markers in clonal populations during dis-
ease progression and transmission. Consistently, this drift was observed most 
frequently in VNTR loci that are in general the most variable in various strain 
populations, such as loci with genome positions 2163b and 4052 (6).
As the cluster investigation was performed only on the basis of RFLP clustering, 
we cannot formally evaluate the epidemiological significance of the newly formed 
clusters on the basis of VNTR typing that were not found as such by RFLP typing. 
However, we can estimate the impact of the slight overclustering by VNTR typing.
We found that 479/3,978 (12%) isolates were clustered on the basis of VNTR 
typing, where they earlier revealed unique RFLP patterns, but also found that 305 
(8%) isolates that were clustered in RFLP typing had unique VNTR patterns. This 
will predictably result in a 12% (174 [479 - 305] of the total 1,462 RFLP-clustered 
cases for which a cluster investigation has been performed) increase in source 
case-finding activities. This may be worth executing because clustering on the 
basis of VNTR typing seems in better agreement with findings in conventional con-
tact tracing. This will most likely optimize the yield of confirmed epidemiological 
links in the future. From a TB control perspective, the slightly lower discriminatory 
power in VNTR typing (i.e., bias toward clustering) could therefore be considered 
preferable over a bias to nonclustering in RFLP typing. Failure to recognize TB 
transmission, on the basis of typing results, may result in less source case finding 
Figure 5  Percentages of single-locus variants (SLV) and multilocus variants (MLV) for the 
isolates clustered by RFLP and split off by VNTR typing in relation to the epidemiological 
information.
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and contact tracing and may enable further transmission of M. tuberculosis. 
To improve the discriminatory power of molecular typing of M. tuberculosis 
isolates by VNTR typing, spoligotyping could be used in combination with this, as 
it has been shown to result in slightly increased discriminatory power in regional 
studies (11, 12, 16). Additional hypervariable VNTR loci have also been investi-
gated and were recommended especially for high-incidence settings where the 
Beijing genotype is prevalent (15, 17). However, Beijing genotype strains only 
make up about 7% of the current data set and thus are not the full explanation 
for the extent of discrepancies observed between RFLP and VNTR typing. The 
switch to VNTR typing also has several technical advantages. First, VNTR typing is 
less time-consuming and provides a faster time to result, because the technique 
is based on DNA amplification and thus requires far less DNA (i.e., less biomass) 
and requires hardly any culture delay, in contrast to RFLP typing. Second, the 
results of VNTR typing are in a simple format, which facilitates a simple exchange 
of typing information and interlaboratory comparison. Third, VNTR typing is much 
easier to perform and can be implemented more efficiently (13). These advan-
tages are in agreement with the implementation of VNTR typing for the outbreak 
detection of methicillin-resistant Staphylococcus aureus (MRSA) (18) and Salmo-
nella enterica (19).
The switch to VNTR typing also had down sides. The first round of worldwide 
proficiency testing initiated by our laboratory within the framework of an ECDC 
project revealed that both the intralaboratory and interlaboratory reproducibilities 
are to be improved in a number of laboratories, indicating the need for careful 
implementation (20). Moreover, new patient cluster identification numbers and 
compositions resulting from the discordances with RFLP typing introduced a major 
challenge for the TB units of the Municipal Health Services. 
However, with a concordance of 78.5%, a strong suggestion that VNTR typing 
results are more in line with the true chains of transmission than the RFLP typing 
and the technical advantages of VNTR typing, we conclude that VNTR typing is 
more suitable than RFLP typing of M. tuberculosis in national tuberculosis surveil-
lance programs, such as that in The Netherlands. We expect that the use of this 
method will ensure the transition until whole genome sequencing, which provides 
the ultimate level of discrimination and is under evaluation for its feasibility and 
impact (21, 22), will become cost effective in routine TB molecular-guided control 
and surveillance.
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The European Centre for Disease Prevention and Control (ECDC) initiated a 
project on the molecular surveillance of multi- and extensively drug-resistant tu-
berculosis (MDR-/XDR-TB) transmission in the European Union (EU) in the period 
from 2009 to 2011. In total, 2,092 variable number of tandem repeat (VNTR) 
patterns of MDR-/XDR-TB Mycobacterium tuberculosis isolates were collected, 
originating from 24 different countries in the period 2003 to 2011. Of the col-
lected VNTR patterns, 45% (n=941) could be assigned to one of the 79 European 
multiple-country molecular fingerprint clusters and 50% of those (n=470) be-
longed to one extremely large cluster caused by Beijing strains of one genotype. 
We conclude that international transmission of MDR-/XDR-TB plays an important 
role in the EU, especially in the eastern part, and is significantly related to the 
spread of one strain or clone of the Beijing genotype. Implementation of inter-
national cluster investigation in EU countries should reveal underlying factors of 
transmission, and show how TB control can be improved regarding case finding, 
contact tracing, infection control and treatment in order to prevent further spread 
of MDR-/XDR-TB in the EU.
INTRODUCTION
Molecular surveillance of multi- and extensively drugresistant tuberculosis 
(MDR-/XDR-TB) in the European Union (EU) on basis of IS6110 restriction frag-
ment length polymorphism (RFLP) typing detected large molecular clusters of 
MDR-/XDR-TB cases across EU countries in the period 2003 to 2007 (1). It also 
identified possible transmission patterns and risk factors for MDR-TB and XDR-TB, 
such as country of origin and infection with the Beijing genotype (2). Following 
up on these findings, the European Centre for Disease Prevention and Control 
(ECDC) initiated a molecular surveillance project on MDR-/XDR-TB in the EU from 
2009 to 2012 which was built on the existing TB network previously funded by 
the European Commission. This new project, carried out by the National Institute 
for Public Health and the Environment (RIVM) on behalf of the ECDC, aimed at 
achieving a higher coverage by expanding molecular typing to countries in the EU 
where this was not yet the practice. For this purpose, the 24-locus mycobacte-
rial interspersed repetitive unit variable number of tandem repeat (MIRU-VNTR) 
 typing method was selected as the main DNA fingerprinting methodology (3). This 
method has become the international gold standard for typing of Mycobacterium 
tuberculosis isolates and offers important advantages over IS6110 RFLP typing, 
while its discriminatory power equals that of IS6110 (3,4). Firstly, VNTR typing 
is easier to perform than RFLP typing and can be implemented more efficiently in 
countries that do not yet perform molecular typing. Secondly, it is based on DNA 
amplification, which abolishes the need for culture of M. tuberculosis and has a 
shorter laboratory turnaround time. Moreover, this approach uses low quantities 
of DNA and allows exchange of (non-viable) mycobacterial culture material by 
regular mail. Finally, the results of VNTR typing are in a simple format, which fa-
cilitates efficient exchange of typing information and inter-laboratory comparison. 
In principle, this introduces more real-time typing and rapid feedback on molecu-
lar clustering to identify newly emerging MDR-/XDR-TB strains. 
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This paper describes the major findings of the ECDC/RIVM project regarding 
the detection of international clusters, the molecular typing coverage of MDR-/
XDR-TB cases, the conclusions drawn from molecular analysis and recommenda-
tions for the future development of molecular surveillance of MDR-/XDR-TB in the 
EU.
METHODS
Project design. Molecular typing data of MDR-/XDR-TB cases from EU coun-
tries were collected in the period from 2009 to 2011 by the RIVM in Bilthoven, the 
Netherlands. Furthermore, retrospective typing of isolates collected from patients 
in the period from 2003 to 2008 and real-time typing of isolates collected from pa-
tients from 2009 to the end of 2011 were included. The RIVM reported clustering 
of MDR-/XDR-TB cases to the ECDC on a regular basis. In addition, the implemen-
tation, standardisation and quality control of VNTR typing in all participating coun-
tries was facilitated by ad hoc email contact, on-site training, by project meetings 
and workshops, and also by the introduction of a proficiency testing programme 
for VNTR typing (5). The collection of samples did not follow a rational selection 
but was driven by the specific situation in the different participating countries.
Participants in the project. This molecular surveillance project was designed 
for all EU, European Economic Area (EEA), and EU candidate countries. The coun-
tries with national reference laboratories participating in the project were: Aus-
tria, Belgium, Bulgaria, Croatia, Cyprus, the Czech Republic, Denmark, Estonia, 
Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Liechtenstein, 
Lithuania, Luxembourg, the Netherlands, Norway, Poland, Portugal, Romania, Slo-
vakia, Slovenia, Spain, Sweden, Turkey and the United Kingdom.
MIRU-VNTR typing. The standard for typing M. tuberculosis complex strains 
was the method described by Supply et al. in 2006 (3). The RIVM offered MIRU-
VNTR typing to the countries that were not able to perform the technique locally or 
were not performing it for other reasons. Specifically, the RIVM performed VNTR 
typing for Cyprus, the Czech Republic, Estonia, Greece, Hungary, Latvia, Norway, 
Slovakia and Spain, and partial typing for Finland and Lithuania.
Drug susceptibility testing. Phenotypic drug susceptibility testing (DST) was 
performed by the TB reference laboratories participating in the project. All M. tu-
berculosis isolates were tested at least for resistance to the first-line antibiotics 
rifampicin and isoniazid, and part of the strains were also tested for resistance 
against second-line antibiotics such as fluoroquinolones and the injectable drugs 
(capreomycin and aminoglycosides), according to national guidelines for DST. All 
participating laboratories were members of the European Reference Laboratory 
Network (ERLN)-TB and had their own national accreditation.
Molecular assessment of susceptibility by MTBDRplus assay. We se-
lected for molecular assessment strains that belonged to the largest European 
MDR-TB cluster, with a view of including a wide spread of country and year of 
isolation. For selected strains, the GenoType MTBDRplus reverse line blot method 
(HAIN Lifescience, Nehren, Germany) (6) was applied to detect mutations in the 
rpoB gene associated with rifampicin resistance and mutations in the katG gene 
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and the inhA gene associated with isoniazid resistance.
Table 1  Information on the total number of notified culture-confirmed MDR-TB 
cases, submitted by country to the ECDC (TESSy system), and the coverage in 
the molecular surveillance project, in the period of 2003-2011. More than 100% 
coverage is the result of incomplete culture data collection by the ECDC
Couintry of 
isolation
2
0
0
3
2
0
0
4
2
0
0
5
2
0
0
6
2
0
0
7
2
0
0
8
2
0
0
9
2
0
1
0
2
0
1
1
Total (n) 
ECDC 
reported 
2003-
2009
Total (n) 
mol. Sur-
veillance 
2003-
2011
Cove-
rage
Austria 12 19 13 10 9 15 22 15 19 134 NR NA
Belgium 9 12 11 18 14 21 10 19 15 129 30 23%
Bulgaria 44 47 47 53 76 31 43 56 55 452 141 31%
Croatia 8 3 7 3 3 4 7 NR 2 37 56 151%a
Cyprus 0 0 1 0 3 1 4 0 1 10 1 10%
Czech Rep. 2 6 13 12 8 11 8 9 7 76 37 49%
Denmark 0 0 5 3 2 0 2 2 3 17 15 88%
Estonia 106 90 78 55 82 73 85 63 78 710 557 78%
Finland 3 0 2 2 2 1 6 6 5 27 20 74%
France 25 26 24 30 20 27 30 23 40 245 87 36%
Germany 91 98 103 82 66 49 62 48 56 655 62 9%
United 
Kingdom
52 47 40 51 56 53 60 60 81 500 120 24%
Greece 22 16 12 13 14 0 14 0 5 96 48 50%
Hungary 20 11 17 14 12 13 18 19 7 131 36 27%
Ireland 1 2 3 4 7 2 1 2 3 25 18 72%
Italy 42 24 22 28 56 71 82 87 81 493 248 50%
Latvia 174 195 161 142 99 128 131 87 95 1212 30 2%
Liechtenstein NR NR NR NR NR NR NR NR NR 0 NR NA
Lithuania 312 318 338 332 314 276 322 310 296 2818 73 3%
Luxembourg 1 1 0 0 0 0 0 0 2 4 NR NA
Norway 3 4 3 3 3 4 8 8 4 40 28 70%
Poland 92 51 46 32 22 19 21 30 41 354 NR NA
Portugal 23 35 31 22 34 32 24 19 22 242 NR NA
Romania 585 810 849 673 673 792 624 502 530 6038 NR NA
Slovakia 6 1 8 7 7 4 1 1 3 38 13 34%
Slovenia 1 0 1 1 0 2 1 0 0 6 6 100%
Spain 47 59 80 50 59 76 56 49 41 517 242 47%
Sweden 7 6 4 3 15 11 13 18 17 94 75 80%
The 
Netherlands
8 3 3 5 3 13 20 11 15 81 92 114%a
Turkey 0 0 191 249 240 263 222 250 262 1677 20 1%
Total 16,858 2,055 12%
NA: not applicable; NR: not reported; ECDC: European Centre for Disease Prevention and 
Control; TESSy: The European Surveillance System at ECDC.
aMore than 100% coverage is the result of incomplete culture data collection by the ECDC.
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Coverage. Based on the tested samples from the period 2003 to 2011, we de-
fined the coverage of molecular fingerprinting of MDR-/XDR-TB as the percentage 
of MDR-/XDR-TB isolates included in the molecular surveillance project among the 
total number of MDR-/XDR-TB cases officially reported to the ECDC for the same 
period. The ECDC published the surveillance results in The European Surveillance 
System (TESSy) and in the annual surveillance reports.
Clustering. A European cluster was defined as two or more MDR-/XDR-TB 
strains with identical 24-locus VNTR typing patterns, isolated in at least two diffe-
rent countries. Results for 15-locus VNTR typing and VNTR patterns for which one 
or more loci were missing were also included in the cluster analysis.
Beijing genotype identification. The Beijing genotype was identified by the 
specific Beijing branch of the dendrogram with a similarity percentage of 24-locus 
VNTR typing of at least 60%. The Beijing branch was determined by 656 iso-
lates confirmed as the Beijing genotype based on spoligotyping. The non-Beijing 
branches were confirmed as such by spoligotyping of 201 isolates.
RESULTS
Coverage. The countries participating in the project reported 16,858 MDR-/
XDR-TB cases to the ECDC for the period 2003 to 2011. The total number of MDR-/
XDR-TB isolates collected in that period for which VNTR typing data were available 
amounted to 2,055. Therefore, the coverage of the molecular surveillance for the 
period 2003 to 2011 was 12%. Six countries reported no molecular typing results 
at all; excluding these countries, the coverage was 20%. The coverage differed 
significantly by country and year (Table 1).
Figure 1  Number of VNTR patterns of multi- and extensively drugresistant Mycobacterium 
tuberculosis isolates included in the molecular surveillance project, by country of isolation, 
sampled 2003–2011 (n=2,092)
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Typing. We collected 2,092 VNTR patterns, originating from 2,055 MDR-/XDR-
TB patients sampled between 2003 and 2011 in 24 different countries (Figure 1). 
There were more VNTR patterns than isolates because double alleles were de-
tected in the VNTR patterns of 37 isolates that were included in the project data-
base as separate patterns. For 53% (n=1,093) of the included isolates, the typing 
results were produced by the reference laboratory of the country of isolation, and 
for 47% (n=962) the molecular typing was performed at the RIVM.
The number of isolates included per year is depicted in Figure 2; 2009 was the 
year with the highest number of isolates included (n=415). The sex was known 
for 69% (n=1,428) of the cases whose isolates were typed: 70% (n=999) of the 
MDR-/XDR-TB cases were male and 30% (n=429) female. The age at the time of 
TB diagnosis was available for 68% (n=1,402) of the MDR-/XDR-TB cases included 
in this study: their mean age was 40 years (range: 1–88 years).
Clustering. Comparison of the 2,092 VNTR patterns included in the project 
resulted in the detection of 79 European clusters. The cluster sizes varied from 
two to 470 cases per cluster (Figure 3). In total, 45% (n=941) of all the collected 
VNTR patterns were part of a European cluster. The geographic composition of 
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Figure 2  Mycobacterium tuberculosis isolates included in the molecular surveillance pro-
ject, by year of isolation, 2003–2011 (n=2,055)
Table 2   24-locus VNTR pattern of the largest MDR-TB cluster detected in the 
EU with a Beijing genotype signature.
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these molecular clusters ranged from two to 17 countries. For 73% (n=691) of 
the European clustered cases, the country of origin of the patient was known. In 
total 73% (n=505) of these patients were resident in the country of isolation and 
27% (n=186) originated from abroad. Excluding all clustered cases from Estonia 
(n=490 for which the country of origin was known) because of the overrepre-
sentation of samples from Estonia, the distribution was 44% (n=89) and 56% 
(n=112), respectively, for the 201 samples for which country of origin was known.
The percentage of samples assigned to a European MDR-/XDR-TB cluster, for 
the countries which submitted at least 10 isolates to the project database, varied 
from 0 to 87% by country. Clustering on national level was also analysed in this 
study and varied from 0 to 92% by country (Figure 4). A number of the VNTR 
typing patterns (n=465; 22%) did not cover all of the 24 loci due to technical 
problems or because these loci were not tested in the participating laboratories. 
In total 60 samples with incomplete VNTR patterns were part of molecular clusters 
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Figure 3  Size of European clusters of multi- and extensively drug-resistant tuberculosis 
cases detected in the molecular surveillance project, 2003–2011 (n=79 clusters)
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Figure 4  Percentage of cases in European (n=941) and national (n=1,086) clusters of 
multi- and extensively drug-resistant tuberculosis, by country, molecular surveillance pro-
ject, 2003–2011
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(among them 32 samples of the Beijing genotype): 48% (n=29) of the samples 
with incomplete VNTR patterns were part of 22 European clusters, while 52% 
(n=31) of them belonged to European clusters which had already been defined 
on the basis of 24-locus VNTR results from at least two other samples from two 
different countries. 
Of all clustered isolates included in the project database, 60% (n=470) were 
part of one large VNTR typing cluster (Figure 3; Table 2). This molecular cluster, 
comprising a VNTR pattern with a Beijing genotype signature, has so far been 
detected in 17 EU countries. The majority of cases that belonged to this cluster 
were detected in the Baltic States, mainly in Estonia (Figure 5). Because of the 
high coverage of reported cases in Estonia, 98% for the period 2003 to 2009, 
the growth dynamics of this largest molecular cluster are depicted in Figure 6. In 
2009, 72 isolates in the cluster originated from Estonia; in the following years, 
this number decreased to 42–55 isolates per year. 
For a selection of 48 (10%) isolates in the largest molecular cluster, isolated 
in different countries and years, we determined the mutations underlying the 
resistance mechanism. All but one of the tested MDR-/XDR-TB isolates in the 
VNTR cluster with Beijing genotype revealed the same combination of mutations 
associated with rifampicin and isoniazid resistance: rpoB S531L and katG S315T. 
One exceptional MDR-/XDR-TB isolate harboured the rpoB H526Y and katG S315T 
mutations. For 39 of these 48 strains, the resistance to fluoroquinolones and the 
injectable drugs was tested phenotypically: 12 were resistant to both, five only to 
fluoroquinolones, 12 only to injectable drugs, and 10 showed no resistance.
Characteristics of clustered MDR-/XDR-TB cases. Sex and age did not 
differ between clustered and nonclustered cases. The overall mean age was 40 
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Figure 5  Geographical distribution of cases in the largest European multi- and extensively 
drug-resistant tuberculosis cluster 2003–2011 (n=470)
BE: Belgium; CZ: Czech Republic; DE: Germany; DK: Denmark; EE: Estonia; ES: Spain; 
FI: Finland; FR: France; GR: Greece; IE: Ireland; IT: Italy; LT: Lithuania; LV: Latvia; NL: 
the Netherlands; NO: Norway; SE: Sweden; UK: United Kingdom.
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years (range: 1–88 years). The percentage of VNTR patterns who were part of 
a European cluster was 54% (n=548) for isolates from male cases and 49% 
(n=213) for isolates from female cases.
Forty-four per cent (n=920) of the analysed VNTR patterns of MDR-/XDR-TB 
isolates were assigned to the Beijing genotype with a similarity of at least 74% 
on the basis of 24-locus VNTR typing. For 71% (n=656) of the 920 isolates, the 
Beijing genotype was confirmed by RFLP typing and/or spoligotyping and a non- 
Beijing genotype was confirmed for 17% (n=201) of the 1,173 strains identified 
as non-Beijing. 
In total, 77% (n=726) of the clustered cases were caused by Beijing genotype 
strains with 37 different VNTR patterns (the two largest molecular clusters were 
caused by Beijing genotype strains). Among non-clustered cases, 17% (n=194) 
were caused by Beijing strains (p<0.05). The mean age for MDR-/XDR-TB cases 
caused by Beijing genotype strains was not different from that of non-Beijing 
MDR-/XDR-TB cases: 41.9 vs 39.5 years. In relation to the sex distribution, the 
Beijing genotype was more often detected in male than in female patients: 53% 
(n=539) vs 47% (n=206).
The susceptibility of the M. tuberculosis  strains to second-line drugs was 
known for 53% (n=1,080) of the isolates. Twelve per cent (n=132) of them were 
XDR-TB, and 135 VNTR patterns were found for them. There were significantly 
more men than women among XDR-TB patients: 69% (n=91) vs 23% (n=31) 
(p<0.05). XDR-TB was significantly more often detected in MDR-TB strains of the 
Beijing genotype than in MDR-TB (n=19) (p<0.01). In addition, 78% (n=105) of 
the XDR-TB VNTR patterns belonged to eight international clusters; six of these 
clusters were determined as the Beijing genotype.
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Figure 6  Multi- and extensively drug-resistant Mycobacterium tuberculosis isolates be-
longing to the largest European cluster, by year, Estonia, 2003–2009 (n=384)
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DISCUSSION
Almost half of the VNTR patterns collected in this molecular surveillance study 
of MDR/XDR M. tuberculosis was assigned to international European clusters, and 
60% of these were part of a single, large European cluster. This molecular cluster, 
associated with the spread of a Beijing genotype strain, has so far been detected 
in 17 European countries. It was previously described in the EU by RFLP typing 
and notified for the first time in 2003 (1, 2). The RFLP typing results were available 
for 63% (n=125) of the isolates obtained from the largest VNTR cluster in 2003 
to 2005. This confirmed the clustering of these cases on the basis of both RFLP 
and VNTR typing. Overall, the Beijing genotype was significantly associated with 
clustering, and therefore with possible (international) transmission and spread.
The high proportion of molecular clustering (45%) in the EU suggests that 
MDR-/XDR-TB cases may be transmitted and not acquired. The lack of coverage 
and the wide variation in the number and time period of collected samples sub-
mitted by the participating countries, however, reduce the representativeness of 
this observation. Furthermore, a high proportion of the European clustered cases 
(73%) were patients originating from the country of isolation rather than immi-
grants. Even when excluding all Estonian isolates, the percentage was still 44%. 
This confirms that MDR-/XDR-TB transmission was taking place and that not all 
detected molecular clusters were a result of human migration.
The high percentage of European and national clustering, especially in Estonia 
(87% and 92%) and Latvia (72% and 66%), indicates that transmission has been 
ongoing in this region for a prolonged period (7), and this calls into question the 
infection control practices and the quality of treatment. In contrast, the low per-
centage of clustering in Italy (8%) and Spain (15%) indicates that the MDR-TB 
problem in these regions is mainly due to TB imported by immigration from coun-
tries not participating in the project, as suggested earlier (8, 9). In addition, coun-
tries with a higher percentage of European clustering compared to the percentage 
of national clustering, e.g. the Netherlands (41% vs 23%) and Finland (57% vs 
19%), are examples of importation of MDR-/XDR-TB from European countries and 
a health system that prevents national transmission.
XDR-TB was detected in 12% (n=132) of the M. tuberculosis isolates for which 
second-line drug susceptibility data was available. This is slightly higher than de-
scribed earlier for the MDR-TB cases examined in the period 2006 to 2009 (2). The 
Beijing genotype is associated with multidrug resistance in many settings (10). In 
this European surveillance project, the Beijing genotype was significantly associ-
ated with XDR-TB, in contrast to strains of non-Beijing genotypes: respectively 
86% (n=116) and 14% (n=19). The association of the Beijing genotype with re-
sistance has been studied extensively; potential underlying mechanisms include 
a higher mutation frequency of the rpoB gene in strains of the Beijing genotype, 
resulting in a higher ability to withstand rifampicin exposure (11).
The most important limitation of our study is the poor coverage and thus the 
possible selection bias; the percentage of MDR/XDR M. tuberculosis isolates that 
were actually submitted by the participating countries in the period from 2003 
to 2011 ranged from 0% to more than 100%. Limited coverage also affected the 
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timeliness of delivery of data. Several countries, including a few large ones, re-
ported limited data, although it was agreed in the project to send real-time typing 
results. The effect of this limitation is a possible underestimation of international 
transmission of MDR-/XDR-TB in the EU. An important implication of our study is 
that especially in western EU countries, the percentage of clustered MDR-/XDR-TB 
cases is low. This implies that resistance was either acquired in the patient in the 
country where the strain was isolated, or a consequence of sequential import of 
unrelated cases from endemic regions.
In contrast, in the eastern EU countries and especially the Baltic States, a large 
proportion of MDR-/XDR-TB isolates belonged to molecular clusters. Moreover, one 
large molecular cluster of 470 cases was caused by Beijing strains with identical 
24-locus VNTR typing patterns. This implies major and ongoing transmission of an 
easily transmissible and virulent strain or clone. Forty-seven of the 48 tested iso-
lates in the largest molecular cluster had the same combination of rpoB S531L and 
katG S315T mutations, associated with rifampicin and isoniazid resistance. There 
is bacteriological and epidemiological data demonstrating that these mutations re-
sult in the lowest loss of fitness in isoniazid- and rifampicin-resistant bacteria (12, 
13). Resistance to second-line drugs was high variable. The largest international 
cluster may therefore be caused by one successful MDR-/XDR-TB strain that is re-
sponsible for many transmissions, with resistance to secondline drugs developing 
further in the affected patients. Alternatively, we may be observing the spread of 
genetically highly similar strains of the Beijing genotype. By whole-genome se-
quencing, the true percentage of similarity can be determined, and this will help 
to answer this question.
Another important limitation in this study was the lack of epidemiological data 
to confirm chains of human transmission. Although the typing data are highly sug-
gestive of spread of successful strains, this still needs to be confirmed.
For this project, we selected VNTR typing as the standard method. This tech-
nique was previously shown to be highly reproducible, both within (14) and be-
tween laboratories (15). However, the participants of the ECDC/RIVM project used 
a large variation in protocols and methodologies and had different levels of experi-
ence in performing VNTR typing. Therefore, we performed two proficiency studies; 
initial results were disappointing regarding both the intra- and inter-laboratory 
reproducibility (5). Although several suggestions for improvements were com-
municated to participants, this lack in quality may still have influenced the results 
of the current study, leading to an underestimation of clustering cases. After im-
plementation of several improvements in the methodology and a higher degree 
of standardisation, the second international proficiency study in 2010 on VNTR 
typing yielded much better results (16). 
In conclusion, large-scale international transmission of MDR-/XDR-TB occurs 
within the EU and demands increased surveillance and public health action. The 
M. tuberculosis strains with Beijing genotype are large drivers of this international 
transmission and are associated with the emergence and spread of XDR-TB.
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ABSTRACT
The Mycobacterium tuberculosis ECDC0002 cluster, characterized by a unique 
fingerprinting profile, continues to spread in the European region and is respon-
sible for a significant proportion of all clustered multidrug resistant tuberculosis 
(MDR-TB) cases in Eastern Europe. This prompted research into potential geneti-
cally encoded selective advantages in these strains. 
In 58 of 59 (98%) ECDC0002 cluster MDR-M. tuberculosis isolates tested, 
identical mutations conferring rifampicin and isoniazid resistance were detected. 
Whole genome sequencing of nine ECDC0002 isolates identified a unique rpoC-
F452S mutation with a potential compensatory function for the expected loss 
of fitness due to the mutation in the rpoB gene. We screened for this muta-
tion in other MDR/XDR (n=24), INH-monoresistant (n=15) and pan-susceptible 
(n=2) isolates with the ECDC0002 VNTR pattern and in 95 unrelated strains. The 
rpoC-F452S mutation proved restricted to MDR-M. tuberculosis isolates of the 
ECDC0002 cluster, suggesting this may be an important factor in the emergence 
of this MDR-TB cluster. Interestingly, the rpoC-F452S mutation was only detected 
in ECDC0002 isolates with both an MDR phenotype and an embB-M306V mutation 
associated with ethambutol resistance.
A compensatory role for the rpoC-F452 is likely as its appearance was strictly 
limited to M. tuberculosis strains carrying a rpoB-S531L mutation and it is located 
in the region usually harboring these compensatory mutations; the rpoC-F452C 
mutation has also arisen independently in a rpoB-S531L non-Beijing genotype 
strain. The combination of the low fitness-cost rpoB-S531L and katG-S315T mu-
tations associated with rifampicin and isoniazid resistance along with the putative 
compensatory rpoC-F452S mutation may, in part, explain the successful spread 
of this MDR-TB outbreak strain. This “super-spreader” strain demands continued 
monitoring and fundamental research is required into its evolutionary develop-
ment. Highly transmissible MDR strains threaten TB control efforts worldwide.
INTRODUCTION
Tuberculosis (TB) remains one of the most important bacterial infectious dis-
eases, causing  an estimated 1.5 million deaths worldwide each year. The effective 
control of TB is hampered by the emergence and spread of drug-resistant forms of 
the disease, mainly multidrug-resistant TB (MDR-TB). MDR-TB is caused by M. tu-
berculosis strains resistant to at least rifampicin and isoniazid, two most effective 
drugs included in current first line treatment regimen, and typically carry resist-
ance-conferring mutations in rpoB and katG genes (1). In regions where MDR-TB 
is highly endemic, such as Eastern Europe, Central and Southeast Asia and South 
Africa, the evolution to more resistant and thereby less treatable forms of TB has 
already been observed (1).The spread of MDR-TB in Europe is monitored, within 
the framework of an ECDC project, by 24-locus variable number of tandem repeat 
(VNTR) typing. This project revealed a high degree of molecular epidemiologi-
cal clustering among MDR-TB cases (51%; 451/892). Moreover, a large MDR-TB 
cluster was detected, representing 22% (451/2068) of all MDR-TB isolates typed 
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within the framework of this project (2). This cluster was designated ECDC0002 
and by overlapping typing tests proved identical to the previously observed domi-
nant cluster EU0051 (3), the Europe-Russia B0/W148 outbreak described by Mok-
rousov et al. (4) and Beijing lineage strain MtbC 15-9 type 100-32, according to 
the standard VNTR typing nomenclature (5, 6); this indicates that this Beijing 
genotype clone continues to spread within the European region and remains re-
sponsible for more than half of all clustered MDR-TB cases in Europe (2).
The successful spread of this MDR-M. tuberculosis clone remains unexplained. 
The different mutations underlying isoniazid and rifampicin resistance in M. tu-
berculosis seem to infer different fitness costs (7, 8). Recent studies have high-
lighted the potential impact of compensatory mutations that reduce or eliminate 
the fitness cost inferred by rpoB gene mutations (9, 10, 11, 12). In addition, it is 
unknown whether this cluster is the result of clonal spread of an individual strain 
that developed a MDR phenotype and managed to maintain or re-establish its 
ability to spread within the human population, or whether the strains belong to a 
MDR-/XDR-TB isolates European study (7)
n = 2055
Cluster ECDC0002
n = 452
First-/second line drug resistance detected 
n = 59
Whole Genome Sequencing
n = 9
Whole Genome Sequencing
n = 1
Detected in 17 European countries, 
mainly Estonia
Selection based on availability, country and year of isolation
Tested by Genotype MTBDRplus and
MTBDRsl reverse line blot method, table 3
Selection based on variability in year of isolation and second  line 
drug resistance after sample reduction because of high quality 
and quantity DNA availability.
Additional strain INH monoresistant, 
identical VNTR pattern to the ECDC0002 
cluster
Figure 1  Schematic overview of the strains selected and used in this study
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clone that can repeatedly generate resistant, but fit, mutants which have emerged 
independently in multiple locations.
To gain insight into bacteriological factors associated with the successful 
spread of this strain and to discriminate between clonal spread of a single mutant 
or multiple independent generation of a resistant genotype, we performed whole 
genome sequencing of a set of representative isolates from the ECDC0002 clus-
ter as well as from unrelated M. tuberculosis isolates for comparison. A potential 
compensatory SNP strongly associated with the successfully spreading MDR-M. 
tuberculosis ECDC0002 strains in Europe was identified
MATERIAL AND METHODS
Strains. The ECDC0002 cluster consists of 452 M. tuberculosis isolates with 
identical MIRU-VNTR profiles, all of which had either a MDR-TB or XDR-TB profile 
(table 1). For this study we selected 59 isolates, based on availability and year of 
isolation. To enable detection of genetic traits specific to the ECDC0002 cluster, 
Table 1 Country of isolation of the MDR-TB strains that belong to the ECDC0002 
cluster and the selection of strains used for molecular drug resistance testing
Country of 
isolation
ECDC0002 MDR- 
M. tuberculosis isolates (n)
ECDC0002 MDR-M. tuberculosis 
isolates selected for molecular 
susceptibility testing (n=59)
Czech Republic 3
Denmark 1
Estonia 384 39
Finland 4 4
France 9 6
Germany 11
Greece 2 1
Ireland 5
Italy 4
Latvia 6
Lithuania 3 3
The Netherlands 2 2
Norway 4 4
Poland 1
Spain 3
Sweden 4
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we included unrelated strains with different characteristics regarding genotype, 
susceptibility and geographic origin. In addition, a selection of isolates from the 
second and third largest European MDR-TB outbreaks was included.
To identify characteristics specific to the MDR members of the cluster, we as-
sembled a set of control strains, including 14 isoniazid-monoresistant isolates 
(from Estonia and The Netherlands) and two pan-susceptible isolates (from Bel-
gium and Ireland) with identical VNTR pattern to the MDR-TB isolates of the 
ECDC0002 cluster as well as 95 MDR-M. tuberculosis isolates from all major geno-
type families. Figure 2 gives an schematic overview of the selected strains.
Drug resistance testing by MTBDR assays. The Genotype MTBDRplus re-
verse line blot method was used to detect mutations associated with isoniazid and 
rifampicin resistance, and the Genotype MTBDRsl was used to detect mutations in 
the gyrA, 16S rDNA and embB genes which are associated with fluoroquinolones, 
aminoglycosides/injectables and ethambutol resistance, respectively (13, 14). 
The selected M. tuberculosis isolates (n=59) isolated in six different European 
countries (table 1) were tested for mutations associated with first- and second 
line drug resistance.
Whole genome sequence analysis. Genomic DNA of 10 M. tuberculosis iso-
lates from the country with the highest prevalence of TB strains belonging to 
MDR-TB ECDC0002 cluster, Estonia, were selected for whole genome sequencing. 
Nine were phenotypically MDR-M. tuberculosis, with different mutations associ-
ated with resistance to second-line antituberculosis drugs by the Genotype MTB-
DRsl, one isolate was INH-monoresistant but yielded the ECDC0002 MIRU-VNTR. 
All were sequenced on an Illumina HiSeq 2000 as paired-end reads of 100 nu-
cleotides. Whole genome sequences of the M. tuberculosis isolates were analyzed 
to identify resistance- and other SNPs and regions of difference (RDs) using the 
ROAST software (unpublished, Hijum et al) which maps Illumina sequence reads 
to the H37Rv reference genome NC_000962.3 using blat (15). ROAST counts the 
number of mapped reads and the number of bases identical to reference sequence 
and the number of mismatches at each position in the genome. H37Rv was used 
as the reference genome for SNP calling. The isolates were first compared to pub-
lished isolates using 268 SNPs, previously described by Schürch et al. (16) to place 
them on the M. tuberculosis phylogenetic tree. In addition, 1006 SNPs and InDels 
were selected to enhance the resolution of typing among the sequenced isolates 
as the 268 SNPs could not distinguish the sequenced isolates. SNPs were called in 
Figure 2  Phylogeny based on analysis of 1,006 SNPs. EEA200503811 is INH mono-resist-
ant, other EEA strains are MDR-TB.
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unique sequences that were at least five kb apart, not exclusively present in the 
5’ or 3’ end of the sequence reads and in which the mutation was represented by 
at least 10 fold more reads than the number of reads with the reference base in 
the H37Rv reference strain and where the mutation was represented by at least 
20 reads. SNPs present in PP/PPE encoding genes, antibiotic resistance-associated 
genes or in regions of difference (RDs) were excluded from subsequent analyses. 
To avoid the effect of homoplasy we performed a filtering procedure to remove un-
informative SNPs, similar to the selection of the 268 SNPs by Schürch et al. (16). 
The results of the SNP typing for the 268 and 1006 SNPs were concatenated and 
treated as alignments for each isolate. A phylogenetic tree was inferred and visu-
alized with Splitstree (Huson 17) and iTOL (Letunic 18), respectively. Sequences 
were submitted to the European Nucleotide Archive (http://www.ebi.ac.uk/ena/
data/view/PRJEB11990). To assess the specificity of potentially important SNPs to 
Table 2  Strains of the control group of unrelated M. tuberculosis isolates
Description Beijing (B)/ 
Non-Beijing (NB)
Country of 
isolation
Resistance and 
number of samples 
tested (n)
Second largest MDR-TB 
cluster in Europe B
EE XDR (2)
NL MDR (1)
Third largest MDR-TB clus-
ter in Europe NB EE MDR (2)
Dutch cluster with variable 
susceptibility patterns B NL
pan-susceptible (2)
INH-R (2)
MDR (2)
Dutch cluster with variable 
susceptibility patterns NB NL
pan-susceptible (1)
MDR (1)
Dutch MDR-TB cluster NB NL MDR (2)
Dutch MDR-TB cluster NB NL MDR (2)
Dutch strains, unique, 
without detected transmis-
sion
B NL MDR (2)
NB NL MDR (1)
Colombian cluster B Colombia MDR (3)
Colombian cluster B Colombia MDR (3)
Colombian cluster B Colombia MDR (2)
Colombian strain B Colombia MDR (1)
Colombian strain B Colombia pan-susceptible (1)
Argentinean clustered and 
unique strains NB Argentina MDR (21)
Belgium strains 2003-2011 B and NB Belgium MDR (44)
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the clustered isolates, we set up a control panel of 95 unrelated M. tuberculosis 
isolates (table 2).
Protein modeling. To predict the effect of specific mutations detected by 
whole genome sequencing, protein structural modeling was used, as has been 
shown for rpoC-D485N (21). To predict the effect of the mutations on the change 
in stability of the RNA polymerase holoenzyme, the S450L, the F452S and the re-
cently described rpoC-F452C mutation (9) were introduced in the structure of RNA 
polymerase of Thermus thermophilus (PDB 4gzy) (19) and analyzed using FoldX 
(20). A decrease in free energy was considered to enhance protein stability. The 
mutations associated with rifampicin, isoniazid and second-line drug-resistance in 
the 59 MDR-TB ECDC0002 cluster isolates are presented in table 3.
Whole genome sequence analysis identified the ten ECDC0002 cluster isolates 
(9 MDR, 1 INH-monoresistant) as ‘modern’ Beijing strains (16) and confirmed the 
mutations associated with first- and second-linedrug-resistance (table 4). Com-
parison with H37Rv identified 2,397 SNPs in these isolates, 1,837 of which were 
common to all 10 sequenced isolates, while 560 SNPs differed between these 
Table 3  Mutations associated with first- and second line drug resistance 
detected in isolates with the ECDC0002 VNTR pattern, by Genotype MTBDRplus 
and MTBDRsl reverse line blot method. M306I* ATG->ATA
S
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isolates. After correcting for uninformative SNPs we retained 1,006 SNPs, with 
only 62 SNPs differing between the isolates and 944 SNPs differing from H37Rv. 
Phylogenetic analysis of this 1,006 SNP marker showed the relatedness and the 
ancestry between these isolates (figure 2). All MDR-M. tuberculosis isolates se-
quenced had an rpoC-F452S mutation.
Phylogenetic analysis using the 268 typing SNPs showed that the 10 Estonian 
isolates sequenced form a single clade and a separate subgroup within the Bei-
jing genotype family. The ECDC0002 cluster is identical to the M. tuberculosis     
B0/W148 Beijing variant (4) and falls within clonal complex two of the Beijing 
genotype (22).
The presence of the rpoC-F452S mutation was tested for the additional 31 M. 
tuberculosis isolates with the specific ECDC0002 24-locus VNTR pattern (15 MDR, 
14 INH-monoresistant, 2 pan-susceptible and for 95 M. tuberculosis isolates of the 
control group (table 2). It was only detected in MDR-M. tuberculosis isolates of the 
ECDC0002 cluster that also had the embB-M306V mutation (n=9). It was absent 
in ECDC0002 cluster MDR-M. tuberculosis strains without an embB-M306V muta-
tion (n=6), INH-monoresistant strains (n=14), pan-susceptible strains (n=2)and 
the 95 control group strains.
Although F452 is located in the region that carries many (putative) compen-
satory mutations, a direct interaction between the aminoacids rpoB-S531 and 
rpoC-F452 could not be shown using structural modeling. FoldX analysis showed 
a change in stability of the holoenzyme because of the rpoC-F452S mutation. The 
rpoB-S531L mutation increases the stability of the protein as the free energy is 
lowered by-3.10 kcal/mol, which increasing the rigidity of the structure. This could 
prevent rifampicin from binding, but may also affect the activity of the holoen-
zyme. The rpoC-F452S mutation increases the free energy of the rpoC protein by 
6.23 kcal/mol and this could compensate for the increase in rigidity. The rpoC-
F452C mutation results in an increase of free energy of 5.52 kcal/mol.
DISCUSSION
The MDR-M. tuberculosis isolates of the ECDC0002 cluster with the  embB-M306V 
mutation harbor a putative rpoC-F452S mutation. The accumulation of mutations 
in the genome that compensate for a loss of fitness due to rpoB mutations result-
ing rifampicin resistance, has been described for two subunits of the RNA poly-
merase gene; rpoA and rpoC (9, 10). Recently, Casali et al. described a specific 
rpoC-F452S mutation that may play a role in the fitness restoration of isolates 
carrying the rpoB-S531L mutation (23). The rpoC-F452S mutation was detected 
in one M. tuberculosis strain, originating from the Russian federation. The VNTR 
pattern of this single strain was identical to the ECDC0002 cluster (M. Stone, 
Personal Communication). Our results confirm the association of the rpoC-F452S 
mutation with MDR-TB isolates with the ECDC0002 cluster genotype. 
This cluster, as defined by 24-loci VNTR typing, is present globally. It has been 
detected in Japan (24), USA (25), Russia (4), China (26, 27), in all cases associ-
ated with drug resistance. Detailed genotyping of these strains circulating world-
wide would be interesting to determine the evolutionary history of this cluster.
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The MDR-M. tuberculosis ECDC0002 clone remains capable of transmission 
and causes disease in large numbers of people. In line with previously published 
studies on the role of compensatory mutations for fitness restoration (10, 21), 
we hypothesize that the rpoC-F452S mutation contributes to the success of the 
ECDC0002 cluster. The combination of mutations associated with rifampicin and 
isoniazid resistance detected for most of the investigated ECDC0002 isolates is 
identical (rpoB-S531L and katG-S315T) and there is bacteriological and epide-
miological data demonstrating that these are the most favorable with respect to 
bacterial survival and transmission (28). Gagneux et al. demonstrated that the 
loss of fitness for clinical strains with this combination of mutations is minimal, 
which likely explains the dominance of this combination of mutations in clustered 
MDR-M. tuberculosis isolates worldwide (28, 29).
The limited genetic diversity detected in the WGS analysis presented here 
(Figure 2) suggests that the cases of MDR-TB caused by this genotype represent 
transmission of a highly transmissible clone which has expanded relatively re-
cently. The nine MDR-M. tuberculosis strains of the large cluster investigated by 
whole genome sequencing differed in only 30 SNPs from the INH-monoresistant 
strain of the same VNTR cluster. This also suggests that the INH-monoresistant 
variant is a member of a precursor clade of the highly successful MDR-M. tuber-
culosis strains. The genomic diversity of strains from the same VNTR cluster with 
a variation in resistance is in line with the results of an earlier published study on 
one drug-susceptible and one MDR-M. tuberculosis strain of the Beijing genotype 
that has been identified as the second most predominant MDR-M. tuberculosis 
strain in Europe (30). 
Although we were unable to identify any evidence of direct interaction of the 
rpoC-F452S mutation with either the RNA/DNA hybrid, or the rifampicin resist-
ance mutation rpoB-S531L using protein structural modeling (results not shown) 
as has been shown for rpoC-D485N (21), the location of the rpoC-F452S mutation 
is in the region that carries many (putative) compensatory mutations. One MDR-
TB strain, carrying the rpoB-S531L mutation, of a non-Beijing genotype isolated 
in South-Africa harbored a different putative compensatory mutation but in the 
same amino acid as the mutation we found, rpoC-F452C (9). This suggests posi-
tive selection at this site and indicates that a mutation in rpoB-F452 may alleviate 
fitness effects associated with the rpoB-S531L mutation The amino-acids of rpoC-
452 after mutation of both strains, serine and cysteine, have similar properties 
and probably a comparable effect on the protein. A decrease in protein flexibility 
of the RNA polymerase holoenzyme has been indicated to play a role in rifampicin 
resistance (31). 
The rpoC-F452S mutation has never been reported in M. tuberculosis isolates 
that do not carry the rpoB-S531L mutation, supporting the assumption that this 
mutation is related to the rpoB-S531L mutation. Strains from the ECDC0002 clus-
ter with the rpoC-F452S mutation appear to be “super-spreader” MDR-TB strains, 
because of the extent and timeline of transmission (2), and deserve continued 
monitoring and clinical, epidemiological, phylogenetic and bacteriological stud-
ies. Highly discriminatory typing methods, i.e. whole genome sequencing, are 
required track and identify these strains in a timely manner (30, 32).
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Resistance to second line drugs is variable among isolates with the rpoC-gene 
mutation, most likely the result of recent or ongoing generation of second line 
drug resistance. It is conceivable that continued antibiotic exposure will result 
in the selection of XDR-M. tuberculosis strains with little or no fitness cost in the 
near future.
In conclusion. We have identified a putative compensatory rpoC gene mu-
tation in a successfully spreading MDR-M. tuberculosis strain. This highly trans-
missible MDR-M. tuberculosis strain is a threat to TB control in Europe and Asia. 
Monitoring the emergence of such compensatory mutations allows new insights in 
M. tuberculosis evolution and could be used to track the spread of these danger-
ous strains.
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This thesis describes the performance of molecular typing of Mycobacterium 
tuberculosis complex isolates by Variable Number of Tandem Repeats (VNTR) typ-
ing at four different levels. First, we assessed the performance of VNTR typing in 
terms of reproducibility of its results, within laboratories as well as between labo-
ratories. Second, we optimized the methodology of VNTR typing, to improve its 
sensitivity and decrease the turnaround time. Third, we studied its performance 
compared to the former gold standard, IS6110 Restriction Fragment Length Poly-
morphism (RFLP) typing, as performed within the framework of a national sur-
veillance system. Fourth, we assessed the performance of VNTR typing in the in-
ternational context. This international study on the spread of multidrug resistant 
tuberculosis in Europe resulted in the finding of a putative compensatory mutation 
for loss of fitness when a strain becomes rifampicin resistant, contributing to the 
spread of a genetically highly conserved and multidrug-resistant M. tuberculosis 
strain of the Beijing genotype.
Reproducibility of VNTR typing
Early in the development of 24-locus VNTR typing of M. tuberculosis complex 
strains, bilateral exchange of blinded reference samples between a limited num-
ber of experienced laboratories demonstrated that VNTR typing was highly repro-
ducible in these settings, both at intra- and inter laboratory level (10, 20, 21, 32, 
38). However, two rounds of third-line international quality control of VNTR typing 
that we organized under the authority of the ECDC in Stockholm revealed that 
the problem of reproducibility had been underestimated (Chapter 2). One third of 
the participating laboratories were not able to perform 24-locus VNTR typing in 
agreement with the reference. We demonstrated that the reproducibility of 24-lo-
cus VNTR typing initially was limited, with an average inter-laboratory reproduc-
ibility of 60% (range 0-100%) and intra-laboratory reproducibility of 72% (range 
0-100%) in the first year of proficiency testing. The results of the second pro-
ficiency study (Chapter 2.3), however, showed a significant improvement in the 
performance of the 33 laboratories that participated in both proficiency studies; 
the average inter- and intra laboratory reproducibility increased from 62% to 79% 
and from 72% to 88%, respectively. This was due to the introduction of a higher 
level of international standardization and the implementation of our advised ad-
justments (Chapter 2.1) on technical aspects to improve the methodology.
Highly similar and perhaps even larger problems in reproducibility were al-
ready known for the former gold standard; IS6110 restriction fragment length 
polymorphism (RFLP) typing. The RFLP inter-laboratory reproducibility was al-
ready studied by Braden et al. (3) in 2002 for eight participating laboratories. The 
results showed that the RFLP images matched completely for only 54% of the 
isolates; accepting  one or two band differences, this increased to 78% and 93%, 
respectively.The interpretation of IS6110 RFLP patterns was overall challenging, 
because of the variation in interpretation of low-intensity bands and the often 
poor quality of the autoradiograms produced (37). These independent observa-
tions indicated that the reproducibility of both molecular typing techniques re-
quired attention. As VNTR typing is technically far less demanding and the results 
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of this method are in a numerical format, this technique appeared more suitable 
for international standardization (40).
The results of the VNTR proficiency studies casted doubt on the validity of 
earlier molecular epidemiological studies previously published. Thus, laboratories 
that obtained unsatisfactory results in this proficiency study may need to re-type 
part of their previously typed isolates with an improved procedure to evaluate 
the reliability of earlier studies. Moreover, this study underlines the importance of 
first-, second- and third-line quality control of DNA fingerprint methods in gen-
eral and of Multiple-Locus Variable number tandem repeat Analysis (MLVA) in 
particular. On the other hand it also showed that with more standardization and 
communication on settings and details in the procedure, the reproducibility can be 
improved significantly. The initially very low reproducibility scores for VNTR typing 
of M. tuberculosis complex in some of the international laboratories participating 
in our studies should prompt the development of proficiency schemes for MLVA of 
other microorganisms (24).
To improve and consolidate the quality of surveillance of tuberculosis, it is 
important to continue the third-line international quality control on typing of M. 
tuberculosis isolates. Techniques for molecular typing are changing all the time, 
as are the workflow and analysis in modern laboratories. In the light of cross-
border detection of TB transmission, the European Centre of Disease Prevention 
and Control (ECDC) started a pilot to collect VNTR data from MDR M. tuberculosis 
strains from European countries in an international database. This has become an 
ongoing and long term activity considered of high importance in monitoring the 
spread of MDR/XDR-TB in Europe. The reproducibility of the selected typing tech-
nique; VNTR typing, is one of the key determinants of the success of this initiative. 
Not only for surveillance, but also for research activities the quality of typing 
is essential. Genotyping studies have provided or tested many hypotheses in the 
epidemiology of tuberculosis studies. DNA fingerprinting has revealed key insights 
in various lines of  TB research. These include differences in M. tuberculosis popu-
lation structures in geographical areas (8, 16, 36), drug resistance in relation to 
transmission (41) and the occurrence of reinfections after curative treatment (25, 
43). Such essential and basic studies need to be based on reliable typing data.
The performance of VNTR typing as compared to IS6110 RFLP typing
For almost two decades, IS6110 RFLP typing has been the gold standard in 
molecular typing of M. tuberculosis. Its systematic use at regional, national and 
international level has provided important insight in the transmission and epi-
demiology of tuberculosis. DNA fingerprinting is much more sensitive in tracing 
epidemiological links than the conventional patient interviews used according to 
the ‘Stone in the pond’ principle (42), and a significant part of the epidemiologi-
cal links that are nowadays disclosed and confirmed by interviews would not have 
been found without the help of DNA fingerprinting. Also, many unsuspected epi-
demiological links have been traced with the help of this tool (44) and it helps to 
dispute or confirm conceivable epidemiological links (11). 
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In 2006, VNTR typing was proposed as the next gold standard in typing of M. 
tuberculosis by a group of international researchers (40). Its benefits included its 
relatively short turnaround time, limited hands-on time and a result format that 
enables efficient inter-laboratory comparisons. In the following years, multiple 
studies have investigated its performance within tuberculosis surveillance sys-
tems, at different scales. 
We have performed the largest comparative study of VNTR and RFLP typing to 
date (Chapter 4). In addition, our study was carried out in the Netherlands, where 
the tuberculosis surveillance system includes obligatory referral of all M. tuber-
culosis cultures (at least one per patient) obtained from clinical specimens to the 
tuberculosis reference laboratory where they are subjected to identification, drug 
susceptibility testing and epidemiological typing. At the same institute, epidemio-
logical data of the municipal health services (MHSs) is systematically collected 
and this enables extensive and detailed epidemiological analysis on transmission. 
In this setting, we detected a slightly higher level of discriminatory power of 
RFLP compared to VNTR typing, i.e. a slightly higher number of distinct RFLP types 
than VNTR types (2,733 vs. 2,607). Hence, somewhat more clusters were identi-
fied by VNTR typing (486 vs. 438) (Chapter 4). This was in accordance with the 
results of a small regional comparison between RFLP and VNTR typing in Germany 
that comprised 277 M. tuberculosis complex isolates obtained during the 2001-
2006 period, in which 231 vs. 220 distinct patterns were detected in RFLP vs. 
VNTR typing (31). It was also in accordance with a study on 196 M. tuberculosis 
complex isolates obtained within the national surveillance system in Slovenia in 
2008, in which 157 vs. 155 distinct patterns were observed in RFLP and VNTR 
typing, respectively (2).
Overall, the concordance between the two typing techniques in the Netherlands 
was 78.5%, as defined by isolates identically clustered (i.e. with a same clus-
ter composition) or identified as unique in both methods. This percentage is low 
compared to the reported concordance of 93.1% by Roetzer et al. in Schleswig-
Holstein, a federal state of Germany, but consistent with linkage between markers 
expected from the clonal evolution of M. tuberculosis (17, 39). One possible ex-
planation for this observation is the difference in percentage of clustering isolates 
in different studies; based on RFLP and VNTR typing, this was 34% and 45% in 
the Netherlands compared to only 23% and 27% in the German study, respec-
tively. The difference in discriminatory power between RFLP and VNTR typing is 
mainly visible in the clustering part of the sample set; most isolates with unique 
RFLP patterns will remain unique by VNTR typing. As a result, the level of concord-
ance will be highest in strain collections with low percentage of clustering isolates.
For the national surveillance program in The Netherlands the linkage of data 
from source case finding activities by MHSs and the results of molecular typing 
is the basis behind the success in this approach. Overestimation of clustering of 
cases, by VNTR and to a lesser extent- by RFLP typing, would lead to unwarranted 
source and contact tracing activities. This would have practical and financial con-
sequences for the national TB control program. Still, overestimation of clustering 
may be preferable over underestimation of clustering, particularly in the light of 
the current efforts towards elimination of TB in Europe. Underestimation of clus-
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tering, thus a less stringent source and contact-tracing effort, may result in more 
ongoing transmission of tuberculosis.
The extensive activities on contact tracing and source case finding in the Neth-
erlands, supported by DNA fingerprinting, are unique. A national study in The 
Netherlands, including five years of DNA fingerprinting data, showed a lineage-
dependent degree of reliability of the inference on transmission and indicated lim-
its in the interpretation of recent transmission based on clustering by VNTR typing 
in the recent-immigrant population (35). In fact there are many clonal complexes 
(‘look-a-likes’) of M. tuberculosis strains circulating in the Netherlands and this 
hampers the resolution of VNTR typing. 
Optimizing the laboratory operating procedures of VNTR typing
In order to improve the internationally mostly applied and commercially avail-
able VNTR typing method described by Supply et al (40), several steps in the 
procedure were optimized. The most commonly encountered problem in perform-
ing this VNTR typing method is the failure of PCR amplification in one- or more of 
the 24 loci analyzed. We found that the combination of seven re-designed primers 
and the use of a more suitable master mix contributed to an increased percentage 
(84.7% compared to 72.3% for the initial method) of complete 24-locus VNTR 
typing profiles in the first multiplex PCR run (Chapter 3). This practical gain is 
considerable, as fewer strains have to be repeated in single-target PCRs and this 
reduces the workload and turnaround time. This cost effectiveness is an impor-
tant aspect of all laboratory analyses, including for the typing of M. tuberculosis. 
The highest incidence of tuberculosis in Europe and also worldwide is detected in 
countries with a relatively low income level. Implementing typing activities will 
depend on several aspects, e.g. laboratory capacity, skills and available financial 
resources. This financial aspect is one of the reasons for the policy makers in 
many reference laboratories in lower income countries to limit molecular typing 
to MDR-TB isolates. 
The high cost of the commercially available VNTR kit and a lack of access 
to Capillary Electrophoresis (CE) DNA analyzers hamper its use. Therefore, the 
optimized in-house method may be an interesting alternative to the expensive 
commercial typing kit in low-resource settings, because the products of single-
locus PCRs can be analyzed on a gel, without the need of a sophisticated DNA 
analyzer (48). In addition, we have determined the minimum amount of DNA 
required for successful VNTR typing of M. tuberculosis directly from clinical sam-
ples. The analytical sensitivity determined makes VNTR typing directly applicable 
to M. tuberculosis in clinical broncho-alveolar lavage fluid samples (Chapter 3). 
Studies performed in Uzbekistan (18) and Slovenia (2) confirmed this observation 
for VNTR typing of M. tuberculosis directly in sputum samples. Both studies men-
tioned the risk of incomplete VNTR patterns and the bacterial load that is needed, 
1:100 dilution of strains with different number of IS6110 elements related to the 
number of quantitation cycles detected by 12 diagnostic M. tuberculosis complex 
assays (Chapter 3) and a bacterial load that belongs to a smear microscopy posi-
tive sample (2). 
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The earlier the DNA fingerprinting information is known to MHSs, the better it 
can support the source case finding and contact-tracing activities. Unfortunately, 
the detection of the number of repeats for the 24 loci included in the VNTR typing 
is still technically demanding for low bacterial loads in clinical material. Further 
optimizations regarding enzymes and DNA isolation can likely improve the sen-
sitivity in the VNTR typing. It is questionable whether increased sensitivity will 
serve the interruption of TB transmission, since the transmission is most signifi-
cant from patients with the highest bacterial loads. Nevertheless, VNTR typing 
can perform well with even low number of bacteria. Even with the risk of missing 
a single locus, an otherwise good-quality VNTR typing result can still exclude the 
possibility of transmission or a relapse of TB, or a laboratory cross contamination.
Performance of VNTR typing in the international setting
VNTR typing was used in the molecular surveillance study on the transmission 
of MDR-/XDR-TB in the European Union, as described in this thesis (Chapter 5). 
The high percentage of European and national clustering, especially in Estonia 
(87% and 92%) and Latvia (72% and 66%), indicates that transmission has been 
ongoing in this region for a prolonged period (22), and this calls into question 
the infection control practices and the quality of treatment in several geographic 
regions. 
Almost half of the VNTR patterns collected within the framework of the ECDC 
molecular surveillance study of international MDR/XDR-TB transmission in Europe 
could be assigned to European clusters, and 60% of these were part of a single, 
large European cluster; labelled ‘ECDC0002’. This molecular cluster, associated 
with the spread of a Beijing genotype strain, has so far been detected in 17 Eu-
ropean countries. 
The high proportion of molecular clustering (45%) in the EU suggests that 
MDR/XDR-TB problem is in a large proportion of the cases due to transmission, 
i.e. primary resistance and not to acquired resistance. The Beijing genotype was 
significantly associated with clustering in this data set. While this may be indica-
tive of increased transmissibility of strains of this genotype family, it may also hint 
at lower discriminatory power of VNTR typing in this particular genotype family. 
This drawback of VNTR typing’ has been previously observed (27, 28) and led to 
the development of a standardized set of additional ‘hypervariable’ VNTR loci, to 
increase discriminatory power within the Beijing genotype family (1). 
There are more reasons not to underestimate the role of the Beijing genotype 
of M. tuberculosis in the spread of MDR/XDR-TB in Europe. Comparison of risk 
factors associated with MDR-TB in Georgia recently pointed out that the Beijing 
genotype of M. tuberculosis was a more important risk factor than any other factor 
analysed (34). This again emphasizes the importance of the identification of the 
genotype in MDR/XDR-M. tuberculosis strains.
In the European study (Chapter 5) there was unfortunately a low coverage 
and a wide variation in the number of collected samples, and the time spacing of 
submitted patterns by the participating countries. This could cause a considerable 
selection bias and reduce the representativeness of the observations.  It is the 
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task of the ECDC to enable and stimulate especially Eastern European countries to 
implement or extend the typing activities and complete the picture on the spread 
of MDR/XDR-TB in the European Union.
The discussion on whether DNA fingerprinting is detecting cross-border trans-
mission or predominant MDR/XDR-M. tuberculosis strains or clones circulating 
in high prevalence settings  remains important. The lack of cross-border con-
tact tracing activities in Europe makes it difficult to distinguish true transmission 
chains in the international context. What is clear is that in Europe, like in former 
Soviet Union States, South Africa and Asia genetically conserved strains of the 
Beijing genotype are the driving forces behind transmission of MDR/XDR-TB (7, 
13, 26, 49) (Chapter 5).
The future of VNTR typing of M. tuberculosis complex
Although much epidemiological insight has been gained from techniques such 
as IS6110 RFLP and 24-loci VNTR typing, they suffer from serious limitations. 
Both types of fingerprints are highly stable over time. Their rate of change is not 
in line with the pace of TB transmission (4). When DNA fingerprint analysis is 
used over years in a given geographic area, the clusters will sometimes grow to 
hundreds of cases, and the epidemiological links in the cluster become less obvi-
ous over time. Ideally, an epidemiological typing method should combine markers 
with a higher turn-over, revealing a minor alteration in the DNA fingerprint pattern 
at each transmission event, with markers with slower turn-over to ensure that 
the overall fingerprint patterns remain recognizable. In that way, the spread from 
primary sources could be distinguished from that of secondary and tertiary cases 
and a more detailed picture would be obtained of the direction of the TB transmis-
sion and the actual transmission chains. Whole Genome Sequencing is likely to 
offer this higher resolution (33), although this has not yet been fully confirmed. 
Whole Genome Sequencing has already proven to be highly informative in out-
breaks of tuberculosis (33) and disease caused by other mycobacteria, like  Myco-
bacterium abscessus (6), but also by Legionella pneumophila (15) and methicillin-
resistant Staphylococcus aureus (MRSA)(23). 
Initially, in two studies on outbreaks of M. tuberculosis in Vancouver and in 
Harlingen, isolates from RFLP/VNTR clustered cases were subjected to WGS to 
investigate whether they were also identical on basis of WGS, or could be distin-
guished. These first studies indeed revealed that in larger outbreaks, on basis of 
identical single nucleotides (SNPs) present in a part of the clustered strains, trans-
mission chains could be distinguished that were not visible on basis of RFLP or 
VNTR typing (14, 33). In other studies the turn-over in the genome of M. tubercu-
losis was calculated by comparing the genomes of isolates from epidemiologically 
linked cases with known time spacing. On basis of the mutations observed and the 
time in which they occurred, it was calculated that the genome of M. tuberculosis 
during transmission and incubation in humans changes with a frequency of 0.36-
0.50 (5, 12, 31, 45) mutations per genome per year. However, in the -from an 
evolutionary point of view- limited time interval studied the mutations occurred 
at a highly irregular pace and therefore it is likely that a part of the cases that 
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are clustered by WGS in a given area will have no direct epidemiological link. In 
fact, this was already found in a study in Amsterdam, in which a part of the pairs 
of isolates were identical on basis of WGS without an obvious epidemiological 
link (5). However, one has to keep in mind that not all true epidemiological links 
can be found by conventional contact tracing based on interviews of the patients. 
Nevertheless, WGS has a higher resolution than the classical typing methods, but 
does currently not include the DNA polymorphisms, insertion elements and tan-
dem repeats, visualized in RFLP- and VNTR typing. Given its discriminatory power, 
it is likely that WGS will become the new gold standard in typing of highly clonal 
micro-organisms such as M. tuberculosis within the next few years.
The use of WGS will be facilitated by more practical software to analyze the 
enormous amount of data and optimizing new sequencing techniques in which 
also the DNA polymorphism associated with repetitive DNA sequences can be vis-
ualized. As for all typing techniques, the switch to sequencing the genome of bac-
teria directly from clinical samples instead of M. tuberculosis isolates will increase 
the utility of this new approach. With the introduction of WGS, new algorithms are 
required to define and visualize clustering. Clusters of cases will gradually expand 
in different directions with highly similar strains and more insight is needed on 
how to use this in a practical way in the daily routine of contact tracing.
The implementation of WGS already occurs in many countries. Its impact on 
diagnostic mycobacteriology will be huge, as WGS data can also be used for ac-
curate (sub) species identification, and drug susceptibility predictions. In addition, 
the costs of WGS will be even less compared to conventional culture and suscep-
tibility testing. Depending on the smear positivity or time to culture positivity and 
the laboratory turnaround time the introduction of WGS can reduce diagnosis time 
from weeks to days and reduce cost (9, 19, 29). 
As we have shown for VNTR typing, external quality control programs remain 
very important to monitor the quality of molecular typing within disease surveil-
lance systems. For a technique as complex as WGS, such a program surely needs 
to be established. Experienced reference laboratories, supported by international 
health organizations, have to take the responsibility to organize an annual profi-
ciency study to monitor the quality of molecular fingerprinting. To be able to study 
cross border transmission of M. tuberculosis in the era of globalization and mo-
bility, international harmonization of WGS methodologies and platforms is highly 
important and this should be arranged even now the switch from VNTR typing to 
WGS is already made by individual countries.
These data on molecular typing and WGS will also help to identify new muta-
tions associated with resistance and fitness. It was shown in our study (Chapter 6) 
that the strains causing the largest outbreak of MDR-TB in Europe have a mutation 
presumably compensating the loss in activity of the RNA polymerase, caused by 
the mutation in the rpoB gene conferring rifampicin resistance. The identification 
of this rpoC F452S mutation is an example of the added potential of WGS. The 
specific mutation also proved a reliable marker to identify strains of this specific 
highly resistant Beijing genotype. An accurate identification and treatment of dis-
ease caused by highly transmissible strains (so called “super-spreaders”) can help 
to control outbreaks and combat TB. High-definition visualization of TB transmis-
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sion will generate insight in the micro-organisms driving the epidemic and WGS 
can provide us with the molecular basis of the success of these super-spreaders. 
Not all countries, especially in high endemic areas, can afford molecular typing 
of all TB cases. It may be the responsibility of larger health authorities to enable 
typing of at least MDR/XDR-M. tuberculosis isolates in countries with a high preva-
lence of resistance, either within the country or in international laboratories. After 
all, TB in Western countries is mainly due to import and it is the responsibility of 
the rich countries to combat the problem of (resistant) TB in the countries where 
the largest problems exist.
For the Dutch TB control program, WGS is since 2016 running for all M. tu-
berculosis complex isolates, to test its utility regarding identification of causative 
bacteria, prediction of resistance and epidemiological typing, simultaneously with 
the conventional approaches. It is expected that within some years almost the 
entire laboratory diagnosis for TB can be replaced by WGS (46). For many other 
settings, VNTR typing will be the preferred typing method for several more years; 
the work described in this thesis was done to allow the introduction and optimal 
use of this important typing tool in TB surveillance programs. 
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In this thesis, we focused on the molecular typing of Mycobacterium tubercu-
losis  complex bacteria. Each chapter reports a different aspect of the molecular 
typing, it starts with the technical aspects followed by its application within the 
Dutch national surveillance program, then the application in the European setting, 
to end with interesting findings useful for the future.
In Chapter 1 we introduced the disease tuberculosis (TB) and its causative 
agent Mycobacterium tuberculosis. Tuberculosis is the second most important in-
fectious disease worldwide and even in a low-incidence country like The Nether-
lands at least 800 new cases are detected annually. Worldwide, treatment is more 
and more a challenge due to the development of drug-resistance.
For molecular typing M. tuberculosis various techniques have been developed 
over time, including spoligotyping, IS6110 restriction fragment length polymor-
phism (RFLP) typing, variable number of tandem repeats (VNTR) typing and most 
recent whole-genome sequencing. Each of these techniques has its own discrimi-
natory power, reproducibility and specific pros and cons. As a result, replacing one 
method by another is complicated. The most important application of molecular 
strain typing is support source case finding and contact tracing, to find the origin 
of TB infections and to trace persons with a recent TB infection. In addition, re-
sults of molecular typing allow distinction between endogenous reactivation and 
recent transmission, as well as between relapses and exogenous reinfections, 
which is useful to monitor the quality of treatment and control programs, and 
about cross-contamination to prevent false diagnoses.
In basic science, molecular typing is the starting point for studies on the distri-
bution of M. tuberculosis genotypes and development of drug resistance.
Chapter 2 describes the results of the first worldwide proficiency study on 
VNTR typing of M. tuberculosis complex strains. VNTR typing has become the new 
standard for the typing of Mycobacterium tuberculosis complex strains and a high 
reproducibility will increase the value of molecular epidemiological studies across 
all settings.
Thirty-seven laboratories were part of the first multicenter study, Chapter 
2.1, and one year later 41 laboratories were able to participate in its follow-up 
study presented in Chapter 2.3. After analyzing the results of the first study we 
concluded that the reproducibility of 24-locus VNTR typing at that time was limi-
ted, with an average interlaboratory reproducibility of 60% (range 0-100%) and 
an average intralaboratory reproducibility of 72% (range 0-100%). In the second 
proficiency study on VNTR typing, the average inter- and intralaboratory repro-
ducibility was 78% (range 0–100%) and 88% (range 0–100%).
The average inter- and intralaboratory reproducibility increased substantially 
for the 33 laboratories that participated in both proficiency studies; from 62% to 
79% and 72% to 88%, respectively. 
Four factors were presented that contributed to improved inter- and intralabo-
ratory reproducibility; 1) specific improvement and standardization in the analysis 
using gel electrophoresis, 2) the reduction of the number of systematic errors, 3) 
an improvement in good laboratory practices based on a decline of sample ex-
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change, 4) the reduction in the total number of locus amplification failures (from 
72 in 19 laboratories to 52 in 10 laboratories).
After the two proficiency studies, we concluded that the first proficiency study 
and the subsequent centrally guided improvements had a positive effect on the 
quality of VNTR typing of M. tuberculosis. Actions undertaken locally to improve 
the performance of VNTR typing were apparently also effective.
In Chapter 2.2 we respond on the critical notes about the DNA quality of the 
samples in the panel sent to the participants and the choice of strains with the 
corresponding VNTR typing patterns. We do agree that the outcome of an external 
quality assessment is highly dependent on the selection of strains and this has 
contributed to a more balanced set of samples for the second proficiency study.
Optimization and standardization are the most important steps after detecting 
the weakest link of a method. Chapter 3 describes the efforts to improve the dif-
ficulties we faced with the VNTR typing at the national institute for public health 
and the environment (RIVM). First and foremost, some of the 24 loci may not be 
amplified in the multiplex PCRs and have to be repeated in a single-locus PCR; 
this holds true both for the commercially available MIRU-VNTR typing kit (Geno-
Screen, Lille, France) as well as for the in-house methods. In practice this involves 
a significant increase in workload and turnaround time.
The modification of  7 primers and the PCR mastermix, resulted in a strongly 
optimized in-house 24-locus VNTR typing method. The percentage of instantly 
complete 24-locus VNTR patterns, detected in the routine flow of typing activities, 
increased to 84.7% compared to 72.3% for the typing conducted with the com-
mercially available MIRU-VNTR typing kit by GenoScreen. This practical improve-
ment is considerable, as fewer strains have to be repeated in single-target PCRs 
and this reduces the workload and turnaround time. In addition, this technique is 
much cheaper compared to the commercial 24-locus VNTR method and useful for 
laboratories without a Capillary Electrophoresis DNA sequencer.
In Chapter 3, we tested also the analytical sensitivity for this improved in-
house VNTR typing method. The detection of the 24-locus VNTR pattern of the M. 
tuberculosis complex in broncho-alveolar lavage fluid, showed that molecular typ-
ing can be applied for clinical specimens. With the risk of missing a single locus, 
VNTR typing can still exclude the possibility of transmission and relapses. The mo-
ment VNTR typing can be performed depends on the bacterial load of the sample.
In Chapter 4 we compared two M. tuberculosis typing methods, IS6110 re-
striction fragment length polymorphism (RFLP) typing versus 24-locus variable 
number of tandem repeat (VNTR) typing. To facilitate the switch from one method 
to the other for the national TB surveillance program in the Netherlands, we inves-
tigated the performance of each test in terms of discriminatory power and cluster 
composition. We performed the comparison on 3,975 M. tuberculosis isolates of 
culture-confirmed TB cases collected in the period 2004-2008 by the RIVM in 
Bilthoven, the Netherlands. Overall, 2,607 different VNTR types were detected, 
compared to 2,733 distinct RFLP types. In this dataset, 47% (n=1,857) of the 
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isolates belonged to one of the 486 VNTR clusters and 42% (n=1,683) belonged 
to one of the 438 clusters identified by RFLP typing. The concordance between the 
two typing techniques was 78.5% (n=3,123), as defined by 1,307 isolates identi-
cally clustered (i.e. with a same cluster composition) and 1,816 isolates labeled 
unique by both methods.
We then analyzed the results of the two molecular typing results in relation to 
the results of cluster investigation that was routinely applied in The Netherlands 
on basis of RFLP cluster results. Most of the isolates (82%) split off from their 
RFLP-based cluster by VNTR typing were from patients without an epidemiological 
link to the cluster or without epidemiological information. Of note, 71 isolates (2% 
of the dataset) were split-off from RFLP clusters by VNTR typing and formed new 
VNTR-based clusters, or expanded existing VNTR clusters. For 82% (n=58) of the 
isolates in this subset, no epidemiological link had been detected on the basis of 
the originally identified RFLP clusters. Taken together, these findings suggest that 
VNTR typing results could, in general, be in better agreement with the true chain 
of transmission than the RFLP typing results were. Yet, this can only be confirmed 
by renewed source case investigation on basis of the VNTR cluster information.
We conclude that VNTR typing has a discriminatory power equal to IS6110 
RFLP typing, but is in better agreement with findings in cluster investigation per-
formed  based on RFLP typing.
The use of molecular typing in an international setting is described in Chapter 
5. VNTR typing was used in a project initiated by the European Centre for Disease 
Prevention and Control (ECDC) to investigate the international transmission of 
multi- and extensively drug-resistant tuberculosis (MDR-/XDR-TB) in the Europe-
an Union (EU). 2,092 typing patterns were collected, originating from 24 countries 
in the period 2003 to 2011. Of the collected VNTR patterns, 45% (n=941) could 
be assigned to one of the 79 European multiple-country VNTR clusters. This result 
suggests that a high proportion of the MDR-/XDR-TB cases in the EU may result 
from recent transmission, i.e. primary resistance rather than acquired resistance. 
The lack of coverage and the wide variation in the number and time period of 
collected samples submitted by the participating countries, however, reduce the 
representativeness of this observation. 
A second interesting observation in this European project was the detection 
of one extremely large cluster (n=470) caused by strains of the so-called Bei-
jing genotype. This highly transmissible MDR-M. tuberculosis strain appears to be 
one of the main threats to TB control in Europe and Asia. The possible selective 
advantage of this specific clone was investigated and the results were reported 
in Chapter 6. Whole genome sequencing of nine of the strains that belonged to 
this specific cluster showed a unique rpoC-F452S mutation. This unique muta-
tion was restricted to MDR-TB isolates of the cluster, suggesting this may be an 
important factor in the emergence of this MDR-TB cluster. A compensatory role 
for rpoC-F452S is likely as its appearance was strictly limited to TB strains carry-
ing a rpoB-S531L mutation and it is located in the region usually harboring these 
compensatory mutations. The single nucleotide polymorphisms identified in this 
study could be used to develop simple assays to track and identify this strain in a 
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timely manner. 
This thesis describes the answers we can and cannot get from molecular typ-
ing of Mycobacterium tuberculosis complex bacteria. Chapter 7 discusses this in 
more detail, to conclude that a high reproducibility is essential to answer ques-
tions regarding national and international transmission of TB. As for any test we 
perform in our laboratories, we have to stay critical, optimize, compare and im-
prove to find the real answers. For the future, molecular typing is already develop-
ing to whole genome sequencing. This technique gives a lot of information but still 
is not standardized and out of reach for most countries with a high incidence of 
TB. In many settings, VNTR typing will be the preferred typing method for several 
more years.   
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Het centrale onderwerp van dit proefschrift is de moleculaire typering van My-
cobacterium tuberculosis complex bacteriën. Elk hoofdstuk geeft een ander facet 
weer van moleculaire typering, beginnend met technische aspecten, gevolgd door 
de toepasbaarheid van de huidige techniek binnen de Nederlandse tuberculosebe-
strijding en de Europese situatie, om te eindigen met interessante bevindingen 
met het oog op toekomstige typeringstechnieken.
In Hoofdstuk 1 introduceren we de ziekte tuberculose (TB) en haar verwek-
ker Mycobacterium tuberculosis. Tuberculose is na hiv/aids wereldwijd de meest 
dodelijke infectieziekte en zelfs in landen met een een lage incidentie, zoals Ned-
erland, worden jaarlijks circa 800 gevallen vastgesteld. Wereldwijd is de behan-
deling van tuberculose een steeds groter wordende uitdaging, onder andere door 
de opkomst van resistentie.
In de loop van de jaren zijn er verschillende moleculaire typeermethoden 
ontwikkeld, waaronder spoligotypering, IS6110 restrictie fragment lengte poly-
morfisme (RFLP) typering en de meest recente methode is de ‘variable number of 
tandem repeats’ (VNTR) typering. Elke techniek heeft een eigen onderscheidend 
vermogen, reproduceerbaarheid en specifieke voor- en nadelen. Het is dan ook 
erg complex om van typeermethode te veranderen. 
De belangrijkste toepassing van moleculaire typering is het ondersteunen 
van bron- en contactonderzoek, waarmee de oorsprong van een TB infectie kan 
worden achterhaald en personen kunnen worden opgespoord die recent zijn bes-
met. Daarnaast maken de resultaten van moleculaire typering het mogelijk onder-
scheid te maken tussen recidieven en herinfecties, wat van groot belang is voor 
het monitoren van de kwaliteit van de toegepaste behandelingen en het totale tu-
berculosebestrijdingsprogramma. De resultaten brengen ook kruis-contaminaties 
en dus onterechte diagnoses aan het licht.
Wetenschappelijk gezien is moleculaire typering het beginpunt van vele studies 
die gericht zijn op de verspreiding van de verschillende M. tuberculosis genotypen 
en de ontwikkeling van resistentie.
Hoofdstuk 2 beschrijft de resultaten van het eerste wereldwijd uitgevoerde 
ringonderzoek voor kwaliteitscontrole van VNTR typering van M. tuberculosis 
complex stammen. De VNTR typeertechniek is de standaard geworden voor het 
typeren van deze stammen en een hoge reproduceerbaarheid is van groot belang 
voor het verhogen van de betrouwbaarheid van epidemiologische studies.
Zevenendertig laboratoria namen deel aan de eerste multicenter studie 
(Hoofdstuk 2.1); één jaar later waren er 41 laboratoria die deelnamen aan de 
vervolg studie, beschreven in Hoofdstuk 2.3. Na de eerste studie concludeerden 
wij dat de reproduceerbaarheid van 24-locus VNTR typering te wensen overliet; 
de gemiddelde inter-laboratorium resproduceerbaarheid was 60% (0-100%) en 
de gemiddelde intra-laboratorium reproduceerbaarheid was 72% (0-100%). De 
analyse van de tweede studie toonde een gemiddelde inter- and intra-laboratori-
um reproduceerbaarheid van 78% (0–100%) en 88% (0–100%). Voor de 33 labo-
ratoria die deelnamen aan beide studies was een substantiële toename zichtbaar 
van de gemiddele inter- en intra-laboratorium reproduceerbaarheid; van 62% 
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naar 79% en van 72% naar 88%.
Vier factoren hebben bijgedragen aan de verbeterde resproduceerbaarheid; 
1) de specifieke verbetering en standaardisatie van de analyses  binnen de groep 
deelnemers die gebruik maakten van gel-electroforeses, 2) de afname van het 
aantal systematische fouten, 3) de verbetering van de algemene laboratorium-
vaardigheden die tot uiting kwam in de afname van monsterverwisselingen, 4) 
de reductie van het totaal aan niet-geamplificeerde loci (van 72 in 19 laboratoria 
naar 52 in 10 laboratoria).
Na twee ringonderzoeken concludeerden we dat de eerste studie en de daarbij 
behorende ondersteuning aan de deelnemende laboratoria een positief effect had 
op de kwaliteit van VNTR typering van M. tuberculosis. Ook de locale activiteiten 
die laboratoria hebben ondernomen om de kwaliteit te verbeteren hebben hieraan 
bijgedragen.
In Hoofdstuk 2.2 beantwoorden we de kritische opmerkingen die zijn ge-
plaatst met betrekking tot de DNA kwaliteit van de verzonden monsters en de 
keuze van van de geïncludeerde stammen met de daarbij behorende VNTR pa-
tronen. Wij onderschrijven dat de conclusie van een externe kwaliteits bepaling 
sterk afhankelijk is van de keuze voor de geïncludeerde stammen, dit heeft geleid 
tot een meer uitgebalanceerde set van stammen voor het tweede ringonderzoek.
Optimalisatie en standaardisatie zijn de belangrijkste stappen na het vaststel-
len van de zwakke punten van een methode. Hoofdstuk 3 beschrijft onze ins-
panningen om de VNTR typeermethode te verbeteren. Enkele van de 24 loci die 
de VNTR typering omvat werden niet altijd geamplificieerd in de multiplex PCRs, 
met als gevolg dat deze herhaald werden in een single-locus PCR variant. Dit 
fenomeen gold voor zowel de commercieel verkrijgbare MIRU-VNTR typerings kit 
(GenoScreen, Lille, Frankrijk) als voor de in-house methode. Praktisch had dit een 
toename van de werkdruk en de doorlooptijd tot gevolg.
De aanpassingen aan 7 primers en de verandering van de PCR mastermix heeft 
geleid tot een verbetering van de in-house 24-locus VNTR typeermethode. Het 
percentage stammen waarvoor in 1 poging een volledig 24-locus VNTR patroon 
kon worden verkregen verhoogde tot 84,7%, vergeleken met 72,3% complete 
patronen verkregen met de commercieel verkrijgbare MIRU-VNTR typerings kit 
van GenoScreen. De praktische verbetering betekende minder stammen herhaald 
moeten worden door middel van een single-locus PCR. Daarbij komt dat de in-
house methode goedkoper is dan de commercieel verkrijgbare methode en bruik-
baar is voor laboratoria die niet beschikken over een Capillaire Electroforese DNA 
sequencer.
In Hoofdstuk 3, hebben we ook de analytische gevoeligheid getest van de 
verbeterde in-house VNTR typeermethode. De detectie van het 24-locus VNTR 
patroon van M. tuberculosis complex in bronchoalveolaire lavage vloeistof liet zien 
dat de moleculaire typering bruikbaar is direct in klinische monsters. Met het risico 
dat het resultaat van een enkel locus ontbreekt, kan VNTR typering nog altijd van 
waarde zijn voor het uitsluiten van mogelijke transmissie en recidieven. De haal-
baarheid van VNTR typering is wel sterk afhankelijk van de hoeveelheid bacterien 
in een monster.
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In Hoofdstuk 4 hebben we twee M. tuberculosis typeertechnieken vergele-
ken, IS6110 restrictie fragment lengte polymorfisme (RFLP) typering en 24-locus 
variable number of tandem repeat (VNTR) typering. We hebben voor beide testen 
onderzocht wat het onderscheidend vermogen is en hoe de samenstelling van de 
clusters is. De vergelijking is uitgevoerd op 3.975 M. tuberculosis isolaten van 
kweek-bevestigde tuberculose gevallen, verzameld in de periode 2004-2008 door 
het RIVM te Bilthoven in Nederland. In totaal werden 2.607 verschillende VNTR 
typen gedetecteerd, in vergelijking tot 2.733 verschillende RFLP typen. In deze 
dataset behoorde 47% (n=1.857) van alle isolaten tot één van de 486 VNTR 
clusters en 42% (n=1.683) behoorde tot één van de 438 clusters geïdentificeerd 
door RFLP typering. De concordantie tussen de twee typeermethoden was 78.5% 
(n=3.123), gedefinieerd als de overeenstemming van 1.307 isolaten welke iden-
tiek clusteren (gelijke clustersamenstelling) en 1.816 isolaten waarvoor unieke 
patronen werden gevonden met beide methoden.
Vervolgens hebben we de resultaten van beide typerings methoden geanaly-
seerd ten opzichte van de resultaten van het op RFLP gebaseerde bron-onderzoek 
dat op reguliere basis wordt uitgevoerd in Nederland. Het grootste deel van de iso-
laten (82%) dat afgesplitst werd door VNTR typering van het oorspronkelijke RFLP 
cluster, was afkomstig van patiënten waarvoor geen epidemiologische relatie kon 
worden vastgesteld met het cluster of waarvoor geen epidemiolo gische gegevens 
beschikbaar waren. Ook werd vastgesteld dat 71 isolaten (2% van de dataset) 
waren afgesplitst door VNTR typering van het oorspronkelijke RFLP cluster en een 
nieuw cluster vormden op basis van de VNTR resultaten, of een bestaand clus-
ter uitbreidden. Voor 82% (n=58) van deze isolaten was geen epidemiologische 
relatie vastgesteld op basis van de originele RFLP clustering. Deze resultaten sug-
gereren dat VNTR typering beter de ware transmissieketen aan het licht brengt 
dan RFLP typering. Dit kan echter alleen worden bevestigd door nieuwe bron-
onderzoeken uit te voeren op basis van VNTR cluster informatie.
We concluderen dat VNTR typering een vergelijkbaar discriminerend vermogen 
heeft als RFLP typering, maar mogelijk beter overeenkomt met de resultaten van 
het bron-onderzoek welke is uitgevoerd op basis van RFLP typering.
Het toepassen van moleculaire typering in een internationale situatie is be-
schreven in Hoofdstuk 5. VNTR typering werd gebruikt bij de uitvoering van 
een project dat de internationale transmissie onderzocht van multi- and extensief 
drug-resistente tuberculose (MDR-/XDR-TB) in de Europese Unie (EU), geïnitieerd 
door de European Centre of Disease Prevention and Control (ECDC). In totaal 
werden 2.092 patronen verzameld, afkomstig uit 24 landen in de periode 2003 tot 
2011. Van alle VNTR patronen behoorde 45% (n=941) tot één van de 79 Europese 
VNTR clusters (d.w.z. clusters van isolaten uit verschillende landen). Dit sugger-
eert dat een groot deel van de MDR-/XDR-TB gevallen binnen de EU een resultaat 
zijn van recente transmissie, oftewel primaire resistentie in plaats van verworven 
resistentie. De representativiteit van deze observatie is beperkt door een aantal 
factoren, namelijk de beperkte deelname vanuit sommige Europese landen, het 
grote verschil in het aantal gerapporteerde patronen per deelnemend land en de 
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tijdsperiode waarover gerapporteerd is.
Een tweede interessante observatie die bij de analyse van de Europese data is 
gedaan, is de detectie van een extreem groot cluster (470 stammen) van stam-
men van het Beijing genotype. Deze zeer goed overdraagbare MDR-M. tubercu-
losis stam is een serieuze bedreiging voor de TB bestrijding in Europa en Azië. 
De mogelijke selectieve voordelen die deze groep stammen heeft is onderzocht 
en de resultaten zijn beschreven in Hoofdstuk 6. Sequentie analyse van het 
hele genoom van negen van deze stammen laten een unieke rpoC-F452S muta-
tie zien. De unieke mutatie werd alleen gedetecteerd bij de multidrug-resistente 
isolaten van het cluster; dit suggereert dat deze mutatie mogelijk een rol speelt 
in het voortbestaan van dit MDR-TB cluster, door te compenseren voor eventueel 
verlies van ‘fitness’ door de mutaties die ten grondslag liggen aan de rifampicine-
resistentie van deze stammen. Het is aannemelijk dat er een compenserende rol 
is voor rpoC-F452S, aangezien deze mutatie alleen werd geconstateerd bij TB 
stammen met rifampicine resistentie door een rpoB-S531L mutatie, en daarbij de 
positie binnen het genoom bekend staat voor het voorkomen van compenserende 
mutaties. De enkel-nucleotide polymorfismen die in deze studie zijn vastgesteld 
kunnen worden gebruikt voor de ontwikkeling van relatief simpele diagnostische 
testen om deze stam sneller te detecteren.
Dit proefschrift beschrijft de antwoorden die we wel en niet kunnen krijgen 
met behulp van moleculaire typering van Mycobacterium tuberculosis complex 
bacteriën. In Hoofdstuk 7 bespreken we dit in meer detail, om te concluderen 
dat een hoge reproduceerbaarheid essentieel is om vragen te beantwoorden met 
betrekking tot nationale en internationale transmissie van TB. Zoals voor elke test 
die we in het laboratorium uitvoeren, geldt ook hier dat we kritisch moeten blijven 
en moeten blijven optimaliseren, vergelijken en verbeteren om de goede ant-
woorden te vinden. Momenteel ontwikkelt moleculaire typering zich in de richting 
van genoom sequentieanalyse. Deze techniek geeft veel informatie maar is nog 
niet  gestandaardiseerd en niet bereikbaar voor veel landen die te maken hebben 
met een hoge TB incidentie. Daarom zal in vele landen VNTR typering de methode 
van eerste voorkeur blijven voor de komende jaren. Met de studies verenigd in dit 
proefschrift hopen wij te hebben bijgedragen aan het succesvol uitvoeren van de 
VNTR typering in deze landen.
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Met het schrijven van dit hoofdstuk kan ik bijna zeggen dat het klaar is. Het 
uitvoeren van de verschillende onderzoeken, publiceren en schrijven van dit proef-
schrift heeft al met al heel wat jaren in beslag genomen. En in die periode heb ik 
zoveel mensen leren kennen, mooie samenwerkingen ervaren en ontzettend veel 
steun gehad op persoonlijk en wetenschappelijk vlak, dat ik nu heel graag de kans 
met beide handen aangrijp om mijn dank te betuigen. 
De belangrijkste moet eerst genoemd worden, mijn promotor prof. dr. Dick van 
Soolingen. Tenslotte ben jij de persoon die als eerste het woord promotie en mijn 
naam in één zin uitprak. Jij als hoofd van de afdeling Mycobacteriën bij het RIVM, 
je enthousiasme en nieuwsgierigheid maakt dat je altijd kansen en mogelijkheden 
ziet om wetenschappelijke vraagstukken te onderzoeken. Daarbij geef je iedereen 
die wil de kans hieraan deel te nemen, wat maakt dat de afdeling Mycobacteriën 
altijd dynamisch en in ontwikkeling is. Dank je wel dat je mij naar het RIVM hebt 
gehaald.
De leden van de manuscriptcommissie; prof. dr. R. van Crevel, dr. M.J. Boeree 
en prof. dr. M.W. Borgdorff wil ik bedanken voor de tijd die nodig was dit manu-
script te lezen en dank voor de uiteindelijke beoordeling.
Dan was er bij mijn komst bij het RIVM het kantoor op de eerste etage. Na 
niet al te lange tijd kreeg ik daar mijn plekje tussen hardwerkende onder zoekers. 
Dr. Jakko van Ingen, mijn co-promoter, was daar één van. Jakko...tja wat zal ik 
zeggen... ik ken niemand die zoveel energie heeft en de wereld zo zonnig ziet. 
Jouw drive is geweldig!!! Wetenschappelijk heb je je naam gevestigd. Maar ik 
wil je hier danken voor alle keren dat je me moed insprak; er waren heel wat 
momenten dat ik het niet meer zag zitten, een appje of telefoontje van jou gaf 
me toch elke keer weer de energie om door te gaan. Zonder jouw steun was dit 
proefschrift nooit geschreven.
Kristen Kremer was die andere hardwerkende onderzoeker. Het was zo fijn om 
jou met al je ervaring naast me te hebben. Dank je wel voor alles wat je me in 
mijn eerste RIVM jaren hebt geleerd.
En dan was daar nog een onderzoeker, Arnold Herrewegh. Jij, de rust zelve, 
wist me precies te vertellen hoe ik mijn weg moest vinden binnen het RIVM, bij 
welke afdelingen ik moest zijn en hoe ik de organisatie van Europese projecten en 
congressen moest aanpakken. Ik vind het dan ook heel leuk dat jij nu, nadat we 
toch al jaren geen collega’s meer zijn, de vormgever bent van dit boekje.
De afdeling Mycobacteriën, gevormd door zoveel verschillende persoonlijk-
heden, maar één ding hebben jullie gemeen: jullie nemen iedere nieuwkomer op 
in de groep. Dank je wel dat ik daar onderdeel van mocht zijn en zonder jullie 
hulp was dit er nooit geweest. Tridia van der Laan en Mimount Enaimi dank je 
wel voor het delen van jullie kennis en ervaring. Arnout Mulder dank je wel voor 
alle  geïsoleerde DNAtjes, VNTR’s die je voor me hebt uitgevoerd en de glaasjes 
Casillero del Diablo. Rina de Zwaan, je bent echt altijd vrolijk en houdt onvoor-
waardelijk van Mycobacteriën, dank je wel dat je aan mijn zijde staat als paranimf. 
Miranda Kamst, dank je wel voor al je hulp maar nog meer voor wie je bent. Col-
lega en paranimf, maar nog belangrijker, een fantastische vriendin. We kunnen 
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samen lachen en huilen en hebben heel weinig nodig om elkaar te begrijpen. 
Samen met Erik en Marleen zijn jullie een topteam met heerlijke boerenkool...
Thanks to the European Centre for Disease Prevention and Control (ECDC) 
that initiated the project “molecular surveillance of multi- and extensively drug- 
resistant tuberculosis (MDR-/XDR-TB) transmission in the European Union (EU)”. 
And many thanks to all the European participants, your commitment and willing-
ness made this project a success. I enjoyed the personal contact by phone and 
email, but the yearly meetings were the best. Especially the one organized in 
Greece on the beautiful island of Crete. The city of Chania was wonderful, the 
weather was good, the meeting was very informative, but the time together was 
great. Great to have time to discuss on tuberculosis diagnostics, transmission and 
much more. Herre Heersma thank you very much for helping me organize this, it 
was not  possible without your Greek connections and enthusiasm. 
In addition to the participants of the ECDC project I want to thank all the par-
ticipants of the EQA from all over the world. Without your effort to perform the 
tests it was not possible to investigate the difficulties followed by the activities to 
improve the worldwide quality of molecular typing of Mycobacterium tuberculosis 
complex. 
De hele RIVM organisatie bedankt! Bij zoveel verschillende afdelingen heb ik 
leuke mensen ontmoet en mee mogen samenwerken. De postkamer, transport, 
inkoop, financiën en binnen het IDS, secretariaat, administratie en de verschil-
lende afdelingen waar mensen met zoveel enthousiasme diagnostiek en onder-
zoek uitvoeren. 
Adri van der Zanden, dank je wel. Door jou ben ik besmet geraakt met het 
enthousiasme voor het tuberculose beestje. Jij hebt me de kans gegeven verder 
te ontwikkelen, mijn Master opleiding te doen en het contact te leggen met het 
RIVM. 
Marion en Aafke, dank je wel, zonder jullie logeerkamers was het voor mij 
 onmogelijk om vanuit Hengelo bij het RIVM te werken. 
Schoonfamilie, ja je krijgt het er bij, maar ik heb echt geluk gehad. Hans, 
 Grieta, Arno, Tessa en de kids ...dank je wel dat jullie er altijd voor me zijn.
Heel veel dank gaat uit naar mijn ouders, uiteindelijk hebben jullie bijgedragen 
aan wie ik ben en hoe ik in het leven sta. Avonden lang heb ik mogen praten over 
hoe het gaat met mijn studie, werk en onderzoeken. Eindeloos heb ik jullie  mogen 
uitleggen over blokjes-, banden- en piekenpatronen. Dank je wel voor jullie steun 
en vertrouwen. Anika en Mart, dank voor jullie interesse in mijn onderzoek en 
voor jullie enthousiasme, ook al was het soms lastig te volgen waar ik het over 
had.
Lieve Arjan, we waren klasgenoten, collega’s, carpool maatjes en vrienden. 
Maar na al die jaren ben ik zo blij samen met je te zijn. Ondanks het feit dat het 
zonnetje niet altijd schijnt, doe je je uiterste best en genieten we. Lieve Eline, 
mijn mini-me, je hebt ons leven voor altijd veranderd en mooier gemaakt. Blijf 
altijd nieuwsgierig en een beetje eigenwijs.
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